var title_f16_2_16416="M mode mitral stenosis II";
var content_f16_2_16416=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F65631&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F65631&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mitral stenosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 261px; height: 189px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    M-mode echocardiogram of severe mitral stenosis shows concordant motion of anterior and posterior mitral valve (MV) leaflets which are thickened. The E-F slope is flat, resulting from very elevated left atrial pressure throughout diastole, suggesting a marked gradient across the mitral valve.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Provided by Thomas Binder, MD, et al. Interactive Echocardiography. A Clinical Atlas. Futura, 1997.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_2_16416=[""].join("\n");
var outline_f16_2_16416=null;
var title_f16_2_16417="Quadrivalent (A, C, Y, W-135) meningococcal conjugate vaccine: Patient drug information";
var content_f16_2_16417=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Quadrivalent (A, C, Y, W-135) meningococcal conjugate vaccine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/35/10807?source=see_link\">",
"     see \"Quadrivalent (A, C, Y, W-135) meningococcal conjugate vaccine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/3/36918?source=see_link\">",
"     see \"Quadrivalent (A, C, Y, W-135) meningococcal conjugate vaccine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F192572\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Menactra&reg;;",
"     </li>",
"     <li>",
"      Menveo&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F12592734\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Menactra&reg;;",
"     </li>",
"     <li>",
"      Menveo&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt adi-os drugH1Div\" id=\"F10030555\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     CDC Information",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Vaccine Information Statements (VIS) are made by the staff of the Centers for Disease Control and Prevention (CDC). Each VIS gives information to properly inform the adult receiving the vaccine or, in the case of a minor, the child's parent or legal representative about the risks and benefits of each vaccine. Before a doctor vaccinates a child or an adult, the provider is required by the National Childhood Vaccine Injury Act to give a copy of the VIS. You can also get foreign language versions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705997",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <a href=\"file://www.immunize.org/vis/vis_meningococcal.asp\" target=\"_blank\">",
"        Vaccine Information Statements (VIS)",
"       </a>",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11558 Version 29.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-183.166.191.243-B4DFEB0FC9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_2_16417=[""].join("\n");
var outline_f16_2_16417=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192572\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12592734\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030555\">",
"      CDC Information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?10/35/10807?source=related_link\">",
"      Quadrivalent (A, C, Y, W-135) meningococcal conjugate vaccine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/3/36918?source=related_link\">",
"      Quadrivalent (A, C, Y, W-135) meningococcal conjugate vaccine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_2_16418="Contents: General medicine";
var content_f16_2_16418=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?23/51/24382\">",
"       Adult Primary Care and Internal Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       General medicine",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			General medicine",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Breast disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/15/24825\">",
"           Breast masses and other common breast problems",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/33/8728\">",
"           Breast pain",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/23/3449\">",
"           Nipple discharge",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/52/11081\">",
"           Overview of benign breast disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/49/41754\">",
"           Screening for breast cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Complementary and alternative medicine",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/50/28457\">",
"           Acupuncture",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/8/27784\">",
"           Clinical use of St. John's wort",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/63/23542\">",
"           Clinical use of echinacea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/28/11720\">",
"           Clinical use of ginkgo biloba",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/18/33061\">",
"           Clinical use of saw palmetto",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/13/40154\">",
"           Complementary and alternative therapies for cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/2/25642\">",
"           Hepatotoxicity due to herbal medications and dietary supplements",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/49/6933\">",
"           Nephropathy induced by aristolochic acid (AA) containing herbs",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/4/20554\">",
"           Overview of herbal medicine and dietary supplements",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypertension",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/60/7113\">",
"           Ambulatory blood pressure monitoring and white coat hypertension in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/39/44659\">",
"           Antihypertensive drugs and lipids",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/57/13206\">",
"           Antihypertensive therapy and progression of chronic kidney disease: Experimental studies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/4/43080\">",
"           Blood pressure measurement in the diagnosis and management of hypertension in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/41/18068\">",
"           Can therapy be discontinued in well-controlled hypertension?",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/30/38375\">",
"           Cardiovascular effects of caffeine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/51/37685\">",
"           Cardiovascular risks of hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/47/20218\">",
"           Choice of therapy in essential hypertension: Clinical trials",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/29/36314\">",
"           Choice of therapy in primary (essential) hypertension: Recommendations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/55/36728\">",
"           Definition, risk factors, and evaluation of resistant hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/43/42679\">",
"           Diet in the treatment and prevention of hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/14/19685\">",
"           Differences between angiotensin converting enzyme inhibitors and receptor blockers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/26/18853\">",
"           Drug treatment of hypertensive emergencies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/63/3060\">",
"           Essential hypertension in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/17/31001\">",
"           Establishing the diagnosis of renovascular hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/59/2998\">",
"           Exercise in the treatment and prevention of hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/4/4169\">",
"           Hypertension: Who should be treated?",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/58/11174\">",
"           Hypertensive complications in blacks",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/26/422\">",
"           Initial evaluation of the hypertensive adult",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/12/32966\">",
"           Major side effects and safety of calcium channel blockers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/2/18473\">",
"           Major side effects of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/27/41398\">",
"           Malignant hypertension and hypertensive encephalopathy in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/37/28246\">",
"           Management of severe asymptomatic hypertension (hypertensive urgencies)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/52/34630\">",
"           Obesity and weight reduction in hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/36/32330\">",
"           Overview of hypertension in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/61/38874\">",
"           Overview of the risks and benefits of alcohol consumption",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/17/23828\">",
"           Patient adherence and the treatment of hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/40/44677\">",
"           Prehypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/40/25224\">",
"           Renin-angiotensin system inhibition in the treatment of hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/35/24120\">",
"           Salt intake, salt restriction, and essential hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/20/3395\">",
"           Smoking and hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/41/4755\">",
"           The prevalence and control of hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/46/13027\">",
"           Thiazides versus loop diuretics in treatment of hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/54/8040\">",
"           Treatment of bilateral atherosclerotic renal artery stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/14/15592\">",
"           Treatment of hypertension in blacks",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/45/21210\">",
"           Treatment of hypertension in patients with diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/27/25018\">",
"           Treatment of hypertension in the elderly patient, particularly isolated systolic hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/27/35256\">",
"           Treatment of resistant hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/11/18614\">",
"           Treatment of specific hypertensive emergencies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/43/29369\">",
"           Treatment of unilateral atherosclerotic renal artery stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/40/33417\">",
"           What is goal blood pressure in the treatment of hypertension?",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/21/27991\">",
"           Who should be evaluated for renovascular or other causes of secondary hypertension?",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/50/1827\">",
"           Withdrawal syndromes with antihypertensive therapy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Medical consultation",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/35/12858\">",
"           Assessing surgical risk in patients with liver disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/27/40378\">",
"           Carotid endarterectomy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/8/1162\">",
"           Evaluation of preoperative pulmonary risk",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/13/15577\">",
"           Identification and management of alcohol use disorders in the perioperative period",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/50/35626\">",
"           Management of anticoagulation before and after elective surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/55/39800\">",
"           Overview of preoperative evaluation and preparation for gynecologic surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/43/32439\">",
"           Preoperative assessment of hemostasis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/35/15929\">",
"           Preoperative evaluation and perioperative management of patients with rheumatic diseases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/2/15400\">",
"           Preoperative evaluation for lung resection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/51/13113\">",
"           Strategies to reduce postoperative pulmonary complications",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Miscellaneous",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/23/19831\">",
"           A patient-centered view of the clinician-patient relationship",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/30/26087\">",
"           A short primer on cost-effectiveness analysis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/42/38569\">",
"           Acute phase reactants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/39/12922\">",
"           Adult lead poisoning",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/41/1690\">",
"           Approach to the adult with epistaxis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/58/12200\">",
"           Approach to the patient",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/10/24745\">",
"           Approach to the patient with eosinophilia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/33/8730\">",
"           Arsenic exposure and poisoning",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/20/8521\">",
"           Chemical terrorism: Diagnosis and treatment of exposure to chemical weapons",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/19/17720\">",
"           Chronic prostatitis/chronic pelvic pain syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/37/31321\">",
"           Classification, clinical features and diagnosis of inguinal and femoral hernias in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/46/37610\">",
"           Clinical care of incarcerated adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/6/30825\">",
"           Clinical features and diagnosis of chronic fatigue syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/53/36696\">",
"           Clinical manifestations and diagnostic evaluation of benign prostatic hyperplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/24/30090\">",
"           Clinical manifestations, pathophysiology, and diagnosis of the hypereosinophilic syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/35/20024\">",
"           Clinical practice guidelines",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/6/35940\">",
"           Coccydynia (coccygodynia)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/14/15591\">",
"           Commercial driver's license examination",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/16/18696\">",
"           Community violence",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/61/24537\">",
"           Cross-cultural care and communication",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/60/22471\">",
"           Decision analysis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/29/28120\">",
"           Diagnostic imaging procedures during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/21/22873\">",
"           Disability assessment and determination in the United States",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/25/2456\">",
"           Drug fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/35/9784\">",
"           Easy bruising",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/2/23593\">",
"           Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/63/44023\">",
"           Eating disorders: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/19/4410\">",
"           Environmental electrical injuries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/19/34104\">",
"           Epidemiology and pathogenesis of benign prostatic hyperplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/4/15431\">",
"           Etiologies of fever of unknown origin in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/12/24778\">",
"           Euthanasia and physician assisted suicide",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/52/10054\">",
"           Evaluating diagnostic tests",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/7/20601\">",
"           Evaluation and management of adult sexual assault victims",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/22/14694\">",
"           Evidence-based medicine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/35/16952\">",
"           Full body CT scan for screening",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/18/22823\">",
"           Glossary of common biostatistical and epidemiological terms",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/4/41029\">",
"           Guide to health information resources for patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/9/44185\">",
"           Health care of homeless persons",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/2/12330\">",
"           Hospital discharge",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/52/37703\">",
"           Hyperventilation syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/27/16823\">",
"           Information and educational resources for occupational and environmental health issues in the United States",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/15/6393\">",
"           Intimate partner violence: Diagnosis and screening",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/41/5784\">",
"           Intimate partner violence: Epidemiology and health consequences",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/54/14183\">",
"           Intimate partner violence: Intervention and patient management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/0/43016\">",
"           Jellyfish stings",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/1/35861\">",
"           Jet lag",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/12/17609\">",
"           Literacy and patient care",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/58/13224\">",
"           Management of Down syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/61/20441\">",
"           Management of moderate and severe alcohol withdrawal syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/49/37657\">",
"           Measuring quality in hospitals in the United States: Core process measures",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/15/10484\">",
"           Medicaid",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/5/28762\">",
"           Medical care of the returning veteran",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/47/26362\">",
"           Medical management of patients after bariatric surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/31/8698\">",
"           Medical treatment of benign prostatic hyperplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/6/24679\">",
"           Medicare",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/14/39142\">",
"           Osteitis pubis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/49/43801\">",
"           Overview of abdominal hernias",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/13/14553\">",
"           Overview of occupational and environmental health",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/46/28394\">",
"           Overview of the benefits and risks of exercise",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/20/29000\">",
"           Overview of treatment for inguinal and femoral hernias",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/14/22760\">",
"           Pathologic gambling",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/26/13737\">",
"           Patient assessment for air travel",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/3/8249\">",
"           Patient-centered interviewing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/26/12713\">",
"           Primary care of the adult with intellectual disability (mental retardation)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/19/8500\">",
"           Proof, p-values, and hypothesis testing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/36/32326\">",
"           Social Security Disability Insurance and workers' compensation in the United States",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/57/20373\">",
"           Sports-related groin pain or 'sports hernia'",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/7/40056\">",
"           Surgical and other invasive therapies of benign prostatic hyperplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/43/39609\">",
"           Systematic review and meta-analysis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/9/35993\">",
"           Tattooing in adolescents and adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/27/23992\">",
"           The difficult patient encounter",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/21/4440\">",
"           Treatment of chronic fatigue syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/38/37479\">",
"           Treatment of minor thermal burns",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Nutrition and vitamins",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/35/2617\">",
"           Approach to the patient with weight loss",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/40/23175\">",
"           Dietary and nutritional assessment in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/47/38649\">",
"           Dietary carbohydrates",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/34/2601\">",
"           Dietary fat",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/12/31946\">",
"           Geriatric nutrition: Nutritional issues in older adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/57/31641\">",
"           Healthy diet in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/53/26456\">",
"           Nutritional antioxidants in coronary heart disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/19/39226\">",
"           Overview of dietary trace minerals",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/37/19034\">",
"           Overview of homocysteine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/14/21736\">",
"           Overview of vitamin A",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/62/28650\">",
"           Overview of water-soluble vitamins",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/46/36586\">",
"           Vitamin supplementation in disease prevention",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Obesity",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/9/8345\">",
"           Dietary therapy for obesity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/4/33866\">",
"           Drug therapy of obesity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/21/3418\">",
"           Etiology and natural history of obesity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/35/30266\">",
"           Health hazards associated with obesity in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/45/13016\">",
"           Overview of therapy for obesity in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/38/13929\">",
"           Pathogenesis of obesity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/41/21144\">",
"           Role of physical activity and exercise in obese adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/20/12615\">",
"           Screening for and clinical evaluation of obesity in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/31/33274\">",
"           Surgical management of severe obesity",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Substance abuse",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/28/12744\">",
"           Internal concealment of drugs of abuse (body packing)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/61/20441\">",
"           Management of moderate and severe alcohol withdrawal syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/51/3897\">",
"           Opioid intoxication in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/5/28758\">",
"           Opioid withdrawal in the emergency setting",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Substance use disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/33/31258\">",
"           Cardiovascular benefits and risks of moderate alcohol consumption",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/39/39545\">",
"           Evaluation and management of the cardiovascular complications of cocaine abuse",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/44/3784\">",
"           Opioid abuse and dependence: Overview and patient evaluation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/61/38874\">",
"           Overview of the risks and benefits of alcohol consumption",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/35/21050\">",
"           Use of androgens and other hormones to enhance athletic performance",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Symptoms",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/44/21194\">",
"           Acute treatment of migraine in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/35/12857\">",
"           Approach to flushing in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/36/23111\">",
"           Approach to the adult patient with fatigue",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/11/31927\">",
"           Approach to the adult with fever of unknown origin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/47/16120\">",
"           Approach to the adult with nausea and vomiting",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/10/18601\">",
"           Approach to the diagnosis and evaluation of low back pain in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/48/15110\">",
"           Approach to the patient with anal pruritus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/43/23223\">",
"           Approach to the patient with dizziness",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/4/27720\">",
"           Approach to the patient with dyspepsia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/4/26694\">",
"           Approach to the patient with muscle weakness",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/23/2424\">",
"           Approach to the patient with myalgia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/14/17641\">",
"           Approach to the patient with night sweats",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/8/31879\">",
"           Approach to the patient with sensory loss",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/19/32057\">",
"           Approach to the patient with vertigo",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/36/34375\">",
"           Clinical manifestations and diagnosis of edema in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/59/16312\">",
"           Definition and pathogenesis of chronic pain",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/15/34042\">",
"           Diagnostic approach to chest pain in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/30/16874\">",
"           Differential diagnosis of abdominal pain in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/0/26634\">",
"           Differential diagnosis of chest pain in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/24/14727\">",
"           Etiology and evaluation of hemoptysis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/22/40296\">",
"           Evaluation of chronic pain in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/51/5942\">",
"           Evaluation of nonacute scrotal pathology in adult men",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/18/5418\">",
"           Evaluation of subacute and chronic cough in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/20/44360\">",
"           Evaluation of the acute scrotum in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/12/17607\">",
"           Evaluation of the red eye",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/34/3624\">",
"           Headache syndromes other than migraine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/10/22694\">",
"           Hematospermia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/24/29060\">",
"           Muscle examination in the evaluation of weakness",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/41/21146\">",
"           Overview of cancer pain syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/36/22087\">",
"           Overview of hiccups",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/41/4758\">",
"           Overview of insomnia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/11/20665\">",
"           Overview of palpitations in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/49/42778\">",
"           Overview of the treatment of chronic pain",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/4/26698\">",
"           Pathophysiology, clinical manifestations, and diagnosis of migraine in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/60/39879\">",
"           Primary dysmenorrhea in adult women: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/54/10090\">",
"           Pruritus: Etiology and patient evaluation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/58/6058\">",
"           Pruritus: Overview of management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/62/13290\">",
"           Treatment of insomnia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/62/4071\">",
"           Treatment of narcolepsy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/36/28233\">",
"           Treatment of primary dysmenorrhea in adult women",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Venous insufficiency",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/17/13592\">",
"           Clinical evaluation of lower extremity chronic venous disease",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-57CCAE7680-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f16_2_16418=[""].join("\n");
var outline_f16_2_16418=null;
var title_f16_2_16419="Patient information: Avoiding asthma triggers (The Basics)";
var content_f16_2_16419=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16111\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_table\" href=\"UTD.htm?6/14/6380\">",
"         Tips for avoiding dust mites in your home",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_table\" href=\"UTD.htm?18/57/19355\">",
"          Tips for avoiding animal allergens (urine, saliva, or dander) in your home",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?4/11/4275\">",
"         Patient information: Asthma in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?16/58/17315\">",
"         Patient information: Asthma in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?12/52/13122\">",
"         Patient information: How to use your child&rsquo;s dry powder inhaler (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?33/4/33858\">",
"         Patient information: How to use your child&rsquo;s metered dose inhaler (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?9/47/9970\">",
"         Patient information: How to use your dry powder inhaler (adults) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?40/34/41506\">",
"         Patient information: How to use your metered dose inhaler (adults) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?29/43/30386\">",
"         Patient information: Inhalers (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?29/22/30052\">",
"         Patient information: Medicines for asthma (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?36/38/37474\">",
"         Patient information: Seasonal allergies in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?13/10/13475\">",
"         Patient information: Seasonal allergies in children (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?38/63/39925\">",
"         Patient information: Asthma treatment in adolescents and adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?17/60/18374\">",
"         Patient information: Asthma treatment in children (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?30/25/31124\">",
"         Patient information: Trigger avoidance in asthma (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Avoiding asthma triggers (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/avoiding-asthma-triggers-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H14324418\">",
"      <span class=\"h1\">",
"       What are asthma triggers?",
"      </span>",
"      &nbsp;&mdash;&nbsp;An asthma trigger is anything that causes asthma symptoms or makes asthma symptoms worse. It&rsquo;s important to know what your asthma triggers are. That way, you can avoid them so that your symptoms don&rsquo;t get worse.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14324425\">",
"      <span class=\"h1\">",
"       What are some common asthma triggers?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Common asthma triggers are:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Cigarette smoke",
"       </li>",
"       <li>",
"        Stress",
"       </li>",
"       <li>",
"        Getting sick with a cold, the flu, or a lung, ear, or sinus infection",
"       </li>",
"       <li>",
"        Strong cleaning products, such as bleach",
"       </li>",
"       <li>",
"        Strong perfumes or scents",
"       </li>",
"       <li>",
"        Air pollution",
"       </li>",
"       <li>",
"        Certain medicines, such as",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?6/12/6342?source=see_link\">",
"         aspirin",
"        </a>",
"        and other medicines for pain or fever",
"       </li>",
"       <li>",
"        Exercise",
"       </li>",
"       <li>",
"        Very cold and dry air",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      People can have other triggers, too. These include things in the environment that they are allergic to. These are called &ldquo;allergic triggers.&rdquo; Examples of allergic triggers are:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Dust mites &mdash; These are tiny bugs that are too small for you to see. They live in beds, couches, carpets, and other places in your home.",
"       </li>",
"       <li>",
"        Mold &mdash; Mold can grow in basements, showers, and other damp and wet places.",
"       </li>",
"       <li>",
"        Dogs and cats &mdash; People can be allergic to animal saliva, urine, or dander (flakes of dead skin).",
"       </li>",
"       <li>",
"        Pollen from trees, grass, and weeds",
"       </li>",
"       <li>",
"        Cockroach droppings",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14324432\">",
"      <span class=\"h1\">",
"       How do I know what my asthma triggers are?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You might already know what makes your asthma symptoms worse. But if you don&rsquo;t, talk with your doctor or nurse. He or she can help you figure it out by talking with you and asking you questions.",
"     </p>",
"     <p>",
"      Your doctor might do allergy tests to see if you have allergic triggers. Allergy tests include blood tests or skin tests. During a skin test, a doctor puts a drop of a substance that you might be allergic to on your skin, and makes a tiny needle prick in the skin. Then, he or she watches your skin to see if it turns red and bumpy.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14324439\">",
"      <span class=\"h1\">",
"       What should I do when I find out what my triggers are?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The best thing to do is to stay away from your triggers. For example, if cigarette smoke makes your asthma symptoms worse, avoid people who are smoking. Here are other things that you can do:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        To avoid getting sick with an infection, wash your hands often. You can also get a flu shot every year so that you don&rsquo;t get the flu.",
"       </li>",
"       <li>",
"        To avoid air pollution, stay indoors when air pollution levels are high, and don&rsquo;t exercise near a busy road",
"       </li>",
"       <li>",
"        On winter days when the air is cold and dry, cover your mouth and nose with a scarf",
"       </li>",
"       <li>",
"        Avoid using bleach and other strong cleaners",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If you have allergic triggers, try to avoid the things you are allergic to:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        To avoid dust mites, cover your pillows and mattresses with special covers that keep dust mites away, and remove carpets from the bedroom. For more tips, see the table (",
"        <a class=\"graphic graphic_table graphicRef79168 \" href=\"UTD.htm?6/14/6380\">",
"         table 1",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        To avoid mold, clean away any mold that you see in your home. To keep mold from growing, use a dehumidifier, fix leaky plumbing, and remove carpets that were damaged by water.",
"       </li>",
"       <li>",
"        To avoid animal saliva, urine, or dander, you can remove the pet from your home and clean your home after the animal has gone. For more tips, see the table (",
"        <a class=\"graphic graphic_table graphicRef58126 \" href=\"UTD.htm?18/57/19355\">",
"         table 2",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        To keep cockroaches away, don&rsquo;t let garbage or dirty dishes pile up. If you have cockroaches, use traps to kill them.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14324446\">",
"      <span class=\"h1\">",
"       What if I can&rsquo;t avoid my triggers?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you can&rsquo;t avoid your triggers, talk with your doctor or nurse about what you can do.",
"     </p>",
"     <p>",
"      Exercise is an example of a trigger that you should not avoid, because exercise keeps you healthy. To prevent asthma symptoms when you exercise:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Take an extra dose of your quick-relief inhaler medicine before you exercise",
"       </li>",
"       <li>",
"        Warm up slowly before each exercise session",
"       </li>",
"       <li>",
"        Avoid exercising outdoors if it is very cold out",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14324453\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?4/11/4275?source=see_link\">",
"       Patient information: Asthma in adults (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?16/58/17315?source=see_link\">",
"       Patient information: Asthma in children (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/38/37474?source=see_link\">",
"       Patient information: Seasonal allergies in adults (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?29/43/30386?source=see_link\">",
"       Patient information: Inhalers (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?40/34/41506?source=see_link\">",
"       Patient information: How to use your metered dose inhaler (adults) (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?9/47/9970?source=see_link\">",
"       Patient information: How to use your dry powder inhaler (adults) (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/4/33858?source=see_link\">",
"       Patient information: How to use your child&rsquo;s metered dose inhaler (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?12/52/13122?source=see_link\">",
"       Patient information: How to use your child&rsquo;s dry powder inhaler (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?29/22/30052?source=see_link\">",
"       Patient information: Medicines for asthma (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?13/10/13475?source=see_link\">",
"       Patient information: Seasonal allergies in children (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?30/25/31124?source=see_link\">",
"       Patient information: Trigger avoidance in asthma (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?38/63/39925?source=see_link\">",
"       Patient information: Asthma treatment in adolescents and adults (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?17/60/18374?source=see_link\">",
"       Patient information: Asthma treatment in children (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?16/2/16419?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16111 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-91.202.164.29-18C9BB78CB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_2_16419=[""].join("\n");
var outline_f16_2_16419=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14324418\">",
"      What are asthma triggers?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14324425\">",
"      What are some common asthma triggers?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14324432\">",
"      How do I know what my asthma triggers are?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14324439\">",
"      What should I do when I find out what my triggers are?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14324446\">",
"      What if I can&rsquo;t avoid my triggers?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14324453\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16111\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/14/6380\">",
"      Tips for avoiding dust mites in your home",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_table\" href=\"UTD.htm?18/57/19355\">",
"       Tips for avoiding animal allergens (urine, saliva, or dander) in your home",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/11/4275?source=related_link\">",
"      Patient information: Asthma in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/58/17315?source=related_link\">",
"      Patient information: Asthma in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/63/39925?source=related_link\">",
"      Patient information: Asthma treatment in adolescents and adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?17/60/18374?source=related_link\">",
"      Patient information: Asthma treatment in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?12/52/13122?source=related_link\">",
"      Patient information: How to use your child&rsquo;s dry powder inhaler (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/4/33858?source=related_link\">",
"      Patient information: How to use your child&rsquo;s metered dose inhaler (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/47/9970?source=related_link\">",
"      Patient information: How to use your dry powder inhaler (adults) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/34/41506?source=related_link\">",
"      Patient information: How to use your metered dose inhaler (adults) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/43/30386?source=related_link\">",
"      Patient information: Inhalers (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/22/30052?source=related_link\">",
"      Patient information: Medicines for asthma (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/38/37474?source=related_link\">",
"      Patient information: Seasonal allergies in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/10/13475?source=related_link\">",
"      Patient information: Seasonal allergies in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/25/31124?source=related_link\">",
"      Patient information: Trigger avoidance in asthma (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_2_16420="Left posterior fascicular block";
var content_f16_2_16420=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Left posterior fascicular block",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/2/16420/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/2/16420/contributors\">",
"     William H Sauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/2/16420/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/2/16420/contributors\">",
"     Ary L Goldberger, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/2/16420/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/2/16420/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/2/16420/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the discussion that follows, it is assumed that the reader understands the general concepts of cardiac vectors, asynchronous activation of the ventricles (delayed as in fascicular or bundle branch block, or early as in preexcitation), and the effects that asynchrony has on the duration, morphology and amplitude of the QRS complex. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/4/9283?source=see_link\">",
"     \"ECG tutorial: Physiology of the conduction system\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/61/13271?source=see_link\">",
"     \"General principles of asynchronous activation and preexcitation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     FASCICLES OF THE LEFT BUNDLE BRANCH",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classic hypothesis proposed by Rosenbaum and his coworkers was that the left bundle branch divides into two fascicles of rapidly conducting Purkinje fibers (ie, phase 0 dependent on the rapid inward sodium current) (",
"    <a class=\"graphic graphic_figure graphicRef63340 \" href=\"UTD.htm?42/52/43841\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16420/abstract/1\">",
"     1",
"    </a>",
"    ]. These fascicles primarily affect the",
"    <strong>",
"     direction",
"    </strong>",
"    of depolarization:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The left anterior fascicle crosses the left ventricular outflow tract and terminates in the Purkinje system of the anterolateral wall of the left ventricle.",
"     </li>",
"     <li>",
"      The left posterior fascicle appears as an extension of the main bundle and fans out extensively posteriorly toward the papillary muscle and inferoposteriorly to the free wall of the left ventricle.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, a third fascicle, called the left septal or median fascicle, is found in nearly 65 percent of people [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16420/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. This fascicle runs to the interventricular septum, and can arise from the common left bundle or from the anterior, posterior or both fascicles.",
"   </p>",
"   <p>",
"    Support for the trifascicular nature of the left bundle comes from the observations in animals and humans that depolarization of the left ventricle begins in three areas corresponding to the terminal portions of the anterior, posterior and septal fascicles [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16420/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. In the normal heart, the three fascicles of the left bundle are simultaneously depolarized.",
"   </p>",
"   <p>",
"    Further evidence of simultaneous activation of the fascicles can be found with routine electroanatomical mapping of a structurally normal heart. Using a catheter to record sharp Purkinje potentials seen after the activation of the His bundle but before the QRS complex, a 3-dimensional reconstruction of the heart with location of the fascicles can be created (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/23/39289?source=see_link\">",
"     \"Electrophysiologic cardiac mapping: Techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is a large amount of individual variability in the size and distribution of the left fascicles. The left bundle may initially branch into two or three initial branches, but these branches further fan out and intersect with each other. This is the basis for fascicular ventricular tachycardia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/14/26858?source=see_link\">",
"     \"Monomorphic ventricular tachycardia in the absence of apparent structural heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In dissections of twenty consecutive cadaveric hearts, there was no discrete pattern of left ventricular fascicle distribution noted [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16420/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Blood supply",
"    </span>",
"    &nbsp;&mdash;&nbsp;The proximal part of the left posterior fascicle is supplied by the artery to the atrioventricular (AV) node and, at times, by septal branches of the left anterior descending (LAD) artery. The distal portion has a dual blood supply from both anterior and posterior septal perforating arteries. The left anterior and median fascicles are supplied either by septal branches of the LAD or by the AV nodal artery (",
"    <a class=\"graphic graphic_figure graphicRef70956 \" href=\"UTD.htm?21/44/22213\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ELECTROCARDIOGRAM IN LEFT POSTERIOR FASCICULAR BLOCK (LEFT POSTERIOR HEMIBLOCK)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anterior and posterior fascicular blocks mainly affect the direction but not the duration of the QRS complex, because the conduction disturbance primarily involves the early phases of activation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/31/16886?source=see_link\">",
"     \"Left anterior fascicular block\"",
"    </a>",
"    .) The electrocardiographic criteria for left posterior fascicular block (LPFB, or left posterior hemiblock) are depicted the ECG (",
"    <a class=\"graphic graphic_waveform graphicRef51923 \" href=\"UTD.htm?31/60/32705\">",
"     waveform 1",
"    </a>",
"    ). The changes that are seen reflect alterations in the different phases of activation.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Early activation &mdash; Early activation by the normally conducting anterior and septal fascicles causes the initial vector to be directed to the left, anteriorly, and superiorly producing initial small r waves in leads I, V1, and V6.",
"     </li>",
"     <li>",
"      Mid-temporal and terminal activation &mdash; The mid-temporal and terminal vectors in LPFB are directed to the right, posteriorly, and inferiorly due to delayed depolarization of the areas normally activated by the left posterior fascicle. This leads to the characteristic",
"      <strong>",
"       rightward axis",
"      </strong>",
"      of +90&ordm; to +180&ordm; [",
"      <a class=\"abstract\" href=\"UTD.htm?16/2/16420/abstract/6\">",
"       6",
"      </a>",
"      ]. As a result, there is a qR morphology in leads II, III, aVF and an rS morphology in leads I and aVL.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The QRS duration usually does not exceed 0.10 sec (100 msec), although the",
"    <span class=\"nowrap\">",
"     WHO/ISFC",
"    </span>",
"    Task Force allows up to 0.12 sec or 0.02 sec above the previous baseline [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16420/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10728456\">",
"    <span class=\"h2\">",
"     Definition",
"    </span>",
"    &nbsp;&mdash;&nbsp;A task force from the American Heart Association, the American College of Cardiology and the Heart Rhythm Society has defined the electrocardiographic features of LPFB. These criteria incorporate the activation forces described above and include [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16420/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Frontal plane axis between 90&deg; and 180&deg; in adults",
"     </li>",
"     <li>",
"      rS pattern in leads I and aVL",
"     </li>",
"     <li>",
"      qR pattern in leads III and aVF",
"     </li>",
"     <li>",
"      QRS duration less than 120 ms.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Diagnostic problems",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of settings which may produce ECG findings similar to LPFB.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The above criteria apply only in the absence of other causes for a rightward axis, such as right ventricular hypertrophy due to valvular heart disease or lung disease with cor pulmonale.",
"     </li>",
"     <li>",
"      A high lateral or anterolateral myocardial infarction (MI) can mimic LPFB. With an infarct, however, the initial r wave in leads 1 and aVL is absent and only a Q wave is seen.",
"     </li>",
"     <li>",
"      The presence of right bundle branch block (RBBB) might suggest right axis deviation because of the deep terminal S wave in leads 1, aVL and V5, and V6. However, these S waves reflect delayed right ventricular activation, not left ventricular forces. An additional potential source of confusion is that RBBB can occur in association with LPFB (",
"      <a class=\"graphic graphic_table graphicRef71386 \" href=\"UTD.htm?13/61/14299\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The small q waves in the inferior leads in LPFB may cause confusion with an inferior wall MI.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL CONSIDERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The left posterior fascicle branch is the first branch of the left bundle and is large in its initial course. It then fans extensively throughout the posterior and inferior left ventricle. The left posterior fascicle is exposed to lower pressures and less turbulence than the left anterior fascicle; it also has a dual blood supply. These characteristics probably explain why isolated LPFB is an uncommon finding.",
"   </p>",
"   <p>",
"    Isolated LPFB can, however, be seen in the setting of extensive arteriosclerotic cardiovascular disease, as an association with inferior MI and extensive coronary disease has been suggested [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16420/abstract/8\">",
"     8",
"    </a>",
"    ]. LPFB can also occur with cardiomyopathies, including those which result from hypertension and Chagas disease, myocarditis, hyperkalemia, acute cor pulmonale, and chronic degenerative and fibrotic processes of the conducting system. Transient LPFB is quite rare, but also suggests extensive coronary artery disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16420/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On occasion, left posterior fascicular block may appear after linear radiofrequency lesions have been delivered to the inferior mid-septum to control ventricular tachycardia not amenable to standard mapping ablation strategies [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16420/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no symptoms induced by an isolated block in one of the left bundle fascicles. Therapy should be considered only in patients with persistent bifascicular or trifascicular block. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/62/12261?source=see_link\">",
"     \"Course and treatment of chronic bifascicular block\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10728511\">",
"    <span class=\"h2\">",
"     Neuromuscular diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of neuromuscular diseases are associated with fascicular block. These include myotonic muscular dystrophy, Kearns-Sayre syndrome, Erb's dystrophy (limb-girdle), and peroneal muscular atrophy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1351?source=see_link\">",
"     \"Inherited syndromes associated with cardiac disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These patients represent a special class and are treated more aggressively with pacemakers due to the potential for unpredictably rapid progression of conduction disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=see_link&amp;anchor=H23#H23\">",
"     \"Indications for permanent cardiac pacing\", section on 'Neuromuscular diseases'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H76096846\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The bundle of His divides into left anterior and right posterior fascicles, and in 65 percent of cases a third fascicle, called the left septal or median fascicle. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Left posterior fascicular block (LPFB) has the following electrocardiographic characteristics (see",
"      <a class=\"local\" href=\"#H10728456\">",
"       'Definition'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Frontal plane axis between 90&deg; and 180&deg; in adults (in the absence of other factors known to cause a rightward QRS axis)",
"     </li>",
"     <li>",
"      rS pattern in leads I and aVL",
"     </li>",
"     <li>",
"      qR pattern in leads III and aVF",
"     </li>",
"     <li>",
"      QRS duration less than 120 ms.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diagnosis of LPFB may be difficult in patients with a high lateral or anterolateral myocardial infarction or the presence of right bundle branch block. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnostic problems'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      LPFB is an uncommon finding. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical considerations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are no symptoms induced by an isolated block in one of the left bundle fascicles. Therapy should be considered only in patients with persistent bifascicular or trifascicular block. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Rosenbaum M, Elizari MV, Lazzari JO. The Hemiblocks. Tampa Tracings, Tampa 1970.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16420/abstract/2\">",
"      Demoulin JC, Kulbertus HE. Histopathological examination of concept of left hemiblock. Br Heart J 1972; 34:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16420/abstract/3\">",
"      Uhley HN. Some controversy regarding the peripheral distribution of the conduction system. Am J Cardiol 1972; 30:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16420/abstract/4\">",
"      Myerburg RJ, Nilsson K, Gelband H. Physiology of canine intraventricular conduction and endocardial excitation. Circ Res 1972; 30:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16420/abstract/5\">",
"      Durrer D, van Dam RT, Freud GE, et al. Total excitation of the isolated human heart. Circulation 1970; 41:899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16420/abstract/6\">",
"      Willems JL, Robles de Medina EO, Bernard R, et al. Criteria for intraventricular conduction disturbances and pre-excitation. World Health Organizational/International Society and Federation for Cardiology Task Force Ad Hoc. J Am Coll Cardiol 1985; 5:1261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16420/abstract/7\">",
"      Surawicz B, Childers R, Deal BJ, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 2009; 53:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16420/abstract/8\">",
"      Godat FJ, Gertsch M. Isolated left posterior fascicular block: a reliable marker for inferior myocardial infarction and associated severe coronary artery disease. Clin Cardiol 1993; 16:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16420/abstract/9\">",
"      Madias JE, Knez P. Transient left posterior hemiblock during myocardial ischemia-eliciting exercise treadmill testing: a report of a case and a critical analysis of the literature. J Electrocardiol 1999; 32:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16420/abstract/10\">",
"      Lin D, Hsia HH, Gerstenfeld EP, et al. Idiopathic fascicular left ventricular tachycardia: linear ablation lesion strategy for noninducible or nonsustained tachycardia. Heart Rhythm 2005; 2:934.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2107 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.247-458F631DC3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_2_16420=[""].join("\n");
var outline_f16_2_16420=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H76096846\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      FASCICLES OF THE LEFT BUNDLE BRANCH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Blood supply",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ELECTROCARDIOGRAM IN LEFT POSTERIOR FASCICULAR BLOCK (LEFT POSTERIOR HEMIBLOCK)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10728456\">",
"      Definition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Diagnostic problems",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10728511\">",
"      Neuromuscular diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H76096846\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/2107\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/2107|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/52/43841\" title=\"figure 1\">",
"      Normal conduction system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/44/22213\" title=\"figure 2\">",
"      Coronary artery anatomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/2107|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/61/14299\" title=\"table 1\">",
"      Major causes of right axis deviation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/2107|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?31/60/32705\" title=\"waveform 1\">",
"      Left posterior fascicular block",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/62/12261?source=related_link\">",
"      Course and treatment of chronic bifascicular block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/4/9283?source=related_link\">",
"      ECG tutorial: Physiology of the conduction system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/23/39289?source=related_link\">",
"      Electrophysiologic cardiac mapping: Techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/61/13271?source=related_link\">",
"      General principles of asynchronous activation and preexcitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=related_link\">",
"      Indications for permanent cardiac pacing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1351?source=related_link\">",
"      Inherited syndromes associated with cardiac disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/31/16886?source=related_link\">",
"      Left anterior fascicular block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/14/26858?source=related_link\">",
"      Monomorphic ventricular tachycardia in the absence of apparent structural heart disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_2_16421="General travel advice";
var content_f16_2_16421=[" <h1 id=\"patTopicTitle\">",
"  Patient information: General travel advice (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?16/2/16421/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/2/16421/contributors\" id=\"au6247\">",
"       Peter F Weller, MD, FACP",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?16/2/16421/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/2/16421/contributors\" id=\"se4537\">",
"       Karin Leder, MBBS, FRACP, PhD, MPH, DTMH",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?16/2/16421/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/2/16421/contributors\" id=\"de1811\">",
"       Elinor L Baron, MD, DTMH",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?16/2/16421?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      TRAVEL AND HEALTH OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     More individuals are traveling internationally now than ever before. International travel can lead to wonderful new experiences and lasting memories. Unfortunately, travel can also lead to health problems that range in severity from unpleasant to life threatening.",
"    </p>",
"    <p>",
"     Travel-related health problems arise from a variety of factors, including exposure to infectious organisms, the use of certain types of transportation, and participation in certain activities, such as diving and high-altitude hiking during travel. Travel-related health problems can also arise when a preexisting medical condition worsens during travel.",
"    </p>",
"    <p>",
"     Fortunately, most travel-related health problems can be prevented with a combination of pre-travel planning, immunizations, and safety precautions during travel. If you are planning travel outside of your home country, consult your healthcare provider at least one month prior to traveling. The provider can give immunizations, travel medications, and tips for staying healthy during the trip, or may recommend a specialized travel medicine provider for some or all of these immunizations, medications, and advice.",
"    </p>",
"    <p>",
"     A general overview of advice related to travel and health will be reviewed here. Immunizations for travel are discussed separately. (See",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/44/21187?source=see_link\">",
"      \"Patient information: Vaccines for travel (The Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      PRE-TRAVEL EVALUATION",
"     </span>",
"    </p>",
"    <p>",
"     Individuals planning international travel should visit their healthcare provider",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     specialized travel medicine clinic. The visit provides an opportunity to discuss the specific details of travel. This information is necessary to formulate individualized travel-related medical advice:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Duration of travel",
"      </li>",
"      <li>",
"       Season of travel",
"      </li>",
"      <li>",
"       Countries and regions that will be visited",
"      </li>",
"      <li>",
"       Planned activities during travel",
"      </li>",
"      <li>",
"       Place of residence during travel (for example, a modern hotel, rural home, campground)",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      TRAVEL-RELATED MEDICAL ADVICE",
"     </span>",
"    </p>",
"    <p>",
"     Once a clinician has assessed your travel plans and overall health, he or she can provide information about the health risks that could be encountered and can give advice for minimizing these risks.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Vaccines",
"     </span>",
"     &nbsp;&mdash;&nbsp;Vaccines recommended for travel are discussed in detail in a separate topic review. (See",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/44/21187?source=see_link\">",
"      \"Patient information: Vaccines for travel (The Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Food and water precautions",
"     </span>",
"     &nbsp;&mdash;&nbsp;Several infections can be acquired by ingesting contaminated food and water, including infectious diarrhea (travelers' diarrhea), hepatitis A, typhoid fever, and, less commonly, trichinellosis. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/30/29156?source=see_link\">",
"      \"Patient information: Food poisoning (food-borne illness) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     In areas where sanitation and personal hygiene are poor, food and water precautions are essential for reducing the risk of these infections. These precautions will be most effective when they are used on a daily basis.",
"    </p>",
"    <p>",
"     Tap water that looks safe to drink can carry infection-causing organisms, but boiling the water for three minutes, followed by cooling, can kill these organisms. Alternatively, a number of filtration devices or chemical disinfection agents (eg, iodine or chlorine tablets) can be used.",
"    </p>",
"    <p>",
"     Travelers can reduce the risk of infection by using the following precautions:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Do not drink or brush the teeth with unboiled tap water",
"      </li>",
"      <li>",
"       Do not drink beverages that contain ice made from unboiled tap water",
"      </li>",
"      <li>",
"       Drink only boiled tap water, drinks made from boiled tap water, carbonated beverages, beer, and wine",
"      </li>",
"      <li>",
"       Be wary of locally bottled water, because safety and bottling conditions might not be adequate. Other drinks are probably safer.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Food can also contain infection-causing organisms. Reduce the risk of infection by following several food precautions:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Do not eat unpeeled fruit. Peel any fruit yourself before eating it.",
"      </li>",
"      <li>",
"       Do not eat raw vegetables",
"      </li>",
"      <li>",
"       Do not eat or drink unpasteurized (\"raw\") dairy products",
"      </li>",
"      <li>",
"       Do not eat raw or rare meat, fish, or shellfish (including ceviche)",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Insect and tick bites",
"     </span>",
"     &nbsp;&mdash;&nbsp;In certain areas of the world, insects (mosquitoes, flies, fleas, bugs, and lice) and arthropods (ticks and mites) can transmit a number of potentially serious infections, including malaria.",
"    </p>",
"    <p>",
"     Before you leave, you should buy insect repellants to bring with you. The best ones are DEET, permethrin, and picaridin; sporting and camping goods stores often sell these products.",
"    </p>",
"    <p>",
"     You can lower your risk of infection by following these precautions every day while you are traveling:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Whenever possible, avoid insect-infested and",
"       <span class=\"nowrap\">",
"        tick/mite-infested",
"       </span>",
"       areas",
"      </li>",
"      <li>",
"       Wear protective clothing, including long-sleeved shirts and pants; if you can, treat your clothing with permethrin",
"      </li>",
"      <li>",
"       Use insect and",
"       <span class=\"nowrap\">",
"        tick/mite",
"       </span>",
"       repellents that contain DEET or picaridin",
"      </li>",
"      <li>",
"       Use mosquito netting over your bed; treat the netting with permethrin",
"      </li>",
"      <li>",
"       Check your skin regularly and remove any insects or",
"       <span class=\"nowrap\">",
"        ticks/mites",
"       </span>",
"      </li>",
"      <li>",
"       Whenever possible, minimize time spent outdoors after dark",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h3\">",
"      Malaria prevention",
"     </span>",
"     &nbsp;&mdash;&nbsp;Malaria is a serious infection that is spread by the bite of an infected mosquito. The above suggestions can reduce the risk of being bitten. Antimalaria medications are also recommended to people who travel to certain areas. These medications should be taken exactly as prescribed, starting before traveling to affected areas and continuing for up to four weeks after returning. The dosage and schedule depends upon which antimalarial medication is used.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Infection-causing organisms",
"     </span>",
"     &nbsp;&mdash;&nbsp;Open water, soil, and sand can harbor infection-causing organisms in some areas of the world.",
"    </p>",
"    <p>",
"     In countries where schistosomiasis (a water-borne parasitic infection) is common, travelers should avoid swimming in fresh water. Even brief exposure to infested water (for example, during rafting) can result in infection. In contrast, swimming in salt water or chlorinated water in these countries is safe.",
"    </p>",
"    <p>",
"     When you are traveling, don't walk barefoot on soil or sand that could be contaminated with dog or human feces. This can lead to hookworm or strongyloidiasis infections (worms that can penetrate the skin and cause itching, stomach symptoms, and other problems).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Sexually transmitted diseases",
"     </span>",
"     &nbsp;&mdash;&nbsp;Studies of travelers' behaviors indicate that many people are more sexually active during travels. The hepatitis B virus, the human immunodeficiency virus (HIV, the virus that causes AIDS), as well as more common infections, such as gonorrhea, chlamydia, and syphilis, are all transmitted by sexual contact, and are often more prevalent in developing countries.",
"    </p>",
"    <p>",
"     Avoiding sexual contact eliminates the risk of acquiring sexually transmitted disease during travel. Use of barrier methods, such as a latex condom or diaphragm, reduces the risk of disease transmission, although they do not eliminate the risk. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/45/31447?source=see_link\">",
"      \"Patient information: Hepatitis B (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/0/7170?source=see_link\">",
"      \"Patient information: Symptoms of HIV infection (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Personal medications",
"     </span>",
"     &nbsp;&mdash;&nbsp;Medications available in the United States may not be available in other countries. Therefore, travelers who must take medication regularly should bring enough medication with them for the duration of their trip. Medications should be taken on the plane in a purse or other carry-on bag, rather than packed in luggage, to avoid loss or theft. Travelers who require syringes to administer medication should carry those syringes along with a letter from a healthcare provider documenting a medical need for the syringes.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Avoiding accidents",
"     </span>",
"     &nbsp;&mdash;&nbsp;Accidents, especially motor vehicle accidents, account for about 25 percent of deaths in American travelers. The risk of accidents, injury, and death may be reduced by taking several precautions:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Avoid driving at night, which can minimize exposure to alcohol-impaired drivers",
"      </li>",
"      <li>",
"       Familiarize yourself with the local driving conditions",
"      </li>",
"      <li>",
"       Wear a seat belt at all times",
"      </li>",
"      <li>",
"       Avoid drinking alcoholic beverages and driving",
"      </li>",
"      <li>",
"       If using motorized cycles, wear helmets and be especially cautious",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Tuberculosis testing",
"     </span>",
"     &nbsp;&mdash;&nbsp;Travelers who are planning travel to regions where tuberculosis (TB) is common may be advised to have a test for tuberculosis before and after their trip. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/35/39475?source=see_link\">",
"      \"Patient information: Tuberculosis (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Anyone who is exposed to or becomes infected with tuberculosis will need treatment if testing is positive. The risk is higher for traveling healthcare workers compared with other types of travelers. The risk of tuberculosis exposure may be reduced by avoiding close contact with people who are coughing or sneezing, although this is not always possible.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H13\">",
"     <span class=\"h1\">",
"      TRANSPORTATION ADVICE",
"     </span>",
"    </p>",
"    <p>",
"     Travel-related health problems can be related to the type of transportation used during travel.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Ships",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Centers for Disease Control and Prevention (CDC) inspects all cruise ships that dock at ports in the United States. This ensures that ships meet strict sanitation guidelines. Information about the past record of a specific cruise ship can be obtained from travel agents, state health departments, or the CDC (",
"     <a class=\"external\" href=\"file://www.cdc.gov/travel/cruiships.htm\">",
"      www.cdc.gov/travel/cruiships.htm",
"     </a>",
"     ).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Air travel",
"     </span>",
"     &nbsp;&mdash;&nbsp;Air travel can be associated with several problems.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h3\">",
"      Lower-oxygen environment",
"     </span>",
"     &nbsp;&mdash;&nbsp;Aircraft that fly at low altitudes may not pressurize the cabin. Jet aircraft that fly at higher altitudes pressurize the cabin, although the pressure is less than that on the ground. Under both conditions, the air in the cabin contains less oxygen than the air on the ground, which reduces the amount of oxygen in the blood.",
"    </p>",
"    <p>",
"     Exposure to a lower-oxygen environment can lead to problems in people with certain medical conditions, including chronic obstructive pulmonary disease (COPD) and some heart conditions. A patient may feel short of breath, which could require the use of supplemental oxygen. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?32/22/33122?source=see_link\">",
"      \"Patient information: Supplemental oxygen on commercial airlines (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     A lower-oxygen environment can also be a problem for people who experience a heart attack while abroad. Such individuals can usually make a return flight home two to three weeks after the heart attack, as long as a healthcare provider accompanies them.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h3\">",
"      Ear and sinus symptoms",
"     </span>",
"     &nbsp;&mdash;&nbsp;The change in air pressure during flight may cause ear and sinus symptoms, especially for travelers with upper respiratory tract infections. These symptoms may include difficulty hearing and pain in the ears or sinuses. In most individuals, the symptoms can be prevented by taking an oral (pseudoephedrine) or nasal (oxymetazoline) spray, decongestants, or antihistamines (diphenhydramine).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h3\">",
"      Blood clots",
"     </span>",
"     &nbsp;&mdash;&nbsp;Sitting for prolonged periods during air travel causes blood to pool in the legs, which can increase the risk of forming blood clots in the legs, especially in individuals who have clotting or vein disorders. People with these conditions may be advised to take certain medications, to stretch frequently,",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     to wear compression stockings during long flights to reduce the risk of blood clots. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?12/44/12998?source=see_link\">",
"      \"Patient information: Deep vein thrombosis (DVT) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     All travelers should consider the following recommendations for flights longer than six to eight hours (",
"     <a class=\"graphic graphic_table graphicRef71028 \" href=\"UTD.htm?16/37/16987\">",
"      table 1",
"     </a>",
"     ).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H19\">",
"     <span class=\"h3\">",
"      Motion sickness",
"     </span>",
"     &nbsp;&mdash;&nbsp;Individuals who suffer with motion sickness can take a medication before a flight (or before sailing if on a cruise ship) to prevent this condition. Over-the-counter drugs work for most individuals; a clinician can recommend a prescription-strength medication if needed.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h3\">",
"      Jet lag",
"     </span>",
"     &nbsp;&mdash;&nbsp;Travelers who cross several time zones may experience jet lag. In general, it takes longer to recover from jet lag after flying west to east than east to west. Adult travelers crossing five or more time zones are likely to benefit from melatonin, especially if they have experienced jet lag on previous journeys. It is also reasonable for people making such a journey for the first time to take melatonin, if jet lag might seriously interfere with work or leisure activities at their destination. Travelers crossing two to four time zones may also try melatonin.",
"    </p>",
"    <p>",
"     The recommended dose of melatonin is 2 or 3 mg about 30 minutes before bedtime on the day of travel and for up to four days after arrival; a dose of 0.5 mg has less effect on sleep but can help the person to adapt to the new time zone. A test dose taken at home before travel may help determine which dose is most appropriate. Alcohol should be avoided with melatonin.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H21\">",
"     <span class=\"h1\">",
"      TRAVELING WITH MEDICAL CONDITIONS",
"     </span>",
"    </p>",
"    <p>",
"     Additional travel considerations are necessary for pregnant women, people with HIV infection, and people with diabetes. More information about traveling with a medical condition is available on the",
"     <a class=\"external\" href=\"file://www.cdc.gov/travel/spec_needs.htm\">",
"      CDC Web site",
"     </a>",
"     .",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H22\">",
"     <span class=\"h2\">",
"      Pregnant women",
"     </span>",
"     &nbsp;&mdash;&nbsp;Most women can travel safely during pregnancy, although the type of travel and possible health hazards must be considered on an individual basis. Air travel does not have any known negative effects on a pregnant woman or the baby. Women who have had complicated pregnancies in the past (premature delivery, late-term miscarriage, high blood pressure, or other complications) should avoid extensive travel during their current pregnancy. In addition, pregnant women should be sure to follow precautions to avoid blood clots since pregnancy increases the risk of clotting. (See",
"     <a class=\"local\" href=\"#H18\">",
"      'Blood clots'",
"     </a>",
"     above.)",
"    </p>",
"    <p>",
"     Pregnant women may not be able to receive certain immunizations and antibiotics. Pregnant women who travel to regions where malaria is common need to understand that exposure to malaria increases her and her baby's risk of complications. Not all antimalarial medications have been studied to determine their safety in pregnancy. Expert advice about the wisdom of traveling in regions where malaria is present, the safety of various antimalarial drugs, and the risks of malaria in pregnancy should be considered prior to travel. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?42/52/43843?source=see_link\">",
"      \"Patient information: Avoiding infections in pregnancy (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23\">",
"     <span class=\"h2\">",
"      HIV infection",
"     </span>",
"     &nbsp;&mdash;&nbsp;HIV infection can pose several problems during travel.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       People with HIV may not be allowed to enter some countries; check with consular offices when planning international travel. In addition, people with HIV should try to locate adequate medical facilities in the planned destinations.",
"      </li>",
"      <li>",
"       People with HIV will not be able to receive certain travel immunizations. HIV-infected travelers should carry all necessary medications with them.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H24\">",
"     <span class=\"h2\">",
"      Diabetes",
"     </span>",
"     &nbsp;&mdash;&nbsp;Travelers with diabetes who take insulin should seek expert advice on modifying timing of insulin doses if traveling over many time zones.",
"    </p>",
"    <p>",
"     Syringes, blood glucose testing supplies, insulin and glucagon or oral medications, and snacks should be packed in a carry-on bag and available at all times. People who require syringes should carry a note from their healthcare provider, explaining the need for diabetes-related supplies. In addition, the person should wear a necklace or bracelet that lists their medical condition and a phone number to locate additional emergency contact information.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H25\">",
"     <span class=\"h1\">",
"      SPECIAL ACTIVITIES",
"     </span>",
"    </p>",
"    <p>",
"     A few activities have specific recommendations to ensure the safety of the traveler during and after the activity.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H26\">",
"     <span class=\"h2\">",
"      Scuba diving",
"     </span>",
"     &nbsp;&mdash;&nbsp;Individuals who scuba dive while traveling should wait 12 to 48 hours (depending on the length of dives) before boarding a jet airplane. This measure is important for avoiding decompression sickness (also called \"the bends\").",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27\">",
"     <span class=\"h2\">",
"      High-altitude exposure",
"     </span>",
"     &nbsp;&mdash;&nbsp;Individuals who will be traveling to mountainous or other high-altitude regions should talk with their healthcare provider about preventing and treating high-altitude illnesses. These illnesses include mountain sickness, high-altitude pulmonary edema, and high-altitude cerebral edema. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?4/19/4403?source=see_link\">",
"      \"Patient information: High altitude illness (including mountain sickness) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H28\">",
"     <span class=\"h2\">",
"      Wilderness travel",
"     </span>",
"     &nbsp;&mdash;&nbsp;Individuals who plan travel to remote areas that lack medical facilities should discuss precautionary measures with their clinician, especially if they will be exposed to extreme climates or exercise-related stress (for example, mountain climbing or long-distance bicycle tours).",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H29\">",
"     <span class=\"h1\">",
"      RETURNING TRAVELERS",
"     </span>",
"    </p>",
"    <p>",
"     Anyone who experiences symptoms of fever, diarrhea, or rash following their return from international travel should consult their healthcare provider immediately.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H30\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1804603540\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H255269\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?26/42/27298?source=see_link\">",
"      Patient information: Staying healthy when you travel (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/39/33395?source=see_link\">",
"      Patient information: Avoiding infections in pregnancy (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/46/41698?source=see_link\">",
"      Patient information: Hepatitis A (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/44/21187?source=see_link\">",
"      Patient information: Vaccines for travel (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/27/16818?source=see_link\">",
"      Patient information: Dengue fever (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/40/37505?source=see_link\">",
"      Patient information: Leptospirosis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/3/20530?source=see_link\">",
"      Patient information: Travelers&rsquo; diarrhea (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/15/8434?source=see_link\">",
"      Patient information: Activity during pregnancy (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/47/3826?source=see_link\">",
"      Patient information: Malaria (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/26/38305?source=see_link\">",
"      Patient information: Typhoid fever (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?30/63/31730?source=see_link\">",
"      Patient information: E. coli (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/9/19602?source=see_link\">",
"      Patient information: Jet lag (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H255276\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/30/29156?source=see_link\">",
"      Patient information: Food poisoning (food-borne illness) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/45/31447?source=see_link\">",
"      Patient information: Hepatitis B (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/0/7170?source=see_link\">",
"      Patient information: Symptoms of HIV infection (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/35/39475?source=see_link\">",
"      Patient information: Tuberculosis (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?32/22/33122?source=see_link\">",
"      Patient information: Supplemental oxygen on commercial airlines (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?12/44/12998?source=see_link\">",
"      Patient information: Deep vein thrombosis (DVT) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?42/52/43843?source=see_link\">",
"      Patient information: Avoiding infections in pregnancy (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?4/19/4403?source=see_link\">",
"      Patient information: High altitude illness (including mountain sickness) (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H31\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/26/5543?source=see_link\">",
"      Clinical manifestations of malaria",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/5/3161?source=see_link\">",
"      Diseases potentially acquired by travel to Central and South America",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/0/13319?source=see_link\">",
"      Diseases potentially acquired by travel to East Asia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/17/12568?source=see_link\">",
"      Diseases potentially acquired by travel to Southeast Asia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/11/40121?source=see_link\">",
"      Diseases potentially acquired by travel to sub-Saharan Africa",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/5/16473?source=see_link\">",
"      Epidemiology, prevention, and control of malaria in endemic areas",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2394?source=see_link\">",
"      Immunizations for travel",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/52/5962?source=see_link\">",
"      Management of Crotalinae (rattlesnake, water moccasin [cottonmouth], or copperhead) bites in the United States",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/48/775?source=see_link\">",
"      Management of Elapidae (coral snake) bites in the United States",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/1/39959?source=see_link\">",
"      Pathogenesis of malaria",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/57/9113?source=see_link\">",
"      Potential health hazards in travelers to Australia, New Zealand, and the southwestern Pacific (Oceania)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/3/13370?source=see_link\">",
"      Prevention of malaria infection in travelers",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/44/31431?source=see_link\">",
"      Principles of snake bite management worldwide",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2393?source=see_link\">",
"      Rabies immune globulin and vaccine",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/48/8967?source=see_link\">",
"      Travel advice",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/29/29145?source=see_link\">",
"      Travelers' diarrhea",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Centers for Disease Control and Prevention (CDC) travel page",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cdc.gov/travel/\">",
"      www.cdc.gov/travel/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;Toll-free: (800) 232-4636",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       World Health Organization page on international travel and health",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.who.int/ith/\">",
"      www.who.int/ith/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Infectious Diseases Society of America",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.idsociety.org\">",
"      www.idsociety.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Society of Tropical Medicine and Hygiene - clinical consultative service in Tropical Medicine, Medical Parasitology and Travelers' Health",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.astmh.org/source/ClinicalDirectory/\">",
"      www.astmh.org/source/ClinicalDirectory/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?16/2/16421/abstract/1-4\">",
"      1-4",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 16, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?16/2/16421?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16421/abstract/1\">",
"      Hill DR. The burden of illness in international travelers. N Engl J Med 2006; 354:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16421/abstract/2\">",
"      Hill DR, Ericsson CD, Pearson RD, et al. The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006; 43:1499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16421/abstract/3\">",
"      Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Update: Prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2007; 56:1080.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.who.int/ihr/en/ (Accessed on February 16, 2012).",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f16_2_16421=[""].join("\n");
var outline_f16_2_16421=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           TRAVEL AND HEALTH OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           PRE-TRAVEL EVALUATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           TRAVEL-RELATED MEDICAL ADVICE",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H13\">",
"           TRANSPORTATION ADVICE",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H21\">",
"           TRAVELING WITH MEDICAL CONDITIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H25\">",
"           SPECIAL ACTIVITIES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H29\">",
"           RETURNING TRAVELERS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H30\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          TABLES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"UTD.htm?16/37/16987\" title=\"table 1\">",
"           Travel tips PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f16_2_16422="Paroxysmal cold hemoglobinuria";
var content_f16_2_16422=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Paroxysmal cold hemoglobinuria",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/2/16422/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/2/16422/contributors\">",
"     Wendell F Rosse, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/2/16422/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/2/16422/contributors\">",
"     Stanley L Schrier, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/2/16422/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/2/16422/contributors\">",
"     Stephen A Landaw, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/2/16422/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 27, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Paroxysmal cold hemoglobinuria (PCH) was one of the first hematologic syndromes to be recognized clinically. The association between red to brown urine (quickly recognized as hemoglobinuria) being passed following exposure to cold was established by 1872. The recognition that this syndrome was often seen in patients with syphilis soon followed and the demonstration of an antibody as the cause came in 1904, from the studies of Donath and Landsteiner [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16422/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic review will discuss the major features of PCH. The more common cold agglutinin syndromes are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30535?source=see_link\">",
"     \"Pathogenesis of autoimmune hemolytic anemia: Cold agglutinin disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/56/33672?source=see_link\">",
"     \"Clinical features and treatment of autoimmune hemolytic anemia: Cold agglutinins\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The antibody in PCH is a cold-reacting IgG. It is always polyclonal. Unlike cold-reacting IgM, it does not cause red cell agglutination but, similar to cold-reacting IgM, it is able to fix complement readily. The maximum temperature at which these antibodies are able to interact (ie, their thermal amplitude) varies greatly from patient to patient, as is also the case with the IgM cold agglutinins.",
"   </p>",
"   <p>",
"    The mechanism of hemolysis in PCH is similar to that in cold agglutinin disease. As the blood circulates to the periphery, it cools, and the antibody and the first two components of complement are fixed to the RBC surface. The complement cascade is completed only when the RBC are subsequently warmed to 37&deg;C. For reasons that are not clearly understood, perhaps because the antigen is located on the RBC membrane surface, these antibodies are quite efficient in bringing about direct lysis by complement; this results in intravascular hemolysis, hemoglobinuria, and hemosiderinuria. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Antibody specificity'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/3/18489?source=see_link&amp;anchor=H14#H14\">",
"     \"Approach to the diagnosis of hemolytic anemia in the adult\", section on 'Intravascular hemolysis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Antibody specificity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The antigen with which the antibody in PCH interacts is the P antigen, a polysaccharide that is usually affixed to a ceramide moiety on the surface of the red cell [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16422/abstract/2\">",
"     2",
"    </a>",
"    ]. This antibody will cause hemolysis in almost all subjects, since only rare individuals have red cells lacking the P antigen (the pp or Tj(a) - phenotype). Of interest, the P antigen structure is also a binding site for parvovirus, one strain of which (B19) causes transient pure red aplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16422/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22377?source=see_link\">",
"     \"Clinical manifestations and pathogenesis of human parvovirus B19 infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/15/27898?source=see_link&amp;anchor=H65#H65\">",
"     \"A primer of red blood cell antigens and antibodies\", section on 'Globoside blood group (P and Pk)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Occasional antibodies in patients with PCH have anti-i or anti-Pr specificity such as that seen in cold agglutinin disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16422/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Associated illnesses",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the past, PCH was primarily a disease of patients with secondary or tertiary syphilis. This relationship may have been due to a syphilis antigen that generated a cross-reacting antibody causative of the syndrome. Post-infectious or autoimmune settings are now the most common causes of PCH.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17640177\">",
"    <span class=\"h3\">",
"     Post-infectious",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children, PCH most often follows a viral infection, often varicella. Other viral infections that have been implicated include measles, mumps, Epstein-Barr virus, cytomegalovirus, adenovirus, and influenza A. PCH may also follow other infections, including Mycoplasma pneumoniae infection, Klebsiella, Escherichia coli, and Hemophilus influenzae. It has also been seen following vaccination for measles. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/59/18362?source=see_link&amp;anchor=H30#H30\">",
"     \"Autoimmune hemolytic anemia in children\", section on 'Infection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17640184\">",
"    <span class=\"h3\">",
"     Autoimmune",
"    </span>",
"    &nbsp;&mdash;&nbsp;In adults, and occasionally in children, PCH is an autoimmune disorder. It may occur in the context of other immune abnormalities and rarely in lymphomas and chronic lymphocytic leukemia [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16422/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. The adult form of PCH is usually chronic, lasting several years.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical scenario for PCH is quite similar to that seen in both warm-antibody hemolytic anemia and idiopathic thrombocytopenic purpura in children in that the antibody appears approximately 7 to 10 days after the onset of the febrile illness and persists for 6 to 12 weeks afterward [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16422/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. The peak antibody titer is reached rapidly and may cause severe hemolytic anemia and even death if not properly controlled.",
"   </p>",
"   <p>",
"    The typical manifestation of PCH is the passage of darkly colored urine (hemoglobinuria), beginning a few minutes to several hours after exposure to cold, a manifestation of intravascular hemolysis. The reason for this delay in some patients is not known. The onset of hemolysis is otherwise rapid but does not persist if cold exposure is ended. Constitutional symptoms, such as back or leg pains, abdominal cramping, chills, and fever may be present. Other symptoms that can occur include the Raynaud phenomenon, caused by arteriolar constriction, and urticaria.",
"   </p>",
"   <p>",
"    Acute renal failure, a rare presentation, has been described in two children with PCH.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H395799\">",
"    <span class=\"h1\">",
"     LABORATORY FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Not all patients with PCH exhibit hemoglobinuria, but the vast majority have evidence of intravascular hemolysis, often with clinical jaundice, reticulocytosis, hemosiderinuria, increased concentrations of indirect bilirubin and lactate dehydrogenase, reduced concentration of haptoglobin, and depressed levels of serum complement. Spherocytes and erythrophagocytosis by neutrophils and monocytes, sometimes striking, may occasionally be found on examination of the peripheral smear during the acute attack [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16422/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/3/18489?source=see_link&amp;anchor=H14#H14\">",
"     \"Approach to the diagnosis of hemolytic anemia in the adult\", section on 'Intravascular hemolysis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The degree of anemia is variable and depends upon the titer of the antibody, its thermal amplitude (ie, the highest temperature at which the antibody can react with the antigen), the exposure to cold ambient temperatures, and patient age. In acute PCH of childhood, the anemia may be severe and has been reported as a common cause of death in this age group. Most adults have a moderate degree of anemia that is seasonally worsened by the onset of cold weather.",
"   </p>",
"   <p>",
"    The direct Coombs test is positive using anti-C3 and negative for IgG during a hemolytic episode (",
"    <a class=\"graphic graphic_table graphicRef69817 \" href=\"UTD.htm?38/6/39020\">",
"     table 1",
"    </a>",
"    ) but may be negative between crises. Neutropenia can occur during severe hemolytic crises, although its cause is unclear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;PCH is an acquired hemolytic anemia caused by a cold-reacting IgG antibody that fixes complement to the red cells in the cold and causes intravascular hemolysis on rewarming. The diagnosis of PCH requires all of the following to be present:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Presence of intravascular hemolysis, typically occurring on rewarming after a cold exposure",
"     </li>",
"     <li>",
"      In vitro demonstration of an IgG antibody that reacts with the red cell at reduced temperature but not at 37&deg;C and causes hemolysis on rewarming (see",
"      <a class=\"local\" href=\"#H24127183\">",
"       'Testing for the Donath-Landsteiner antibody'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      A Coombs test that is positive for complement but negative for IgG during a hemolytic episode",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24127183\">",
"    <span class=\"h2\">",
"     Testing for the Donath-Landsteiner antibody",
"    </span>",
"    &nbsp;&mdash;&nbsp;Donath and Landsteiner used a hemolytic assay in which the patient's serum was incubated with normal red cells and complement at 4&deg;C for a period of time (during which antibody and the early components of complement were fixed) and then incubated at 37&deg;C in order to allow the later components of complement to be activated. Hemolysis occurred if antibody was present but did not occur if the reaction mixture was continuously maintained at 37&deg;C.",
"   </p>",
"   <p>",
"    This diagnostic test is not very sensitive, as normal red cells are hemolyzed only with difficulty by human complement; thus, many patients with PCH of mild to moderate severity remain undiagnosed. A few more sensitive tests exist, although they are not generally available:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The sensitivity of this test can be increased by the use of red cells from a patient with paroxysmal nocturnal hemoglobinuria (PNH), which are much more susceptible to lysis by complement. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/17/13593?source=see_link\">",
"       \"Pathogenesis of paroxysmal nocturnal hemoglobinuria: Missing cell proteins\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If red cells from a patient with PNH are not available, &ldquo;artificial&rdquo; PNH cells can be made from normal red cells by treatment with aminoethylisothiouronium bromide (AET) or other mercaptide-bearing compound [",
"      <a class=\"abstract\" href=\"UTD.htm?16/2/16422/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Tests using radiolabeled monoclonal anti-IgG are the most sensitive. In these tests, the patient's serum and normal red cells are incubated at 4&deg;C, washed with cold buffer, and incubated again at 4&deg;C with the anti-IgG reagent. The cells are then centrifuged through cold medium that separates them from the unreacted reagent and the amount of radioactivity remaining on the cells is calculated; this will be elevated if the antibody is present. The control experiment is conducted at 37&deg;C throughout. Although the endpoint of this test is not in vitro hemolysis, it is able to detect PCH antibodies that are not found even with the more sensitive hemolytic assays.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the author&rsquo;s laboratory, the serum of 14 patients with PCH was examined; four were positive in the Donath-Landsteiner test using normal cells, 12 were positive using PNH cells, and all 14 were positive using the radiolabeled antibody; AET-treated cells were not tested.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24127175\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis for a patient who has developed hemolytic anemia following exposure to cold is limited:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Cold agglutinin disease",
"      </strong>",
"      ��� In this condition there is the presence of a high titer of cold agglutinins of the IgM type. The typical patient with cold agglutinin disease has a titer in excess of 1 in 10,000 and the test for Donath-Landsteiner antibodies is negative. In PCH the cold agglutinin titer is, at most, only moderately elevated (ie, &lt;1:160). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/56/33672?source=see_link&amp;anchor=H13#H13\">",
"       \"Clinical features and treatment of autoimmune hemolytic anemia: Cold agglutinins\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Drug-induced autoimmune hemolytic anemia",
"      </strong>",
"      ��� This condition may be associated with a positive Coombs test for bound complement. A positive drug history, lack of an elevated titer of cold agglutinins, and lack of Donath-Landsteiner antibodies help to make this diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/2/20521?source=see_link\">",
"       \"Pathogenesis of autoimmune hemolytic anemia: Warm agglutinins and drugs\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Cryoglobulins or cryoproteins",
"      </strong>",
"      ��� A history of symptoms induced by exposure to cold may be present in patients with cryoglobulinemia or the Raynaud phenomenon. However, the Coombs test is usually negative and cold agglutinins are not increased. Rarely, cold agglutinins may be cold-precipitable (cryoglobulin); in such patients, acral necrosis is sometimes seen, but hemolysis is often less than expected for the titer of antibody. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/63/22522?source=see_link\">",
"       \"Overview of cryoglobulins and cryoglobulinemia\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/48/6921?source=see_link\">",
"       \"Clinical manifestations and diagnosis of the Raynaud phenomenon\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24127299\">",
"    <span class=\"h2\">",
"     Acute episode",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of an acute attack of PCH in children is supportive, as the syndrome usually resolves in a few weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16422/abstract/9\">",
"     9",
"    </a>",
"    ]. The patient should be kept warm, confined to a very warm environment, and observed carefully with frequent blood counts, as the anemia may suddenly become severe and occasionally life-threatening. (See",
"    <a class=\"local\" href=\"#H24127340\">",
"     'Avoidance of cold'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If life-threatening anemia occurs, transfusion of packed red cells through a blood-warming device is needed, even though fully compatible blood (ie, blood lacking the P antigen) may not be available.",
"     </li>",
"     <li>",
"      Glucocorticoids in the doses employed for the treatment of warm autoimmune hemolytic anemia (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      in a dose of 1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day) have often been given as adjunctive treatment, although evidence for their efficacy in this setting is anecdotal. Their use might be most appropriate if symptoms are severe",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      life-threatening.",
"     </li>",
"     <li>",
"      Theoretically,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/63/28662?source=see_link\">",
"       eculizumab",
"      </a>",
"      (an antibody to complement component 5[C5]) should arrest hemolysis, but data are lacking.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24127306\">",
"    <span class=\"h2\">",
"     Chronic episode(s)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The therapy of chronic hemolytic anemia due to PCH combines elements of the treatment of cold agglutinin disease (ie, avoidance of cold) with that of warm-type autoimmune hemolytic anemia (ie, use of immunosuppressive agents). (See",
"    <a class=\"local\" href=\"#H24127340\">",
"     'Avoidance of cold'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Since the antibody in PCH is an IgG, glucocorticoids may be useful in reducing antibody production",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      complement receptor-mediated phagocytosis, although evidence for their efficacy in this setting is sparse [",
"      <a class=\"abstract\" href=\"UTD.htm?16/2/16422/abstract/13\">",
"       13",
"      </a>",
"      ]. The",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      regimen is the same as that employed in IgG-mediated warm agglutinin disease (ie, 1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day by mouth). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/62/14313?source=see_link\">",
"       \"Treatment of autoimmune hemolytic anemia: Warm agglutinins\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Blood transfusion may be needed for those with symptomatic anemia, but truly compatible donors (ie, P antigen-negative) are rare [",
"      <a class=\"abstract\" href=\"UTD.htm?16/2/16422/abstract/14\">",
"       14",
"      </a>",
"      ]. Antigen typing, if available, should help in selecting the optimal units for transfusion. &nbsp;In no case should transfusion be omitted if it is life-saving.",
"     </li>",
"     <li>",
"      If",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      should fail to achieve remission at reasonable doses,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      (100",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      orally for adults) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"       azathioprine",
"      </a>",
"      (100",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      orally for adults) can be tried.",
"     </li>",
"     <li>",
"      The role of the anti-CD20 antibody",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       rituximab",
"      </a>",
"      in the treatment of PCH has not been established, but the drug has been effective in at least one patient with refractory PCH [",
"      <a class=\"abstract\" href=\"UTD.htm?16/2/16422/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/63/28662?source=see_link\">",
"       eculizumab",
"      </a>",
"      , a monoclonal antibody against the C5 component of complement, was ineffective when used in a single patient with multiple myeloma and PCH who had glucocorticoid- and oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      -refractory hemolytic anemia [",
"      <a class=\"abstract\" href=\"UTD.htm?16/2/16422/abstract/16\">",
"       16",
"      </a>",
"      ]. The patient&rsquo;s hemolysis subsided after treatment with a single dose of intravenous cyclophosphamide (4",
"      <span class=\"nowrap\">",
"       g/m",
"       <sup>",
"        2",
"       </sup>",
"       ).",
"      </span>",
"     </li>",
"     <li>",
"      The spleen plays no role in the pathogenesis of the intravascular hemolysis in PCH. As a result, splenectomy is not indicated.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24127340\">",
"    <span class=\"h2\">",
"     Avoidance of cold",
"    </span>",
"    &nbsp;&mdash;&nbsp;Strict avoidance of exposure to cold in the environment, as well as in all ingested and infused fluids, is as important, if not more so, in PCH as it is in cold agglutinin syndrome, since the effects of cold are more clear cut in PCH [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16422/abstract/17\">",
"     17",
"    </a>",
"    ]. The patient may need to be kept in an uncomfortably warm environment or clothed in uncomfortably warm garments, particularly if the temperature at which the antibody fixes complement to the red cells is high (eg, as high or higher than normal room temperature) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16422/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Pathophysiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In one case report in a 2.5-year-old boy with PCH, hemoglobinuria and hemolysis recurred when he was subjected to physical cooling as a means to control fever associated with hospital-acquired croup [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16422/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24127152\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Paroxysmal cold hemoglobinuria (PCH) is caused by an IgG antibody which fixes complement in the cold and causes intravascular hemolysis (and hemoglobinuria) upon rewarming. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Pathophysiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The two most common scenarios for the development of PCH are following infection in children (most often viral), or as an autoimmune phenomenon, occasionally associated with a lymphoproliferative disorder. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Associated illnesses'",
"      </a>",
"      above.) Rarely, PCH may complicate tertiary syphilis.",
"     </li>",
"     <li>",
"      The cardinal manifestation of PCH is intravascular hemolysis with the passage of darkly colored urine (hemoglobinuria), beginning a few minutes to several hours after exposure to cold. Back or leg pain, abdominal cramping, chills, and fever may be present. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laboratory findings reveal a Coombs test positive for complement and negative for IgG, along with the presence of an antibody of the Donath-Landsteiner type. (See",
"      <a class=\"local\" href=\"#H395799\">",
"       'Laboratory findings'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of the",
"      <strong>",
"       acute",
"      </strong>",
"      attack of hemolysis is supportive and includes keeping the patient warm, avoidance of exposure to cold fluids (ingested or infused), and transfusion of warmed packed red cells for symptomatic anemia. (See",
"      <a class=\"local\" href=\"#H24127299\">",
"       'Acute episode'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H24127340\">",
"       'Avoidance of cold'",
"      </a>",
"      above.)",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       Prednisone",
"      </a>",
"      (1",
"      <span class=\"nowrap\">",
"       mg/kg/day)",
"      </span>",
"      may be useful in some cases.",
"     </li>",
"     <li>",
"      Treatment of patients with",
"      <strong>",
"       chronic",
"      </strong>",
"      symptomatic hemolytic anemia due to PCH requires avoidance of cold. We suggest the addition of glucocorticoids if cold avoidance is either not possible or has been ineffective in controlling symptomatic anemia (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). If the above measures are ineffective, we suggest the use of an immunosuppressive agent (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"       azathioprine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       rituximab",
"      </a>",
"      ) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). There is no evidence supporting the use of one immunosuppressive agent over another. (See",
"      <a class=\"local\" href=\"#H24127306\">",
"       'Chronic episode(s)'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H24127340\">",
"       'Avoidance of cold'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16422/abstract/1\">",
"      Donath J, Landsteiner K. Uber paroxysmale h&auml;moglobinurie. M&uuml;nch Med Wochenschr 1904; 51:1590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16422/abstract/2\">",
"      Levine P, Celano MJ, Falkowski F. The specificity of the antibody in paroxysmal cold hemoglobinuria (P.C.H.). Ann N Y Acad Sci 1965; 124:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16422/abstract/3\">",
"      Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993; 262:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16422/abstract/4\">",
"      Shirey RS, Park K, Ness PM, et al. An anti-i biphasic hemolysin in chronic paroxysmal cold hemoglobinuria. Transfusion 1986; 26:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16422/abstract/5\">",
"      Sharara AI, Hillsley RE, Wax TD, Rosse WF. Paroxysmal cold hemoglobinuria associated with non-Hodgkin's lymphoma. South Med J 1994; 87:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16422/abstract/6\">",
"      Sivakumaran M, Murphy PT, Booker DJ, et al. Paroxysmal cold haemoglobinuria caused by non-Hodgkin's lymphoma. Br J Haematol 1999; 105:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16422/abstract/7\">",
"      Heddle NM. Acute paroxysmal cold hemoglobinuria. Transfus Med Rev 1989; 3:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16422/abstract/8\">",
"      Bird GW, Wingham J, Martin AJ, et al. Idiopathic non-syphilitic paroxysmal cold haemoglobinuria in children. J Clin Pathol 1976; 29:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16422/abstract/9\">",
"      Gertz MA. Management of cold haemolytic syndrome. Br J Haematol 2007; 138:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16422/abstract/10\">",
"      Hernandez JA, Steane SM. Erythrophagocytosis by segmented neutrophils in paroxysmal cold hemoglobinuria. Am J Clin Pathol 1984; 81:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16422/abstract/11\">",
"      Mukhopadhyay S, Keating L, Souid AK. Erythrophagocytosis in paroxysmal cold hemoglobinuria. Am J Hematol 2003; 74:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16422/abstract/12\">",
"      SIRCHIA G, FERRONE S, MERCURIALI F. THE ACTION OF TWO SULFHYDRYL COMPOUNDS ON NORMAL HUMAN RED CELLS. RELATIONSHIP TO RED CELLS OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA. Blood 1965; 25:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16422/abstract/13\">",
"      Ries CA, Garratty G, Petz LD, Fudenberg HH. Paroxysmal cold hemoglobinuria: report of a case with an exceptionally high thermal range Donath-Landsteiner antibody. Blood 1971; 38:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16422/abstract/14\">",
"      Rausen AR, LeVine R, Hsu TC, Rosenfield RE. Compatible transfusion therapy for paroxysmal cold hemoglobinuria. Pediatrics 1975; 55:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16422/abstract/15\">",
"      Koppel A, Lim S, Osby M, et al. Rituximab as successful therapy in a patient with refractory paroxysmal cold hemoglobinuria. Transfusion 2007; 47:1902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16422/abstract/16\">",
"      Gregory GP, Opat S, Quach H, et al. Failure of eculizumab to correct paroxysmal cold hemoglobinuria. Ann Hematol 2011; 90:989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16422/abstract/17\">",
"      Djaldetti M. Paroxysmal cold hemoglobinuria. CRC Crit Rev Clin Lab Sci 1978; 9:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16422/abstract/18\">",
"      Mantadakis E, Bezirgiannidou Z, Martinis G, Chatzimichael A. Recurrence of paroxysmal cold hemoglobinuria in a boy after physical cooling for fever. J Pediatr Hematol Oncol 2011; 33:40.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7085 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-213.134.24.46-B0B7A2AA67-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_2_16422=[""].join("\n");
var outline_f16_2_16422=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24127152\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Antibody specificity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Associated illnesses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17640177\">",
"      - Post-infectious",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17640184\">",
"      - Autoimmune",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H395799\">",
"      LABORATORY FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24127183\">",
"      Testing for the Donath-Landsteiner antibody",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24127175\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24127299\">",
"      Acute episode",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24127306\">",
"      Chronic episode(s)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24127340\">",
"      Avoidance of cold",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24127152\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/7085\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7085|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/6/39020\" title=\"table 1\">",
"      Coombs test in AIHA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/15/27898?source=related_link\">",
"      A primer of red blood cell antigens and antibodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/3/18489?source=related_link\">",
"      Approach to the diagnosis of hemolytic anemia in the adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/59/18362?source=related_link\">",
"      Autoimmune hemolytic anemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/56/33672?source=related_link\">",
"      Clinical features and treatment of autoimmune hemolytic anemia: Cold agglutinins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/48/6921?source=related_link\">",
"      Clinical manifestations and diagnosis of the Raynaud phenomenon",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22377?source=related_link\">",
"      Clinical manifestations and pathogenesis of human parvovirus B19 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/63/22522?source=related_link\">",
"      Overview of cryoglobulins and cryoglobulinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30535?source=related_link\">",
"      Pathogenesis of autoimmune hemolytic anemia: Cold agglutinin disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/2/20521?source=related_link\">",
"      Pathogenesis of autoimmune hemolytic anemia: Warm agglutinins and drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/17/13593?source=related_link\">",
"      Pathogenesis of paroxysmal nocturnal hemoglobinuria: Missing cell proteins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/62/14313?source=related_link\">",
"      Treatment of autoimmune hemolytic anemia: Warm agglutinins",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_2_16423="Treatment of necrotic tissue with maggots";
var content_f16_2_16423=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F67885&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F67885&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 534px\">",
"   <div class=\"ttl\">",
"    Treatment of necrotic tissue with maggots",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 514px; height: 488px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Infection of necrotic skin associated with ulcerated cancer.",
"    <br>",
"     (B) After treatment with maggots.",
"     <br>",
"      (C) Maggots in a tea bag.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"       Courtesy of Michael J Dixon, MD.",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_2_16423=[""].join("\n");
var outline_f16_2_16423=null;
var title_f16_2_16424="Benign teratoma ultrasound";
var content_f16_2_16424=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F77727%7EOBGYN%2F51762%7EOBGYN%2F62484&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F77727%7EOBGYN%2F51762%7EOBGYN%2F62484&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Benign ovarian teratoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 318px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ultrasound image of a benign teratoma which has the appearance of a complex mass (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jorge Londono, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Transabdominal image of the left adnexa",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 343px; height: 298px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEqAVcDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5UooooAKKKKACiiigAoord8KaLFrcuqJNM8QtNOnvV2gHc0a5Cn2NAGFRXUfD3RdJ8Q69DperXV7bTXTrFbNbRK43E878kYH0zWTr8WmQ6lJHos13NZqAA91GqPu78KSMZ96AM2iiigAp21tm7aducZxxmm12/wAOtf0+BL3w34m/5FzVyolmC5ezmHEdwn+7nBHdSRQBxFWtPsbjUbgwWaB5djSYLBflVSxOSR2Bq/4u8O33hbX7nStTVfNiIKSIcpNGeVkQ91YYINVdMtGmfzGTManjI4Y+lAFvTLEmB2dQzNgFMfMB7VDNpzLIojxhvujPI+tdOszWoiFzBIr4zHIn3ge3PcUO6XyM89sWwv7yVBtI56+9AHJyQyplnXaRwTjg1LbzZzuYgqMiuhFhbTW/mNMxVhwpHSs250t1uCsYCA/3jQBFHMwdWVPnI/g71EyW828vHsbONu3v7Yq9JZz29srPbtHuXcrbuo9qY8YeFPtcZV0OAynk96AMyayjUHa/zE8AHOBUC2jOW2MDjjHerTWMkrPJEQEU9WbtUUiTxOTNEVxzgDHH+FAETWU4PCEg9DipItMuJVYoFIHXmmia4Dbkd0BHXJp8d1KIiGkkDA5GKAGjTpcgFkHrzkipTpbAAmQfTac1I8zhCwkG4jPHBpYLGa7c5kZWAzgg/nQBBHZodxdvl7HcB+dTbLZY1NurSSE8rszj8asrYKkAO0MxGOnf8at2kN3Cgdz5MRbBIHSgDMkWfdut4mUD++elR5uzEEGcZI4HHvWvIpmuGCwOVZty7u9WV0C5aES3MqRJ94YPLegxQBz9tZSNMA2CwPQ81fgQx5jjieWUnCqucD8utdAnhmcW6TSvIiA5cgYwPWtTRtLWGaUxzLEU6SBucHuP/rUAcmuh3d8BHNuNwxCopIzuPAB9Mn1rm7u3ltLqa2uE2TQuY3XIOGBwRxXr0dpbbhEIpPLYbnlkOCTzkkVw3i+xtlbzbXcXThmPSRexHv8A0oA5SiiigAooooAKKKKACiiigAooooAKKKKACiiigArqvh7qenabqeojWLiW3tbzTriz82KLzSjSLgHbkZ/OuVooA7Hw9d6H4b+IOjX1rqNxfaXbSpNLM1r5TjrkBNxz271yVwweeRl6MxI/Oo6KACiiigAoopQCSABknoBQB6f4TeP4ieHYPCF/IieIrBSdCu5DjzU6taOfQ8lD2OR3qWx09LG3ggv7cxeWDFtAwwfvnvn2NQ+EYUl/s2K+ZoriABN0UQR4gGLKcjGSCc5PPbsK9V8SWq+JNIl16yiR9VsmC6pEBt89eguQB/49780AebSaZdR750eOZQ+EV2HX6VHMI7UiK7tzDlsvgYOf6iugxBd2RW7jmR0ysckY3D9OfxrDN5PZOxfN0+MICu4gDr9RQBAtpBPEHceW7t0UfL0/wrOgt3kMQCeb82SpO0c1utcI9sk9xbZLEkLEhH/6qZpkgdSxjjinTGwyNjBI7eooAT+y5SFP+phTgI2Tg9sGtSLQFvrAEWjrgE+ZGc72z1NXC9xYtGqxGaNwGfaCwLH0zWtYX8FsZGiY28LRkGNnxyeoxQB52fCM0dz5b/OjE8BSB9fpVMaFcGeTaCSeASePavV98lxEphkYiKIhmKDj8azLiySSeOQ+SzMgG2OXGPr6fSgDzqXw9qDSSK9q8si8bUwMADt61WGkTQYaayZQcptbAz7GvRxphZ4roSyB1O1gGyB2GMd8VPb6faeVLJdxTqFwobzOGz0A79cUAeb2sUNsVEaRI4BIR488H3NSCa4V5JDtaUYVSOAAeO3au+bSbOCJpp7RAxYKQxzg+n61uJBBGqvLY21sYxzhVOcdvpQB5HDYSyTuGhkCIuQVGQST1z2rcs/Dvnqkdy8y7WwdmXy2OOK68zwJIkduuISu6QxKNxyeMg+lWrbUJxA0iW115TjB5AwRxxjrQBysfhtwlq1wZYsthRgKAAa0mi0qwdoGkiM2AQG6DPc+tFzfXt1arHBGoiA+VQmSPdj61imKSONI5ZoJS7EkuhBXju3U0AaWp61BfWhgCzSKHAJX5UI6c+9ZcVxDFdIi3jbwflRF+ZR6ZqFxLcQNDDbGdQdrFGKhm7E1Vexu7l18mKOENwIo+CB2yaAJ9cZYJnhhM5ckclunTiqsmizXqWhluYPJIJY4+5/vf4VeuNEn4trdSb3kuAcn65/oK07PTJrK2ghv38psjJJywJ/2aAPKvFGjPo9/s2OsEg3R7xhse47f4Vi173q2mw3nhyazuQD9qO8sVzKzD7uD1AHU+1eFXdu9rcyQSjDoxB9/egCGiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKkgjMs0cYZVLsFyx4GfWptTsLnTL+azvYjFcQttdT/npQBVrtPAHh37ddJeX6slpyEbB+9/e+gNY/hayg1K5ls57feZAu248wr5ADAk4/iyMrg+ua9m8PWBtbmGO0JCH5Uj5OxQegzQBTs9Hi0q4F2br5wuHjfnzVPTj+tbOi38ei6tb3Fhcyx3MeCysuY5F/iR+xUg4Iqxq6QfvoNQt02RIUDJ/Dn37Y9KxNL1O4SbyWtEuIEBEkTH7uBwRjvigDe8XeGzEU1bw4rTaVeEhF3fNaS9WjY56DOQe4xWXZadC25L2VLedxtwyZPTqD068VveDPEOm2zXVpqvmCxu1EdzbuckD+F0/2l/lkVPrto2j3wsNQdLm3kUtbzoufNiPKsD6EfkRQByWoWBsbdo7qNlizw2dvQ8HHes6K3tmhcxkNImFIK5IJ/irS1145dsMzO8RYn5jzGR19qz1C28CCJmc4G6RvUdifxoAvW26UjMi/O3IQFclRj8KS7kW4vlFrIqsqZdZk3Ej69Pxqsss0ZaaJT5RYMUxn5iOfwq9DeMA6vMjBVGQU5A7AHvQAulrdx7otpAkBDLHyMep9sUptrtndZoYHhIBBRuCF9fetW3ORIBBC0rqCojkwwPaqyyXbKS6SRSlTtk7DJ6ge4oAiuYbeC2YWKx+Yw3Sqx4U9gDT9EhM6tuhjC7SrMvVD19etSzyT26JCLYmPOM7Blz71dLPCislu/wAyb3AJUkfUCgChMlmqxGdHnjJO1ZF9O59SOaYmnwGKJXui0TPvUbQA3sT9KvX8kN02xIgrggA4J2DGCc+hqD7GJLfaI3cIuUVV6nn+vegDOafSorr5bAbEbayjIJPoPUU/Sje3dzts7WCGPJXIHzKn48VJdxTLLbzz2UjAKUYOMBCff0qxpDXn2siD08thsJVR0Bz/AFoAi1O0mSzcW4Ldc4wNo7EgcGvR9B0K8t/hbqDXnh6OaC5tWS1tkjWWcMV5mkmIz1ywwRtGFGT05GWwkENzbvcWvmzvEfMScFEKFjgEDgHPP071z91aW9lLi2jge6U7jLbyCSPp2IHXkigDBsRK6LAIpInjbKSdMj/ax796mvryOwmAhfznCkPJEPzBz9etabakiyoziXb90s3zfL3FDRWxZXt5IWjZSPm4A4yMjnmgBNPvNRl3JZ24to3UDeoDMR3+btWtDp8cErSzLE07BdksrcBvTBPX3rMm1WACK3EZXeAWaPnb7DtiprSaOARvelrh2l+ZCPl9jkdfpQA290W/vtQYWp3xKQGkGR1681x3xA8JSSWH2uCEC6iz8ituMiD2/WvRbeW8GoYnaKGCbBCoccdOeeKr6xeJNdsnlrGiYQFTkt6AKO1AHzbSV2XxF0eC01Fr7TolitJzhoVYt5bgc5PucnHbpXG0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAFvTL6TTrtLmBIXkXoJo1kX8jWp4l8RX3iq7tWvYLX7SiiFGgi2M47A8847fWsCuu0nSEtb15YZ472IELHcRKdpyASQGAPqOnY0Aavh7S30iUJNGhdhhyff/Cu80+982EC4BBUja6dh6iuVMYkdd0jOACQ2QSPwqYahGkMaSrJv65AoA6fU7xFWQ5aaDIEkvVv+BD696zLJFkcNEGyxwAvt/WsyIMXEkbl1mXkDgMO+a07BZHlihginkdTliBnp6UAad9NFAsURjHmvyC/ynIPevSvhX4ei8beHHtfEHlSWVhcb7QxTf6RED99D6If59K8au7t5J/MnhEsxOWQjO0j3qxpWuajoWox6npN41tdLg4R8qR3VgeCDQB0nxI8NP4X8WX1lAjLYyETWzbiSFboPw5H4VhSeXcIQxSNSu/KrnJHqPrXf+LvEun/Ejw1aXQi+yeJtMG+S3VsedEepjbvg4OOoya8muL+4tNQdgjOOGKlRyf7pPTFAHSMLIx24a4KSyR+ZhPu57hvSpZrqFonaBUk2gMuB8qNjoR39c1xt7qSOC6wxxK53fukIAPofWpdKuHW4ieV9kWOc/dHofegDu9OCGMSS7Q23aSVyef8A69SS6y0E0MTwymY5BjGMBfY9vas6x1SKzsIlZt5XDlon3Z56Y9c1WuNSmkiLGN4RtJXzFBBGex60AaKalKkqRCKaNAuQCwyp7nOKrw+JWO+GVS/lrgMcqW9Oc9vasV9Y1G3TaZ4p+QyKy7goJ71Yj8RTTSxtJp8LyqRuOzBA6cdqANIam7WkUkVvHHLziZicHPHIpq61d3cjgv5aMhAZVJwO4x6cVqJqEs0SLFZ2axvlPMwXB/z0rEuYNakMUcEkRjYZzBGdqj6jvQA691y7mkTzImuIhlCrcAnH6DpzVq11vULeOEQ/uwGyRGu7BPAyaoxeHr64ufMupFMYXczGQKfqR71s3V5LbWJ4RIY08tRGuNx/+t60AUNU13UptNmRYhJLM8RZ+VKmMsePruOfpWDLqUs7ebO7HLfMsZ9uM1rQW7XcMspuJI2XlYlQt175zipLTQdPd4kheb7QciUKMqfUD/69AFKOF8Ss0USwld2A+4heOvqal0BLVn5lKys3TGxR7fl6V1KWemRaSyXYeOAnyhHAPnf8a47V9Kms7wTKksC/KUEgJfb759fWgDY1gWtvORsRWf7uG5PHBqCGV7tVtIoiZeoO7O3vkdsdan+zC60ZS6wySklkBf5gv+FN02xkfTxLMVLSEkqMA4/woAvQac15piR3bvDFzuXcNz46bT70y4tRa2M9nY25kmkUF5O656BTTEvHt4EjltmniGAitwFJ4zj/ABqzd3PnWygQKrp8m3OVQeox3oA4/WtLhNm9rO6zFuGDHoevyjuR615Jq2ny6bdtDMrbeqMVxvX1r3O80s+S8+ovGoBzHHGfnJ9T6D61xXijSI9VindrmO3mt0JhRgSZCP4AR0J688cUAeaUUrAqSCMEcEUlABRRRQAUUUUAFFFFABRRRQAUUUUAFFFacGhanNpkeopZzfYHm+zi4K/Jv9M0ARaTZ/a7oBziJeWP9K7eASyooJHynaCFxjH9Kh0u0+wpHaJty3zNnksfUGrL5QSJudgTgBzjaR9KALCRAblkYeaRncOh+lP8t5R1DqAOAoz9Paq1o0plK7RtI++eBn61u6ZpDxymZWaZdv3V4ZT647/hQBWhSEQb0VkLHaUbse+D/OiOa4tYFNjNgo27IJz+Bzmr05LSmJy0Sv8AKSxA3H6f1qXw5omp6nrS6PpkMl1dYJSNVG0D1Y9l5GT0oAqK4dSJZEiugm4rKMB81lSzyRJskAKMuMryCM9Pak164a31e4t7hNtxbyPA6hgVDK20jPsQeazLpj5iSI/ysORn7uPUUATRagbaU7Jih6Bl/hqMT3Nz5SmTfK7feY4H1qnLcRqSyqA3RhnrSfa9/C5MYGR0B/8A1UAWbhZFYRTLJkdWHTGaI5WDCFpWKjkcZGf5Uw3REuANpXG3DZC057iS63qZBuTpgAbvagC6l09rcRhm3qR93HHNdH4c8+9mQSXHlMBnLjcMYx3NcyI54CssyNu6J0NaNnPJHCFdWjLNkJjrz60AdfaWKXsl0HCu/mKvzHGfoK2U0CwikhVZBAw4fbLnNZNnKGtoZN5ScDbtKqqlfXIq3Z297Pez26wxxfKF4HzN3yM9fegDU1TRtOiKpb/aAMbWVnILNjO70pdMgigtltkglBR9z7gXGKkj0yGPT5ReXLyXcTjzNygAr6Kx7/SsjVL4PdE6bJc26Mu3BO4KB24oA0NRYLcAwQMquoBdbfAYjpkE1l2dkNRkeGeMxPkM5fK5TJ5GelZ1xc6jZXLW5ukYOwUFs7Fz6k1JaSsscrS3qFtuzHX3O0/pQB1ElppiaYqx2V1HMxIZ8/IOP14rK02VI50S2mMaKSQxADN+GKw/7QklkMN3OyxRDekWOfw+vvVdbhWkSZZHjEZyfmLAAjpn60Adxc3VpGI7kxPC4Bba5wzMM9K4nxVq9zqN/FJcOY0K4+ZtzDNPgv8ATYJM6hJdXGW3Hc/Q+1Vr/wAR2jL9mis7SH5gPO2b3J/HpQBd0V7WOAJ5sk0wyq46n6g/0rpLRmEUbyxKjk4CkZOD2FcRpeqOl6hiVGcuWDEZyD2rqvtE094ftXmRxgBlA+bBHUf/AKqALN1cCfUkRIizKMEMcDGO9ZN3ayW9y0shQHpgAjb+HerV+yz29wtsZJYzjLZwzj8fT2rMuNrqJVBQlRuLHgAen1oAzrlwk8jN5YDLkbiSB+HrWddyeda/6SHJA5VR97Hard4z3Dh0JcLxwP5VE6+TGXnVzKoye3XvQB594j04J/pUKFQf9YgHC+hrAr0G9l8xhFHEDEwyy4zuz61y2v6DfaQLee4tZo7O7Be2ldcCQDrj6f8A16AMeiiigAooooAKKKKACiiigAooooAK6rRLm/i0sWMk05tHk82OAuQiseN2OmaxtGs/tNyGdQ0ackH+L2ru9OiSVC2wOpPPYr9BQBnuhDbJdyyL1A7/AE9KkgmCSm4JLRj5eeufQ1cu7WZlZCQwHAOMD86zNrRwAO3z5wy7aAL6zmUttjKIffBANbWlXcixu0kokwMAA4+WuXkhuAyMjERkYwo/Wr6RSGMOkhYrzgnHNAG9D52E+2NiAEsCV3gD1Bq/oWq6d4c8daRqetXN28enzLPttIleVztyqkFlwpU+p+lct/bAtoJIb03FxuUiMpNtVMjncMHP6VBqMggN3BqcMz3+xDHKs4wuVBXcMHdxjuPSgBviW90/UfFeq3ukG6ezvLmS5AvIljkVnYsVKqzDAJODnkelU5LKWU7sBV6hhxj0zTbCzklZ5EI6c9vwFbul2jSOpug6cbdw6E+/pQBitp8/ls5gd1Ax8q5APqaMQCw/e28e85G9Thl+ten6HbyorSQxCUeYVO8ggkDj3q+fCsHiC3Zmt4o5S2fOjJxgjuPagDx/T45rp8W6If7m4gFvzraj1BEhNtf6fbecMKrgYYe+RXSv4BmtJWD7WVGxlWyv+PvWzD4X0qExGeS3lhdCHZJCCeeMg96AMezltJYlthbQYGG8yTLMvuAKdqBmVjGtyJ4wN6qFxwO/r0rTDf2U8kNuVdDxu4yPQkmuY1i/dLvcI2Vv4mLZI9//ANVAGmosVmjI3whzv5fI6dMdK39OuLO4t3kluJA0Y4xxlj6H0xjmuEa+jz5cUYYDk73DDp0HvV2y1NF3QLGUXGQ/Bb8+lAHoEX23U5DZRk3MCbW24xn3z3z60/VfKktZbKznkikYbTbwxkKGznqe9YHh/VLiIhbQ3Mly3AO44Vf7px2p6ajLFfyTQRy+eSylScc9SMj1oAx76zDXHlzo8ZH3TK3BPrisVx5Ny5uC0YUhkI4P612HiC+nVIZo7WGMou5XQZIPZTnrXI+IY76+JuJx9oYHLlMDp247UAR20s8MrvbGSQlSXYgEMO1Z/wBo3RyE7g0mdwzhc0It0EKxoRDI2CwHT2qzdQfY/KVI3Ayd2/jP0zQBWteE+doGA+VVORkeua1IS09x/wAeiZGNxKbu/pUdlbQzTOt5cLDDt3AhSzEegA6Gt+yvILaJo9JsbyWVuFl6YGOpNAFfUdPl06WG8EQgUt/rJSB+S0+O+RrQG5kjk2vyE4+uff2rY0rwfNrCvea1cyRhTwOSW9hzzWT4h0630uWSKBDiQ8LIN3b07UAJe3xcxOgUSFyPlPKKPxqpcTySTb1Jcc7ghAAx04/wqhEDJFtWNY2LY9cev0prGWFPNEeNjcsWxn2FAFiSZoYWdZT8/O3IGB71SvZ/PVEkQKOuckDjvU/2iJ4ZGeF5ZW+UbudtZQVYppDc7mDD8fwoAiLRyKyW6OZG4LHpj/Cq2ufatRs4bK6nkaO2U/Zw7fJGPRfrVhzIkjlQfLBC7VHX2qG/t5ppFDuo+p6e1AHCupR2VhhlOCKK6HW9NMwEluh8xflYf3veigDnKKKKACiiigAooooAKv6HNNb6nDLbJE0i5/1sQkUAggkqeDgGqFdRo1kILclh+9kAy2Puj0FAGlDBBHaCGONSqfcYfeJ9asWk8yMgKksDtDDPX3qkyeUNobLjowzxUysWBVpWXIyT0yaAOy0q6TesVwYiknB3Hhc8VH4g8LO80lzpOJIlXa6BuM9yK5+wubdowsu5sLyA3T3966zw3q0BuY45ZJY4yu1mU5UfUf40AYOl3sEUItdTtmGw4WQLn86lvJLZIElXEZOQ2/Iye3Heu+1Gwsr22eAfZtshxHcwjlW/2h/WvPtb0rUNJnZLlo7mIj5XUZGO1AHNXk6hpN6qykgAg5Xmq8u6ebzJ2Mj+pJJ44HX2pb1gZF+Up6jPFOto3aVFXJJwQf6UAdBpkTgeXbSKJJThkdevH8PvXUWNvJHZxSTwSQhjlXGCDjqcGucsvNYq4ZiEIyrHDY+tdSuoQR2Z+ZQyADbIc8noMevvQBqaNJbzXDFYpHSRdnmI+CWHPfvXRacqKXWCJoZQu9ld9pX3yDjn6VwEN7JJO7xBHLDaqr/M9ga2I9ZaGKOO2jJuChUoRkv9aAOmm0yKSd2W4dX2htqtlc9wT657Vz2ppFZzqGRnjlyZCpILHsKhXWriR3hYmKMjDBB0OO/qayRdTLqCRSzjZjKq6jcuOhFAFbU7mKa6W2ieSBX+VgxDDA6DNS2WkW12mbuWdYlOwuABzjrjtRNb20bMwdLggne8a4Jz3/8A1VZSwtLu3RftbtEhAfcdrAe/qDQByM1tHbNKi5dVY4dVPzCo7eS4juIRGxRXxnIz+FdFrtg+x4baVWbJ2qDxjHqK5yW2ldVBLsU48xO34d6AOs0i+ngmL28kkUoA+VTtL/jV+a9tTEvnfaRfnksAMDPXNc7pVkk2wyOJXxmNi+3Z64966CHyYYZHnwy52pu++cjtigCfVdVa4tobJZ5GU4x+6C+YMc5NUrLZLbXMW6TYfmJVMMMd/Ssy4nlZy8JygyQzDp+PerWjvdSmSSZ2d24aJeO3FAB5EtzLL9ngdwzfIdmSB64rInsL4TsbgDKZCiQcn2/rXoVkESFGKSJgZIhI2qe24jnPtRLFGjo05a4j28BwMgk55HrQBxun6bOZvPd2dTy+ep9uK7HS5IJ2aJHmgCkBlDYKj1Jx+lUxd3SXXmKgaL5twYcD3A+la+mzuhBhQFyRt2xjbk9S1ABcXMdrIDCszxRrgY3Dn1561xmuWsr3Lz3Nx5TK2Qm7cTnp+ldfe399JKYZFjVQCwVeAaykjsRYST3Cu5XlFJyW59fr0FAHHWpd58YMcWSMjHPtUsrpIBHjbHG2D3zS6w6qUbBEchzwMbj6H1rNvi0cKmRPlL7QVOMe35UASm/axjfaGwxPl5Gc84/GqjGRiskzYR+VDLtJr1H4iyxan4Y8EStqmg3N1p9nLDew2d3bsyOxUgCOM9MKckDAPXrXm15drc7CsZUAcLz1oAqyGMx7wTs5yKNhl+5CxcngnnA9cVHZsWuQJFG/p8o4I9K15BIiFFQmZ/4h6f0oAyZIGQFWjbJPy89aKstbq0X72bcxP8Z549KKAPMaKKKACiinKjPkIpbAJOBnAHU0ANopansrZrqcIoJA5YjsKANG1t7RobSaBbgSqjecZNuwybjjbjnG3HXvW1E88PMgVSOSQOCPeoxGIFWIKFTaBg+laNoI3URtg5HzEHtQBFADcIzqRuOfl6ZqNI5EkyrcgZBAIA9sVcmgjjyY5AGjwACP1quBvkB8xlYdcdG/CgCOUSxOJkT5h2I7+tTx34VGZSwlI/hOB9K3NI+zyEYZCP4ozwQPUe9aWp+D0vLf7XpUokUrllYYP/16AOe0PWbi1y8TMQOST+orpbm4a9j8+ErJAR80WdwX8O1cBcW9xa3LI6vEehQjH4Cktblo1fY7KW7E/wAqALGoc3EmEXC8kg8CrdjCJIRIshWRAGwBxj/69ZW7eXMgYbhggc1f06ZYyW+ZVK4wvU/4UAdVawwNC01wQpwON3T8O9RXJf7RuR18gAKCDnIrFMjTzCPDlGwSpzx7jFa8Mr21gWjLqXBVmHII9x6UAadqtzaK8ywId+AUiGdx9fQ1LOl0LmYqoNwE34CYA+tV49QAj8pJiqhAwdV5H0rZS4vJ4muf3R2IFZkk2swPXPrQBTt9WtoG8q+tvLd1xmHIA9SfTNYuoatZm7iaEAhWK/Mfuj39as6g2xpTsSRf4gx5/HFYX2WCZQ7+bk/dCLkD24oAmluiHYh40iTozZUE9a0F1SS4syq25Z2+dmUg5P8ASsWKM52z7tobqT1qnNcSx3LNFJjJ28tjH+NAGi16fIEUDvGxbPztx09ap3jbX2Krn5cE7+p9qoTtI7IrSKRnoDT5N0KqmGK+uTjFAGlbs0ax+bIAykfIDmurmMUkUMqMd6LkMCBz9K4e1nZZFKgkhSD8ucVeWR3Ksw6cEIMHNAHQQzIkkkLQmeQ5LM0mwDPYCrumFPlhtZpHJPGEyFH9axIZXYFYGG9gM5XGMD1rVsJkWFGeMxyA43Be3oOaAOo06e2MaRKi5ibO6Q7DkduOtaH2oXEUckrx+YXLEMfv+wH9etYCiW3SK5mIkBbcICvK+nT1p8F1EJwlxBKrOxfLZwp/pQBpT3M0lurCKOBo8hV29B9D19qzXluEtsTjzcYBwcZH1rclvoTAgMjPI5CYUYCn1Pf8ayTHMJ9l47yJk7EU7sjufagCd54DpgMEDPKigbR8q+/PU1z0EF1Fcxu5RUGTtZSyofbJrpA7pbstqEYBeUJwxz6+1czfE4eGeFAwcY2PjaD3oAoajdC5m2ztLsDZD7MlfUhRisxnG1ohPINPM/meebfkNsxwueuO2fermptHHL+6YyOFB2lsE8Vjy3M8sLws22NZBMRtwQ2NufyoALmNJL7KStIp5EjDy2I9x2+lTWSl5NhXcEGN4GRVczIpaOIiSQ47Zx+FaSW8k9vGodzLk/u24wPagCWSzt5ZkW2fMjc9eRUltpojhKSyCRmyOGxyfU0W1o63AuZ2MKIuOF5NWXkdrhlijV2UfeHIX39M0AZZtljlYM+7adpXOc+49qK3pY1WMMzbRjG4EAmigDwqiiigArofBWqabo2sRXupwXU3lk7UhZcMCCCGDDkEH1rnqKANzU7ax1HUtRn8Pq0FhGnnLDdOiyAEgFF5+c5PAHOPpV7SLPyICqjMzcse30qp4esQGF1NgY/1YP8AOuheMMV2hCucEg/0oApyRKoHlkmQDOCcjFLFtVMrlW7getWpUiTayoffHaocNuOEAx0YHigCX7WpjXJC+2MmrLpbTxK6KROOfr+FUSH8tTGoMgBI4wG/pVy1ERwLndGz9FYH9DQBq2unm5aIOijdyHiPK/Uda73w9u0+6LM5ngxgSRjO36rXC6RJd2Fy1zbsm37uQc9P5V1X2uPUYkntrlbO+xxjKZb0I6GgCfxbY6Pf27TCZEnzksOFPvg9K8l1iyFtebopFePrlTkfSuq8T6neLGY9Qt42lHSRDtJ/Lg1yO5iCWO3PDZ5oAii5TqobrjNTwuY2yfmLc4B6UiRxnhWB9CO1SomMBvvDjnuKALFpMYLpSGJ/3T2rZttRZrgLEgIxtDHtWIbUxFCVyQflKnrU0ESS5Una5+YEMR+HtQBrqyxy5AlK7iCo4xmtq11G2gQQxtKBEQxV8Ffz/pXNJd3FtOEWXaWXpjOKjcmYHz8EqdzKrYJFAHQajJbXFq8sTLEx6KO/Pauee4u7aR1tpSV35OQOTU9tqMSLNEpDRkfLuXJ/OoorUS+a5n8tRhvu9/QGgCvdPeqjrcBi0gyOMmqeA8bsxZD0KnufWp5p5VbDTDgflVJhI7uY5CQOSxOMmgCEpsLNnI/vY5x6VJFKxJAUqMY9qkUSSoQ0hKsOcVXmjxIPvEDptbOKALUBWNdys+T17bav2qSXJHkziNh2YfeFZvyvtJBB6Ag8GrsDr5wKkEA8t/KgC/LdmF2V4kiYfKCuWBrSsXY24RULyMOFzgDFZkStJMPM2kJyGL9Ce1TWTMsz5zgP3PUUAdTpsiyBollxuIJAwNntU8NzHHeYluRvR+ASef8AaIrmTKEbAyPMbgDk/iamjQyqI42bfnJYdVX8KAOutrp4nQgNlnY70QMTnpn2zSGeU3atNL5a5IZFOeDxn2rJsmnhP7oqDGozI/U/rVeaSU71gYberFjz/OgDporKC+cPJds1qhGJGIXjvk1kX0kEUjpazq/UbwhIwOmTWVJfySyxWwjjUpyV5yR70+6kujGohfylb5goA5HvQBhag7yTSyRlnkYYxj9apwOkbRmYruLYBU5NaV9F5VwHYB3A5VBnP1rPhaIEv5YJY4ye1AGqotyhLRxx553J8zVo2KQJJxCS5UEMW7+9Z+mIUeQSbHz1YjOBV62ltYJ0KL5ku7gv0FAGhNpl9qLqJG22qclmOAcUt0bS2tRBCxL5DF1x+QFULzWbp5yjNgH7qryB64qq85YKGYBmOfpQBo20EdyQZGdSckE8UVkXd2EiX99s5+6o5zRQB5DRRRQAVo2Wl3Et55M8TwlVDsJFKnBGR19RVKGJ5pVjiUs7HAA713EVvKsS+fcNPcMAHMrkucDA5PYAYHsKAF2mOKMGIIAuFGOw7e9TxpJIeGADDoafFbs8OUO9IzjHqfahldWVJInU/wC0cEehFAFfYzBo5HCsD06fiKQqBGsTIzITyc5INWpE27XdQ+DkEd6fZNHHM5UnYw+4efyoAqxtIjIsY3qG6OvH0rsfDwsdQjMd/GYs8CQY/dn6Vjx6dJh3gHJ5zjn6VJb6deBwcKzsclSe3rjvQBr+J9Eit4BJbXCB+7gHa/1rljIwPzTbUHfd0ro7qdYI1gmlZWPIXOUJ9PasDUJUmIQquc4OAMGgDNuL4zxSRthx2BH61RUDbtXkAdO9WLmEKx2AKw6dzVd4SseTkHpgfzoAZbhlJywXBxtAqyHMgwGxjqzVCVKco4YleTjmgP8AvQxO+TuCKAL0aSKuEyCBkZ71Z2MVO9Cq+oGTx3qjFPIyKqElSeScfrVssGdo5Q4442nI/OgB8qqkO6Bj/tLjgD0qoREzB1BIC8k96tOsUKR+Yd0ZX+E5wfeqVwQQApAUHjJxn6igBYmVI2Q7SwOc5zgfSpIYWuCznKjgDnAFVXB+6GDKecgYxVi2nkRfLRFcdct2NACXFuYnCsAZBj5geo9qey7Y2LAg9h1H40lxdK67Fzkd+lUWeRnYoSy5Gcjv9KAGSAImTwD6cVXLL5WRgNjqT19qknDEEpFznr1ppUqfmyshPBxjFAFm3jaRQAw46Y6j2qzEJBOEBWUAdCOFqlbGMM38TEfNnoDVi1CybnBKrjkCgDQ8yJ2255YYY84NWowBG2xwVfjFZsa5kA8pj33egqwgQxBEOHUEOCetAF8B4miAVHd+GBPQVozFo1R9/wAx/uEDA9OO1Ykflhful2H8W7AA9hVpGEu3yAy5H3mOQR9PWgDUuJZZJF3SKiHgAj5ifc04IiswaZXI7AgAmswps2hSpCkFgW5/L0qypErJJ5OUJPQY59KAF8sIZZIIpEjIySCWz/8AWpBfvFGVtnYseMsvQfSmXtxIflhG1j0HPJqmrzKWMrK4xznt7AUAS3Dv9mLLukbPOFwPzqkl00MO5yCfXPIHripvNmQiNWBiHPA7VDevEZT8pSMjjH86ALtpOfLIJYbucZwKkRVlO4SkKBjatZkMrq7GMswHTI6mp47xtzDzCAR1xj60AaKRRxqrxg5xxnnNVLyRpQg8vK9cjgio4XjVChZwQPkGepPrmmyFmQLsIbPHOAPfNADQUU4KAsByTn8qKhETZb5xnOctzkUUAed0UV0+j3tpN4bl0p9ItWuWuVmGosT5igD/AFf0P5cnjOKAJvCOnxKHuLsEMV+Qeg9fqa6L7KI4wJDveXkHH3RWNHJ0Vlwy8jHANWINTCs3mDlxtznpQB0lnbxIrFc+RHgDP8RpmqaeXAbc4fG76CqNhdcrGJNoBz+NbguGaKTzQd8uDuxnC0AcxNtQEO7qAuM4yDVxLQyqjwPkpzuUcj8KfdrGXdVCKcdVGaITJBhraXYRjOBmgDpNNnhMKrqLEJwonQYyfQit2WwsZdkscwMidG9D7iuPn1Z3hKTKsbOP9YOFb61DFqEjWzRrIoPThiDj60AaGsXW+RoJ1hUg4Dbcbvx9a554FbdJD+8weUB6fhU93M7uwfZKeMbuxrMiF3BKXVSEPXHegBWZcDap3Z53DpQ8SSjBUbz0K8GtWzt4r5HDMNzAjbnGKqy6PcQELFHIynoSOR/jQBkGJll2/wAxTFQ+dtCEDqSBwKtSh49ySRyq69Mjg1WBCMQB8/8AF6EUAPk3Rn5x8rcEYBAp8aoCGLtsPJDdQadtUnkN8owSDkA0ixq6ttcmRenHOKANK3t7dk3mdT3Ht9arXkEYkLIQxbg7f8KqgyQxNyqsPxFSR3xdUR1RyP0oAjltyiKdxC46kdPanW4i80CUORt/h4BFTSfvG+5Mu7t2FNjE8eI13HJzlx19qAJJWtNmDEwbHfpWfI7u+1duzp1FatxBcTRjEIZcdk5rPIeMfONjjsV/rQBUwd21xtOMZHJNNAVuNg44y3PNPkjuJXzEu4e46V0c/hjXbLw9Drl1o13FpMgUi7MZ2kN0IPoex75oA52G2fftYKF6/wD1qsCzljDE7Qp6Hqf0pGnDqzEOuO/GcVYhlAi3R7Wdu2cUAV0jEYJd8A/xAkkf4VJEY/ODEFkUfL7k0+HDyfPHw3VkOQTV8wKLfhcHOckUAUcL9rG1XwewOK0raKRzmGNkCjIOTz9feoIoJQyrtUn0A5P410mkaQsxBuLp48/wgE0AY0dtI7nzZUVu5HU1IIJBOVt0lYY+8eRmu8h07QNNiLzAySYz+8b+lZ97q3mlks4UhgXoQuCwoA494ZY/mmYpjJ2gc/WqsK3DXW+NtqgdWGdx9TWhehZ5Qpdg68KFO7n3p62V1dBASxXJ5PFADUtfKTztwDsMkgdfwrNuEjLAHKg9Bj9a3vs8FpEWuZ8+2cj8qzLoxqxMa55+7yeKAM4Rum1UwSR82eBSCJZWIDfP1OBwDTndjKAqYUdcccVO8CRpkRtkjgDkfjQAy4uEjUIqB2Hfb1NRNcnZ8+1X6EEdKR0l2ALHxkDkcU2MKd7MqlicKFJ4/H1oAaVkkw0j5BGcBelFOjlVHZSfz70UAcBFGZZFRepNdBZxLGvlLuXA7iqkVutrJIYJfMUOQrFCpZM8HHbPXFWw525C89x3FAFpSduARkDtzTjghcAAn15FUkUhzsIXuCehqUMQxzgkHgA/yoAvKTggEBO+D0PrW3pt7JHF+8JkB+UH2rm924fNtGe/WiCZopCyORjop6ZoA6C8mSOUzQMNuMbSeKW2aOfaSCrfxY6GsgTmVA8RCnuMU6GcJjzTnPPBwRQBfmkZZFSZPkJyhzwamgugobfGu3sw4Iqj525G2yF1IwATyKrOxK8P8vYdOaALlzdRAnarBgOeKbb3cqLHknaTyegrPZ2jlDOQYz1Iq1C6McOAFAyDjkUAbIaKQhnBU4zuHX86ltr6aCcD7Y2w9COQKyYrjC4yQ36U6KZfMC+UrK3Ug9KAOwmld4yZIbe5U45HytWVPpunXjtske0uP4g/TFRJbSgCW2mZBjkZyKo3Vxe+aVuNoQfxHnigBtxpNxaSHDpcRj7pRxwKqMfn3MCh6dOauwBD+8SRCeowKhlleQv5zlecD5MYoAzlLBm2l+O+O3vTtn+kK5QBVHBHf61aDIEVGC4/veoqJ0QSEx7pAx456UAacEhVVkhkDuwyFbpW/oVxpc6ZvbI/aF4PlA9a4hN7MEZtpHYmtW31FYbc7XZJAOooA7+XSYLyEtbAx8fxPgiucvvDTA5SVJFHQBSxz7GqWm6+0UqCVSGJ+/k13On6zLhZPtTGL+JUjGfwz3+tAHnbaDq+JStjcvHuC/L6kEgH6gH8jXq2uavpkHwyuNItPEy3OqX6pJqCy2U8e7YF2wQrsCRqNoyc8496p3HiqKKKWcw3rWccsayT+SnmB9rbRtB25xvxz9azT4r0+6uCJLWeeAcq0yKG/EDIH50AeZwxrC4DR4Dc7jzTpJEZ1jixlThQRgGvRtQ1rS5k8m20w7iM8r0qgh0xYdqwxrcnkeYnegDnbOB4wCzJvHYcH6YFasDXM0ZV4XOThQABio5702DZWMls54UFT+FWYdcllQEPFEM5+WOgC3p1tBAQ10zj0UDkfU0mqXUckZW1LJjqS5BpP7XQIzHEh75GM1iXU0t5c7ljKjHVWFAE6zMkIBQzFeQTVWS7mnYqJisZGMEc0y5uJI12xDkjkN0qGOaFpPvg4GMhc4NAFu2uTGw8mMLt43Y6/Q1aOoM+M7skevFY1yysuV3Kw6DOAas2cpdWj8xSwA+6MUAW4UjWTfMPPY9AR0qK+uXOVii+XsAOQaesEaMzSzEZ546/Sm3VzbxqyRJkkckmgCKG2QqHnbB9CagupbZEyg3beOei01rd7lwVDIpHLZ4FVJ4IVbGd5Xjg5A9zQA2SVpHTyyxyP72AKikzwrEAdz6fTFNYorMC7Dsdnf6moQVO1ACdpzjtQA95kAAWQk9tooppKb+VUjt0BzRQBkIoyQflA6N708cud3LfT9aiXaIzg89RmpEb93uZfxFAEjDClVxjPPNAdNwZVIK8Y9ai8zYAcnaTycUMSAQGwAfTrQBbjZGJIAAPb1pCWYgKOR696gwFTLKd/se1LG23JBOPQ96AHmQh/vYPXAOMVNDIC2UbA6jIqNf3hOBz1yDUZIHf5c9D1oAteaQ4+VfLzwemDTkllLkLhgemDVQyglsY2joOmaVj8owMMeoA5oAmaY+bh1xt4x609cPyOn8QNQWzEg5G5T6g/wA6MK0vzcH37igC68iggEYAGQScGgP8wbOd3vVby85KHcByAadGwDqJB8oPQ8flQBpWd7PBuQuxA5Gac13LdJtl+6eSMZ4qIYChoxvHp1p8LpKu1k+71XvQA+3JgUDaqrjIfPH0olu5PNTIBD8HPNa2mzIqBCHX2cU7UPsjEFolWQ/dYUAZn2CeYExrHtPTjnFV2he3lWOUbVHQg1Kz3UTFFdth7j+VVpBMQHkLM3QLnj8aAFnCOCchscZH86ZG7cqgyR3x2+tNxOUYqOh/iGKWJuqYB9fegB0Ux3KZ8FV5UEZFba6s3lqiEc8jbXP7EZ9yFwndcYP51NAu7HlK8Z74oAvf2hf/AGWWFJyLd5FlkTHBdQQp57gE/nSQXM0ilWnJGPu5xUcqSINwdWwM4IxVNWKz/MoLEZz2oAvwXjRNiNXLdyRzSGSZ5xu3Ek8EDcf/AK1XrOZygLRqSB7VFfXLk7S0MYPTAGTQBG1y0ce0mWUkbcNwKdbkB8JbhHb5SzHArP3yYGCHLHg1JIJMj94FUDlc5oAszhxKA8oz6etORJCHLM4IHABqgsYeRWeTG3kcmrEUsvmbo5FKZxigBzSiT/WBl/3TuNPlCFAEDkDpx/SpOHBCBQ3c4p8MwtVLM5YAdMcCgCBbeV8Exu+5eAVwB9auwQARhZHMfP3U61VuNZNwAofy06HcMZFGlyyO7LGDISeWzigC/LHbxZcwHBI5laqv2oSS4ijjZs9QOlWruwmnCm4nCD0Xk0yGSKyXECGR/wC83NAEckFw8e6XeEHI3cAVkSKGJjjZX5zkdBVy9mvbxvnbEanGOlUZJWiCx5jUk9u1AETxbCA7845A6GqTylpCA+GB5OKW6lO8rljg5JJ4piELIWZck8j3oAQZwOGGO3c0VGzliVJOevTpRQBWh27Q6nB74OaHOMFSTn0rJimeI/Ixx6dqvx3azLhiVb0Pf8aAJ2cjiQ9eeBinebhSMAjqOKgDM7AMeO2R1oO9T0O3p04oAttPhQCgOeMmgAnBXDFevFQyMrAMCDx3FKqMPuYIxnINAEispxvwpB55604sTgZBGeMdaiI47j1xzilgPmkq3b1NAEpXoVfao9e1P3KeQQvv3NRzFCwCtu7YOeKUfMRgEDpgnj86AJlnaPIG7DdcdzR8sbExkEn+I81BvAyC2F6NmmAjO3rnoTQBZWVSeQ289cDFNWQEYwHAOfeq7qBj5s4OCfT8am85VHz/AHe5zk0ATRNLHhg+1iM+1WIX8xhvwOckg45qrvDglOn8Pr+NCTKrlSrICOuMCgDVa/KkRzHen+yeaVmjJBjn5P8ACT0rGdM4w4K+tTQLjIQEt1oA0nkiCkeYVbGcA1V+1yooVVDemTmk+UkCVR65po+U/u4sc4JxkUAL5/BbLZ9+lI4KJlX3E87d3T3p00rbSu0FfUVD5jcFR8p4GT0oAlErHIIOwdiKkjYrgkMpHdW4xVXe+So57cdKjaUqq4BODgigDRk+Ylg+7j8qiZyH+aQ8/jUMUzABRgD26mnqxVM7hwM8jvQBN9oCqEcDae4bDGmGRnlJRNy9M1XFzxkKSB3IxU6ThW+WNkU98dfxoAkcuvAcgDuTmnJIpIEijJ/iI7VTY7iH4CtnjtSpuIyWG3HFAFpMSMW3kjPy4qQMsZC79rN3xz+NZ3lOJNzSYUc/L0zU0vKf63n0JoAuhZB8wlKjuS1OEgT+MSHqccgVlxHaAHyzKfXil807g5cLn+HbQBaCmaUnDbc9W9Ksrdm3f9yVA9jmqK3W0AFhITySKidyGAjUM3U5oA0n1K6dQZOE65PFRnVWyQh4Htms+TfIRvJO3tjinAqYwHA5oAtyagXG1mY59qqNzkgeW5PYdRSJIh+6zhjwcDk0wyPGeHOCeQO9AEbvtbDFgD7U1nEj/Ir5XjJ/wqd3jX5mYY9COfzqvkknYwAPWgB67PMB5Y4yetFQbhgnLFug29aKAMKiiigCeG5ki4BBX0PNXYrtZMbmw3o3Q1l0UAbD4JOCoJHGBiiIgIfmGfTNZsU7x8A5X0NWoLiMkbyQff8AxoAlXOduT7nrU25FwVAb17U1Am/O/BPbsaUOMsoIA64xQBIB8pJ4Bpr7wwK56du496jZ8hck+wH+NPXBAKsQw7ZoAc0yvtBBGehFPDr9w8gdDjmo2Y7doOR6E00bVIJbjPXvQBIrkICM4NKCqhuhc+3IprOpG5TyOvFO480EOpIXkNzQBIuAoKsFz37U9nVyBu/wIqrvKOWY/L2A5oB3oScg56kYoAtsRwoAA9cc08NhCEGSB2qrCzZ4wcjqOtIrliUJIx69vxoAtozFQW3Z9CcGlEikMQHyOTnpVeN2U9W3dMmlfl8DdwOeeM0AOEof7jgHvn+VIJGGdq7ueQRUBPOAQXHPIpQ4RcrkA9dvegCU3DfMBnAHCnoKkilOzIC5PUbRUUThiSVz6f8A16JSpc5yr9vagCZWGQQuCp5Bp0ksbqQHwevFVy3ALbiT0PJzTuNo3gA/7VAEj+X8pYk579qbG+GP3cdsnim7wVJG3IHQiu1vdN0WzuRF/ZbSMqoxf7S4ySoPT8aAOPEeIwXJwe6imOpRAoKknua67ytHJz/ZT5/6+3oMOjnP/Epbnj/j7egDlRMxfau3IHXGaZLI5IAVFI6811Yt9GByNJfP/X29KbfRj10l/wDwLegDkmZo1OQPm75/nTfMU43cqTx7V14g0YKB/ZDY6/8AH0/+FJ9m0Xn/AIk7YPb7U9AHLJNGCeOc9AOBUyGR1JTYOe9dGtvoqfd0hwOvF29PEejjppLf+BT0AcvKuAWdgSDyKi24K5cBCK6l7bRXbL6TI31vHpVttFAAGkPxz/x9vQByKkRqX5KnofSomlbOAQf51d1w2329xbW3kQrgeXvL5PqSaoFoyWyD7A0ABYN97Oe+30qFigbO3avfmnhWwQrALS5AbGM44Ax1oAYWAwACF9AMUU0hixJXkUUAZFFFFABRRRQAUUUUAPSRkIKkjFWfthcgyA7vUVTooA0TOpACsCB6iniWMn5VIzwcVmU9JWU5Bz9aANYOdvAHt60FgmQwYHrntVJLvIAfsc9KmSbzNu1lzn7rUAWHbauTtdexpqSKzD5VUenvTWlZn8uQKoHpRtXpkFfb1oAeY96nqGB5z0p43joDjvzmo42XgN16dakcHkE7QOwHNAAxLKNwCn6YoUh1bqG7YNRH72A5K+hFKzuHCr+eaAJSzxk4yeOuKUfvEKqSTj6U1ZC4wAAfbvTdrOwUEcc9OlAClsKEkBI781IQEUbNpU8j1FNx8uCWIxjIFMjQFDt3Ej1Gc0ASq42A5x685pFPdACOvWkVVMZXG0e4ppIVVC5BHGaAFLybjjqvTPenZUcsCQ3Uk8UzKFiRkEdiORTnfGCw+X3/AJ0APfKIW46etd9rv/ISf/rnH/6Ated3cibSMBgRyccivWINCvvEfiddO0qNJLp4VdQ7hBhYgSSScDgUAc5VrTLVL2+it5by2skfOZ7nd5aYBPO1WPOMcA8mtm58G6raXdtFdfZkiuopJoLlJlmglVBltrx7gTxjHuM4rMtNF1S7ihlttPu5IZpBFHKIm2MxOAN3Trx1oAutoNsIrx/+Ei0YmBiqoDPmf5Qcp+6xjnHzY5B7YJm/4Rqz+1eT/wAJToO3Zv8ANzcbM5xt/wBTnPfpj3rJ1jSr7RdSm0/U7Z7e7hYq8bYPIOOCOCPccVBJa3EaF5IJUQdWZCAKAO4s9G0uf4RanqcenSHVbW9jiN4ZWZXQliSq4AUYwDnPTPHSsJfDtoZLdT4n0NRKhcsTcYiIx8rfuupz2yODz0zr+D9N8Za9octro2q3UGkB/sYgk1AwwyPJk+UqFsEtkkjGDnnrXKQ6VfTav/ZcNrJJqHmmHyEGW3g4I4+hoA0R4ftTCsn/AAkei5Mxi2Zn3Abyvmf6rG3A3dc4PTPFZ2r2UdheGCG/tL9AoPnWu/Yc9vnVTn8K3I/AmvP4ovPD/wBmhXU7SHz50edFVE2q2SxOOjjvWXeaBqFvq76ZHCt5dqobbZOLgEEZ4KZB60AZVFXRpOolJHFhdlIgxkbyWwgU4bPHGDwfSoLu1uLKcw3lvLbzAAmOVCjAHkcGgDkdVx9uly2ME9qqFwin5QwAzuPFWdXx/aMuSQSeKz5XCgCRlGOlAEvmKQCgJ56AUyVnCkkYBOB7VXkvVHCjd6HpVaS5kYnnAPpQBeDhVyZlH8zRWWTnrRQAlFFFABRRRQAUUUUAFFFFABRRRQAUUUUAPErj+In681MLpsAMoODmq1FAF77VGyjeDkd+9WFmQqFWUAnvntWTRQBrIHywxlfepFkwgDLnP5CshZHX7rMPoak+0yn7zbh6GgDWBG4btoX6daRXwCVAx25zWb9tc/fVW4xS/a8sTggHsDQBeWThiOSKUbiNy5XjPHJqvFeoFKkY+ooS8QHg4+uaALXnYQ5Zivv1phkywOcjoCTVeSWIkfvBk9gOBSsYyu3cuR6EUATmSNQOBj6ZpdxYMRt9/pUCXCICFYH0pFnO/cWUD6igCRpFZGQnGO9e5+EPEFn4Y8fRalqSXElqlsY2Fuqs/wA8G0YBIHU+teGSPC6NiRRx0Jr0nXP+Qi3/AFzj/wDQFoA9C0nx9oujQ6TpthBqMul2MV4WmmRBNJLNGVGEDYVRn+8TTm+Iumr4R06x8rUZ9Ts47WOOTAgEYiZWI3I/7xfl4DICOCSSM15ZVrS7RL6+it5by2skfOZ7nd5aYBPO1WPOMcA8mgDd+IGu2uveMLnV7CW/kgmfzAt5hXi5J2LtZvlHbkfQVoeI/H02taNcae8OoKs23Jl1e5nUYYNyjsVPTuOOvasVtBtRDeOPEWjE27FVQGfM/wAoOU/dYxzj5scg9sEz/wDCNWf2ryf+Ep0Hbs3+bm42Zzjb/qc579Me9AHT/C3x9p/hLSpra6S/jne9jumkto45VnjVSPJZXICjJzvX5vyrlL+fw7e3SXCx6lZNPeTSXEcapKkUBbMax5ILMOQdxHaut8N6XaSfDnV7rWPD9uLaO3kSx1GJZDcXN1uJUjnHlqOp2gcdck1yaeHbRnt1/wCEm0MCVC5Ym4xERj5W/ddTntkcHnpkA7PWfHOh3nxHv/EdjeeIbCK9thE5ggg81GURqAAzkMpCHPIOSOozll38QNHvNW8SlbW/02z1aK3jW7slj+0qYjksygqvz/xAEdB1rjB4ftTCsn/CR6LkzGLZmfcBvK+Z/qsbcDd1zg9M8VnatZR6feGCG/tL9AoPnWu/Yc9vnVTn8KAPT9M+J9npqaVBBca68Nr/AGj57SOu+czf6l2w+GZTkknoTxmuK8deIovEj6HKhuWns9Lhs7iS4wWklVnJYHJJGGHJwfauYooA4fxK7DVJVDEDrgVkE5rV8T/8haT6Vk0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFe5W2hX3iPxKmnaVGkl08CMqu4QYWIEnJ4HANeG19EeDfEFn4Y8eQ6nqSXD2qWvlsLdVZ/ng2jAJA7+tAGVc+DdVtLq2iuvsyRXUUk0FykyzQSqgJba8e4E8Yx7jOKzLTRdUu4oZbbT7qSGaQRRyiJtjMTgDd068da9B0nx9oujRaTpthBqMul2MV4WmmRBNJLNGVGEDYVRn+8TTm+Iumr4R06x8rUZ9TtI7WOOTAgEYiZWI3I/7xeOAyAjgkkjNAHnOsaVfaNqU1hqds9vdwsVeNsHkHHBHBHuOKgktbiNS8kEqKOpZCAK6H4ga9a694vudXsJb+SCZ/MC3mFeLknYu1m+UduR9BWh4j8fTa1otxp7w6gqzbcmXV7mdRhg3KOxU9O4469qAIfDH/CW6no91Dp2t3dnodqvlzNPqLQWyB8/JgsB83PygHrXO6dpc2oauunW8tqJmZlDyTqkXygknexC444554rufhj4+tPC+mS2N9/aEaC+ivkksgjGTaNrROGI+Rhxkc9eK525vPDd/qkF9dW+o2/n38s97bwCMxpAzblSHkHdgkHOB0xQBYuvh7rlpqFvZ3R06GS4tzdRPJfwrG8eQMhy2DnIwM8jJrO1rwlrWj662j3VlJJqIQSGG3/fHaRkH5c10V14w0rWPibFr2u2t0dFtWUW1lAikrHGP3UZBIAGeW5PUil0zx2lzeeKpNde+gk11o2N3YYM1vsfIRQxXKEYUjcOFFAHGDStRKSOLC7KRBjI3kthApw2eOMHg+lQXlpcWU5hvIJbeYAExyoUYAjI4NeraZ8TrPTU0qCC4114bX+0fPaRl3zmb/Us2HwzKckk9CeM1xXjvxHF4kfQ5UNy09npcVncSXGC0kqs5LA5JI+Ycnn2oA8e8T/8AIWk+lZNa3ib/AJC0n0/rWTQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV6pquoWc14XiuoWXy41yHHUIAf1FeV0poA9I+123/PxD/wB9ij7Xbf8APxF/32K82ooA9J+123/PxD/32KPtdt/z8Q/99ivNqKAPSvtdv/z8Rf8AfYpPtdv/AM/EX/fYrzaigD0n7Xbf8/EX/fYo+123/PxD/wB9ivNqKAPSftdt/wA/EX/fYo+12/8Az8Rf99ivNqKANTxG6yao7IwZSOCPrWXRRQAUUUUAFFFFAH//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Benign cystic teratoma (dermoid tumor) of the left ovary is indicated by the arrow. The complex nature of this tumor is demonstrated with both hypoechoic and hyperechoic echogenic areas intermixed. The similarity to surrounding bowel and overlying abdominal wall can make this tumor difficult to visualize. The margins are measured with the electronic calipers.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas D Shipp, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Transvaginal image of the right adnexa",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 310px; height: 249px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Benign cystic teratoma (dermoid tumor) of the right ovary. The complex nature of this small tumor is demonstrated. The long arrow indicates the solid hyperechoic echogenic portion with shadowing of the ultrasound beam distal to the echogenic portion. The short arrow demonstrates the anechoic cystic portion with post cyst enhancement of the ultrasound beam.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas D Shipp, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_2_16424=[""].join("\n");
var outline_f16_2_16424=null;
var title_f16_2_16425="Vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus infections";
var content_f16_2_16425=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"13\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus infections",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/2/16425/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/2/16425/contributors\">",
"     Franklin D Lowy, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/2/16425/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/2/16425/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/2/16425/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/2/16425/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/2/16425/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The emergence of S. aureus with diminished",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    susceptibility was anticipated when vancomycin-resistant enterococci (VRE) were initially described in the late 1980s [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The expected mechanism of vancomycin resistance in S. aureus was plasmid-mediated transfer of the vanA gene cluster from VRE. It was a surprise, therefore, when the first reported case of diminished vancomycin susceptibility in a clinical isolate of S. aureus in 1997 was mediated not via acquisition of vanA by a strain of methicillin-resistant S. aureus (MRSA), but by an unusually thickened cell wall containing dipeptides capable of binding vancomycin, thereby reducing availability of the drug for intracellular target molecules [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/3-8\">",
"     3-8",
"    </a>",
"    ]. This was the first observation of vancomycin-intermediate S. aureus (VISA). The predicted mechanism of vanA gene plasmid-mediated transfer from enterococci to S. aureus was later observed for the first time in 2002; this was the first description of vancomycin-resistant S. aureus (VRSA) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Issues related to the mechanism, epidemiology, laboratory definitions, treatment and prevention of S. aureus with reduced susceptibility to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    will be reviewed here. Issues related to MRSA are discussed separately. (See related topics).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both the Clinical and Laboratory Standards Institute (CLSI) and the United States Food and Drug Administration (FDA) have established the following",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    minimal inhibitory concentration interpretive criteria for S. aureus. The definitions have been modified in response to increasing reports of vancomycin treatment failure in infections due to strains with elevated MICs (2",
"    <span class=\"nowrap\">",
"     mcg/mL),",
"    </span>",
"    as well as to flag those isolates that are likely to be heteroresistant; the definitions prior to 2006 are noted in parentheses [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Heteroresistance'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       Vancomycin",
"      </a>",
"      susceptible &mdash; &le;2",
"      <span class=\"nowrap\">",
"       mcg/mL",
"      </span>",
"      (&le;4",
"      <span class=\"nowrap\">",
"       mcg/mL)",
"      </span>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       Vancomycin",
"      </a>",
"      intermediate (VISA) &mdash; 4 to 8",
"      <span class=\"nowrap\">",
"       mcg/mL",
"      </span>",
"      (8 to 16",
"      <span class=\"nowrap\">",
"       mcg/mL)",
"      </span>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       Vancomycin",
"      </a>",
"      resistant (VRSA) &mdash; &ge;16",
"      <span class=\"nowrap\">",
"       mcg/mL",
"      </span>",
"      (&ge;32",
"      <span class=\"nowrap\">",
"       mcg/mL)",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The acronyms for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    -intermediate S. aureus (VISA), glycopeptide-intermediate S. aureus (GISA) and vancomycin-resistant S. aureus (VRSA) are derived from these criteria. VISA and GISA refer to the same susceptibility cutoff. The term VISA is more commonly used, although the term GISA may be more accurate since early reports indicated that most of these strains also had intermediate resistance to the glycopeptide teicoplanin.",
"   </p>",
"   <p>",
"    Repeated isolation of S. aureus from normally sterile sites despite seemingly appropriate therapy for longer than 7 days should prompt consideration of infection with a strain of S. aureus with reduced susceptibility to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    , even if the MIC of the original isolate was within the susceptible range [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/13-16\">",
"     13-16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Reduced",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    susceptibility can occur in S. aureus irrespective of background methicillin susceptibility and may result in increased tolerance to several classes of antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Treatment'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     VISA",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Mechanism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reduced susceptibility to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    in vancomycin-intermediate S. aureus (VISA) isolates is due to the synthesis of an unusually thickened cell wall containing dipeptides (D-Ala-D-Ala) capable of binding vancomycin, thereby reducing availability of the drug for intracellular target molecules [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/3-8,18-20\">",
"     3-8,18-20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The genetic basis for these cell wall alterations is not fully understood. Several studies have identified mutations in selected genes, including vraR, graRS, and walRK, that appear to contribute to the development of resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/21-24\">",
"     21-24",
"    </a>",
"    ]. The group II polymorphism at the accessory gene regulator (agr) locus is present in some VISA strains (as well as some MRSA strains) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/20,25\">",
"     20,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    VISA strains may have developed from preexisting MRSA strains in the presence of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    ; this was suggested by the similarity between pulse-field gel electrophoresis patterns of the MRSA and subsequent VISA strains isolated from individual patients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/26-31\">",
"     26-31",
"    </a>",
"    ]. This course of events may have resulted from failure to eradicate the initial MRSA strain or subsequent reinfection with the same strain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Epidemiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several VISA strains associated with clinical infection have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/3,26-30,32,33\">",
"     3,26-30,32,33",
"    </a>",
"    ]. The first reported case was observed in 1997 in Japan and occurred in a four-month-old with a surgical site infection. This original",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    -intermediate S. aureus (VISA) strain was designated Mu50; its vancomycin MIC was 8",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/3\">",
"     3",
"    </a>",
"    ]. The patient was successfully treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/56/43912?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    . However, the first infection with VISA appears to have occurred in 1995 in France, in a 2-year-old with leukemia and central catheter-associated bacteremia; management was successful with surgical drainage and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/17/34068?source=see_link\">",
"     quinupristin-dalfopristin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Subsequently, clinical infections with similar strains have been reported in the United States and around the world [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/26-29,32,34,35\">",
"     26-29,32,34,35",
"    </a>",
"    ]. Features common to many of the United States cases included ongoing or recent dialysis, MRSA bacteremia related to central venous catheter or prosthetic graft material, and prolonged",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    exposure (6 to 18 weeks) in the three to six months preceding infection [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/26,28-30\">",
"     26,28-30",
"    </a>",
"    ]. Contact investigation for two patients with VISA infection (including 177 contacts) yielded no VISA carriers [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most published studies show a correlation between rising MIC values to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    and a poorer clinical outcome as measured by treatment failure or mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/36\">",
"     36",
"    </a>",
"    ]. A study comparing outcomes among patients with MSSA and MRSA bacteremia has raised additional questions concerning the basis for the poorer clinical outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/37\">",
"     37",
"    </a>",
"    ]. Patients with S. aureus bacteremia caused by strains with vancomycin MIC (by Etest) &gt;1.5",
"    <span class=\"nowrap\">",
"     &micro;g/ml",
"    </span>",
"    had a poorer outcome than those infected with strains having an MIC of &le;1.5",
"    <span class=\"nowrap\">",
"     &micro;g/ml.",
"    </span>",
"    Notably, this outcome was",
"    <strong>",
"     independent",
"    </strong>",
"    of the methicillin susceptibility of the isolate and whether the patients were treated with vancomycin or a beta-lactam. This observation suggests that there may be structural differences in the strains with higher vancomycin MICs, or other host factors. &nbsp;",
"   </p>",
"   <p>",
"    Infection with S. aureus with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    MICs &ge;4",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    is rare, although the incidence is difficult to estimate given the rarity of infection and challenges related to laboratory detection. Surveillance data from the United States and Europe indicate that S. aureus isolates with vancomycin MICs &ge;4",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    represent less than 0.3 percent of MIC values [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/13\">",
"     13",
"    </a>",
"    ]. In a CDC study of 630 clinical isolates from 33 United States hospitals, no strains of VISA were identified, but two isolates demonstrated heteroresistance [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Heteroresistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heteroresistant",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    -intermediate S. aureus (hVISA) refers to VISA strains in which subpopulations display variable rather than uniform susceptibility to vancomycin [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/3,31\">",
"     3,31",
"    </a>",
"    ]. Heteroresistant strains of S. aureus contain subpopulations of bacteria with vancomycin MICs in the intermediate range, but the vancomycin MIC for the entire population of the strain remains within the susceptible range [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/31\">",
"     31",
"    </a>",
"    ]. Like VISA strains, hVISA populations withstand vancomycin by means of an unusually thickened cell wall. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/5/17495?source=see_link&amp;anchor=H10046302#H10046302\">",
"     \"Overview of antibacterial susceptibility testing\", section on 'Heteroresistance'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The prototype heteroresistant strain was S. aureus Mu3, a clinical isolate recovered from a Japanese patient with staphylococcal pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/31\">",
"     31",
"    </a>",
"    ]. The reported frequency of heteroresistance is variable. Most studies describe a frequency of 0.5 to 1.5 percent, but frequencies as high as 20 percent have been reported in Japan [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/13,31,39\">",
"     13,31,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The relevance of heteroresistance to clinical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    failure is still not fully understood [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/32\">",
"     32",
"    </a>",
"    ]. However, there are several reports of vancomycin failure and persistent infection due to hVISA [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/40-42\">",
"     40-42",
"    </a>",
"    ]. In a review of 65 patients with endocarditis due to MRSA, 19 isolates (29 percent) exhibited the hVISA phenotype by population analysis profiling [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. Patients with these isolates were more likely to have persistent bacteremia (68 versus 37 percent) and heart failure (47 versus 19 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no practical, validated laboratory test for accurate routine detection of heteroresistant S. aureus. As a result, the CLSI lowered the intermediate",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    MIC breakpoint to 4",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    (as described below) in order to flag those isolates that are likely to be heteroresistant",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    clinically refractory to vancomycin therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/5/17495?source=see_link&amp;anchor=H10046302#H10046302\">",
"     \"Overview of antibacterial susceptibility testing\", section on 'Heteroresistance'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     VRSA",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Mechanism",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanism of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    resistance in vancomycin-resistant S. aureus (VRSA) is plasmid-mediated transfer of the vanA gene cluster from enterococci with vancomycin resistance (via mobile genetic element Tn1546) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/44-46\">",
"     44-46",
"    </a>",
"    ]. Resistance in VRSA isolates is due to the synthesis of an alternative cell wall terminal peptide (D-ala-D-lac), rather than the normal terminal peptide (D-ala-D-ala). Vancomycin is unable to bind to the former peptide. Expression of the vanA genes is only initiated by exposure to vancomycin so that there is limited effect on the fitness of the isolate (in contrast with the vancomycin-intermediate S. aureus [VISA] strains).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Epidemiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;At least 12 patients with infection due",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    -resistant S. aureus (VRSA) have been identified in the United States:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The first isolate of VRSA was reported in 2002 from a patient in Michigan with diabetes, peripheral artery disease, and chronic renal failure on hemodialysis [",
"      <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/9\">",
"       9",
"      </a>",
"      ]. The isolate grew from both a catheter exit site swab specimen and from a chronic foot ulcer that appeared newly infected. The MIC was 1024",
"      <span class=\"nowrap\">",
"       mcg/mL.",
"      </span>",
"      A strain of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      -resistant Enterococcus faecalis (VRE) was also cultured from the ulcer, and DNA sequencing demonstrated that the vanA genes in the staphylococcus and enterococcus isolates were identical [",
"      <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/47\">",
"       47",
"      </a>",
"      ]. Contact investigation for this patient (including 547 people) yielded no VRSA carriers.",
"     </li>",
"     <li>",
"      The second isolate of VRSA was reported in 2002 in Pennsylvania [",
"      <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/48,49\">",
"       48,49",
"      </a>",
"      ]. The isolate was identified from a patient with a chronic foot ulcer undergoing evaluation for possible osteomyelitis. The MIC by the broth dilution method was 32",
"      <span class=\"nowrap\">",
"       mcg/mL.",
"      </span>",
"      The foot ulcer culture also demonstrated VRE, although the patient had not received",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The third isolate of VRSA was reported in 2004 in New York [",
"      <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/51\">",
"       51",
"      </a>",
"      ]. It grew from a urine culture obtained from a patient in a long-term care facility; the MIC by the broth dilution method was 64",
"      <span class=\"nowrap\">",
"       mcg/mL.",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    After the first three isolates were reported, four additional cases of VRSA were described in Michigan in 2005-2006 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/52\">",
"     52",
"    </a>",
"    ]. Because co-colonization with methicillin-resistant S. aureus (MRSA) and VRE is common, development of further VRSA strains is likely [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. A comparative genomic analysis of the 12 reported VRSA isolates concluded that they represent separate events in which the plasmid containing the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    resistant transposon was acquired. There did not appear to be evidence of clonal dissemination of a single VRSA strain [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     LABORATORY TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Confirmatory MIC testing should be performed on S. aureus isolates for which the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    MIC is &ge;2",
"    <span class=\"nowrap\">",
"     mcg/mL.",
"    </span>",
"    Laboratory detection of S. aureus with reduced susceptibility to vancomycin may require special inquiry with the microbiology laboratory about susceptibility testing methods [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/56\">",
"     56",
"    </a>",
"    ]. An MIC susceptibility testing method (such as broth microdilution, agar dilution, or agar-gradient diffusion [E-test]) must be used for detection of S. aureus with reduced susceptibility to vancomycin; disk diffusion and automated methods are not sufficient [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/57-60\">",
"     57-60",
"    </a>",
"    ]. A full 24-hour incubation period should be used with all methods.",
"   </p>",
"   <p>",
"    A routine approach to S. aureus susceptibility testing should be tailored to the clinical scope of a particular laboratory [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/38,61\">",
"     38,61",
"    </a>",
"    ]. The most accurate method for detecting heteroresistant subpopulations is with performance of population analysis profiles [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/43\">",
"     43",
"    </a>",
"    ]. Additional susceptibility testing is warranted in patients with repeated isolates of S. aureus from normally sterile sites despite seemingly appropriate therapy for longer than seven days. Isolates should also be sent to the state public health laboratory or the Centers for Disease Control and Prevention for confirmatory evaluation when S. aureus with reduced susceptibility is suspected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The observation of repeated isolates of S. aureus from normally sterile sites despite seemingly appropriate therapy for longer than seven days should prompt consideration of infection with a strain of S. aureus with reduced susceptibility to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    , even if the MIC is within the susceptible range [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/13-16\">",
"     13-16",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Heteroresistance'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     Vancomycin",
"    </a>",
"    failure appears more likely for patients with infection due to S. aureus isolates with a vancomycin MIC &gt;0.5",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    than those with an MIC &le;0.5",
"    <span class=\"nowrap\">",
"     mcg/mL.",
"    </span>",
"    This was illustrated in a retrospective study of 30 patients with methicillin-resistant S. aureus (MRSA) bacteremia refractory to vancomycin therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/14\">",
"     14",
"    </a>",
"    ]. The frequency of successful therapy for 23 patients whose isolates had an MIC of 1 or 2",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    was much lower than for the 9 patients with an isolate with an MIC &le;0.5",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    (9.5 versus 55.6 percent, respectively).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Antibiotic selection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal antimicrobial regimen for S. aureus with reduced susceptibility to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    is unknown [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/62\">",
"     62",
"    </a>",
"    ]. An appropriate approach is treatment with at least one antimicrobial to which the organism is known to be susceptible by in vitro testing, particularly for isolates with vancomycin MIC &gt;2",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/32,63-66\">",
"     32,63-66",
"    </a>",
"    ]. These isolates are frequently susceptible to the alternative antistaphylococcal agents such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/10/20646?source=see_link\">",
"     daptomycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"     linezolid",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/42/27301?source=see_link\">",
"     telavancin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/33/4628?source=see_link\">",
"     ceftaroline",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/10/3240?source=see_link\">",
"     minocycline",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/17/34068?source=see_link\">",
"     quinupristin-dalfopristin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/64-68\">",
"     64-68",
"    </a>",
"    ]. There are now several reports of isolates with reduced susceptibility to vancomycin also having reduced susceptibility to daptomycin. The clinical relevance of this observation remains uncertain [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/69\">",
"     69",
"    </a>",
"    ]. There are limited data regarding the efficacy of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/7/40053?source=see_link\">",
"     tigecycline",
"    </a>",
"    , especially in the setting of bacteremia. Vancomycin-intermediate S. aureus (VISA) and vancomycin-resistant S. aureus (VRSA) isolates have demonstrated variable susceptibility to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1897?source=see_link\">",
"     chloramphenicol",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/3,26-30,33,58,70,71\">",
"     3,26-30,33,58,70,71",
"    </a>",
"    ]. Even if reported as susceptible, quinolones should not be used for the treatment of these infections due to the risk of resistance emerging during therapy.",
"   </p>",
"   <p>",
"    Increasing the dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    may not safely overcome its poor activity or limited tissue penetration [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/62,72\">",
"     62,72",
"    </a>",
"    ]. This was illustrated in a study of 95 cases of MRSA infection (including 51 due to strains with an MIC &ge;2",
"    <span class=\"nowrap\">",
"     mcg/mL)",
"    </span>",
"    with two target vancomycin trough groups (&ge;15 or &lt;15",
"    <span class=\"nowrap\">",
"     mcg/mL)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/72\">",
"     72",
"    </a>",
"    ]. The patients with infection due to strains with MIC &ge;2",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    had a significantly lower treatment response than patients with an MIC &lt;2",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    (62 versus 85 percent) and a trend toward increased mortality (24 versus 10 percent). Nephrotoxicity occurred only in the group with the goal vancomycin trough &ge;15",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    (12 versus 0 percent in the group with goal trough &lt;15",
"    <span class=\"nowrap\">",
"     mcg/mL),",
"    </span>",
"    but was predicted by concomitant therapy with other nephrotoxic agents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/47/15096?source=see_link\">",
"     \"Vancomycin dosing and serum concentration monitoring in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Using",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    in combination with a second antistaphylococcal antibiotic may not improve its therapeutic efficacy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/62,73,74\">",
"     62,73,74",
"    </a>",
"    ]. As an example, treatment with vancomycin and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    compared with vancomycin alone in a randomized trial of 42 patients with MRSA endocarditis was associated with a possible prolongation of bacteremia (median nine versus seven days) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/73\">",
"     73",
"    </a>",
"    ]. There are limited data on the efficacy on combination therapy with vancomycin and an aminoglycoside [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For patients with persistent MRSA bacteremia in the setting of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    treatment failure, the optimal approach is uncertain. Treatment with high dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/10/20646?source=see_link\">",
"     daptomycin",
"    </a>",
"    (10",
"    <span class=\"nowrap\">",
"     mg/kg/day)",
"    </span>",
"    in combination with another agent (such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV every eight hours,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    600 mg",
"    <span class=\"nowrap\">",
"     PO/IV",
"    </span>",
"    daily or 300 to 450 mg",
"    <span class=\"nowrap\">",
"     PO/IV",
"    </span>",
"    twice daily,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"     linezolid",
"    </a>",
"    600 mg",
"    <span class=\"nowrap\">",
"     PO/IV",
"    </span>",
"    twice daily, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV twice daily) may be considered [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/66\">",
"     66",
"    </a>",
"    ]. In addition, the combination of daptomycin with a beta-lactam has been shown to be effective in several cases of refractory S. aureus bacteremia [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/76\">",
"     76",
"    </a>",
"    ]. The in vitro bactericidal activity of daptomycin was enhanced by increased binding to the cytoplasmic membrane in the presence of the anti-staphylococcal beta-lactam.",
"   </p>",
"   <p>",
"    Experimental data suggest that beta-lactams and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    may be synergistic against selected VISA isolates; these observations are of potential clinical interest but require further evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/77,78\">",
"     77,78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Duration of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The duration of therapy depends upon the site of infection and should parallel the duration of therapy for MRSA infections. In addition, treatment must include removal of implicated sources of infection such as central venous catheters; depending on individual patient circumstances, surgical debridement",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    removal of prosthetic material may also be required. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/48/21258?source=see_link\">",
"     \"Treatment of invasive methicillin-resistant Staphylococcus aureus infections in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/43/24249?source=see_link&amp;anchor=H11#H11\">",
"     \"Treatment of Staphylococcus aureus bacteremia in adults\", section on 'Duration of therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with methicillin-resistant S. aureus (MRSA), S. aureus strains with reduced susceptibility to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    are transmissible between individuals. The first report of an outbreak due to a single vancomycin-intermediate S. aureus (VISA) strain involved 21 ICU patients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/79\">",
"     79",
"    </a>",
"    ]. Severe infection (eg, pneumonia, bacteremia, endocarditis) was diagnosed in 11 of the 21 patients, and eight patients died. Extensive colonization of the inanimate environment was described. In spite of maximum contact precautions, the outbreak was not curtailed until additional policies were implemented including restricted admissions and twice daily environmental cleaning.",
"   </p>",
"   <p>",
"    Special efforts to insure compliance with contact precautions and handwashing should be instituted when patients are infected or colonized with VISA or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    -resistant S. aureus (VRSA) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/80\">",
"     80",
"    </a>",
"    ]. In addition, healthcare providers should be vigilant about removing temporary venous catheters when they are no longer needed and minimizing prolonged empiric antimicrobial therapy whenever possible [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16425/abstract/16,81\">",
"     16,81",
"    </a>",
"    ]. Consultation with infectious disease specialists, hospital epidemiologists, the local health department, and the CDC is appropriate for optimizing laboratory investigation, patient management and infection control issues. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/59/17338?source=see_link\">",
"     \"Prevention and control of methicillin-resistant Staphylococcus aureus in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19658?source=see_link\">",
"     \"General principles of infection control\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Failure of treatment for methicillin-resistant Staphylococcus aureus (MRSA) infection with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      should prompt consideration of infection with vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA), or heteroresistant S. aureus strains. Evaluation and management should involve cooperation between infectious disease specialists, laboratory personnel, and epidemiologists.",
"     </li>",
"     <li>",
"      The Clinical and Laboratory Standards Institute definitions for S. aureus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      minimal inhibitory concentrations are as follows (see",
"      <a class=\"local\" href=\"#H2\">",
"       'Definitions'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       Vancomycin",
"      </a>",
"      susceptible &mdash; &le;2",
"      <span class=\"nowrap\">",
"       mcg/mL",
"      </span>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       Vancomycin",
"      </a>",
"      intermediate (VISA) &mdash; 4 to 8",
"      <span class=\"nowrap\">",
"       mcg/mL",
"      </span>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       Vancomycin",
"      </a>",
"      resistant (VRSA) &mdash; &ge;16",
"      <span class=\"nowrap\">",
"       mcg/mL",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The mechanisms of resistance for VRSA involve vanA gene plasmid-mediated transfer from enterococci to S. aureus. For VISA strains, the mechanism involves the binding of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      to bacterial cell wall dipeptide to reduce drug availability for intracellular targets. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Mechanism'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Mechanism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Heteroresistant strains of S. aureus contain subpopulations of bacteria with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      MICs in the intermediate range, but the vancomycin MIC for the entire population of the strain is within the susceptible range. There is not yet a practical, validated laboratory test for accurate routine detection of heteroresistant S. aureus. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Heteroresistance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An MIC susceptibility testing method (such as broth microdilution, agar dilution, or agar-gradient diffusion) must be used for detection of S. aureus with reduced susceptibility to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      ; disk diffusion or automated methods are not sufficient. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Laboratory testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest treatment with at least one antimicrobial agent to which the organism is susceptible (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infection control measures should be implemented as for MRSA. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/1\">",
"      Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/2\">",
"      Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988; 1:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/3\">",
"      Hiramatsu K, Hanaki H, Ino T, et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/4\">",
"      Cui L, Ma X, Sato K, et al. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol 2003; 41:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/5\">",
"      Sieradzki K, Tomasz A. Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus. J Bacteriol 1999; 181:7566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/6\">",
"      Cui L, Iwamoto A, Lian JQ, et al. Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 2006; 50:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/7\">",
"      Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, et al. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J Antimicrob Chemother 1998; 42:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/8\">",
"      Cui L, Murakami H, Kuwahara-Arai K, et al. Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrob Agents Chemother 2000; 44:2276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/9\">",
"      Centers for Disease Control and Prevention (CDC). Staphylococcus aureus resistant to vancomycin--United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/10\">",
"      Howden BP, Davies JK, Johnson PD, et al. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev 2010; 23:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/11\">",
"      Soriano A, Marco F, Mart&iacute;nez JA, et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2008; 46:193.",
"     </a>",
"    </li>",
"    <li>",
"     Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement. M100-S16 Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved Standard. Vol 26. No 3. CLSI, Wayne, Pennsylvania, USA, 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/13\">",
"      Tenover FC, Moellering RC Jr. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin Infect Dis 2007; 44:1208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/14\">",
"      Sakoulas G, Moise-Broder PA, Schentag J, et al. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 2004; 42:2398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/15\">",
"      Hussain FM, Boyle-Vavra S, Shete PB, Daum RS. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates. J Infect Dis 2002; 186:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/16\">",
"      Song JH, Hiramatsu K, Suh JY, et al. Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 2004; 48:4926.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/17\">",
"      Pillai SK, Wennersten C, Venkataraman L, et al. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus. Clin Infect Dis 2009; 49:1169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/18\">",
"      Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/19\">",
"      Howden BP, Johnson PD, Ward PB, et al. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2006; 50:3039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/20\">",
"      Walsh TR, Howe RA. The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. Annu Rev Microbiol 2002; 56:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/21\">",
"      Mwangi MM, Wu SW, Zhou Y, et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci U S A 2007; 104:9451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/22\">",
"      Howden BP, Stinear TP, Allen DL, et al. Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus. Antimicrob Agents Chemother 2008; 52:3755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/23\">",
"      Howden BP, McEvoy CR, Allen DL, et al. Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR. PLoS Pathog 2011; 7:e1002359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/24\">",
"      Shoji M, Cui L, Iizuka R, et al. walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus. Antimicrob Agents Chemother 2011; 55:3870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/25\">",
"      Sakoulas G, Eliopoulos GM, Moellering RC Jr, et al. Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 2002; 46:1492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/26\">",
"      Smith TL, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 1999; 340:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/27\">",
"      Rotun SS, McMath V, Schoonmaker DJ, et al. Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia. Emerg Infect Dis 1999; 5:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/28\">",
"      Sieradzki K, Roberts RB, Haber SW, Tomasz A. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med 1999; 340:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/29\">",
"      Centers for Disease Control and Prevention (CDC). Staphylococcus aureus with reduced susceptibility to vancomycin--Illinois, 1999. MMWR Morb Mortal Wkly Rep 2000; 48:1165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/30\">",
"      Centers for Disease Control and Prevention (CDC). Update: Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997. MMWR Morb Mortal Wkly Rep 1997; 46:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/31\">",
"      Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350:1670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/32\">",
"      Fridkin SK. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin Infect Dis 2001; 32:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/33\">",
"      Ploy MC, Gr&eacute;laud C, Martin C, et al. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet 1998; 351:1212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/34\">",
"      Oliveira GA, Dell'Aquila AM, Masiero RL, et al. Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin. Infect Control Hosp Epidemiol 2001; 22:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/35\">",
"      Kim MN, Pai CH, Woo JH, et al. Vancomycin-intermediate Staphylococcus aureus in Korea. J Clin Microbiol 2000; 38:3879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/36\">",
"      Holland TL, Fowler VG Jr. Vancomycin minimum inhibitory concentration and outcome in patients with Staphylococcus aureus bacteremia: pearl or pellet? J Infect Dis 2011; 204:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/37\">",
"      Holmes NE, Turnidge JD, Munckhof WJ, et al. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations. J Infect Dis 2011; 204:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/38\">",
"      Hubert SK, Mohammed JM, Fridkin SK, et al. Glycopeptide-intermediate Staphylococcus aureus: evaluation of a novel screening method and results of a survey of selected U.S. hospitals. J Clin Microbiol 1999; 37:3590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/39\">",
"      Wong SS, Ho PL, Woo PC, Yuen KY. Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. Clin Infect Dis 1999; 29:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/40\">",
"      Deresinski S. Vancomycin heteroresistance and methicillin-resistant Staphylococcus aureus. J Infect Dis 2009; 199:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/41\">",
"      Charles PG, Ward PB, Johnson PD, et al. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin Infect Dis 2004; 38:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/42\">",
"      Bae IG, Federspiel JJ, Mir&oacute; JM, et al. Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance. J Infect Dis 2009; 200:1355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/43\">",
"      Wootton M, Howe RA, Hillman R, et al. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J Antimicrob Chemother 2001; 47:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/44\">",
"      Noble WC, Virani Z, Cree RG. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992; 72:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/45\">",
"      Clark NC, Weigel LM, Patel JB, Tenover FC. Comparison of Tn1546-like elements in vancomycin-resistant Staphylococcus aureus isolates from Michigan and Pennsylvania. Antimicrob Agents Chemother 2005; 49:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/46\">",
"      Courvalin P. Vancomycin resistance in gram-positive cocci. Clin Infect Dis 2006; 42 Suppl 1:S25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/47\">",
"      Chang S, Sievert DM, Hageman JC, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003; 348:1342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/48\">",
"      Centers for Disease Control and Prevention (CDC). Vancomycin-resistant Staphylococcus aureus--Pennsylvania, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/49\">",
"      Tenover FC, Weigel LM, Appelbaum PC, et al. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother 2004; 48:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/50\">",
"      Whitener CJ, Park SY, Browne FA, et al. Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clin Infect Dis 2004; 38:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/51\">",
"      Centers for Disease Control and Prevention (CDC). Vancomycin-resistant Staphylococcus aureus--New York, 2004. MMWR Morb Mortal Wkly Rep 2004; 53:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/52\">",
"      Sievert DM, Rudrik JT, Patel JB, et al. Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin Infect Dis 2008; 46:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/53\">",
"      Furuno JP, Perencevich EN, Johnson JA, et al. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci co-colonization. Emerg Infect Dis 2005; 11:1539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/54\">",
"      Tenover FC. Vancomycin-resistant Staphylococcus aureus: a perfect but geographically limited storm? Clin Infect Dis 2008; 46:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/55\">",
"      Kos VN, Desjardins CA, Griggs A, et al. Comparative genomics of vancomycin-resistant Staphylococcus aureus strains and their positions within the clade most commonly associated with Methicillin-resistant S. aureus hospital-acquired infection in the United States. MBio 2012; 3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/56\">",
"      Swenson JM, Anderson KF, Lonsway DR, et al. Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus. J Clin Microbiol 2009; 47:2013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/57\">",
"      Centers for Disease Control and Prevention (CDC). Laboratory capacity to detect antimicrobial resistance, 1998. MMWR Morb Mortal Wkly Rep 2000; 48:1167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/58\">",
"      Tenover FC, Lancaster MV, Hill BC, et al. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol 1998; 36:1020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/59\">",
"      Tenover FC, Biddle JW, Lancaster MV. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg Infect Dis 2001; 7:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/60\">",
"      Cosgrove SE, Carroll KC, Perl TM. Staphylococcus aureus with reduced susceptibility to vancomycin. Clin Infect Dis 2004; 39:539.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.cdc.gov/ncidod/dhqp/ar_visavrsa_algo.html (Accessed on August 20, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/62\">",
"      Deresinski S. Counterpoint: Vancomycin and Staphylococcus aureus--an antibiotic enters obsolescence. Clin Infect Dis 2007; 44:1543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/63\">",
"      Choice of antibacterial drugs. Treat Guidel Med Lett 2007; 5:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/64\">",
"      Drew RH, Perfect JR, Srinath L, et al. Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study Group. J Antimicrob Chemother 2000; 46:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/65\">",
"      Moise PA, Forrest A, Birmingham MC, Schentag JJ. The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin. J Antimicrob Chemother 2002; 50:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/66\">",
"      Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52:e18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/67\">",
"      Cha R, Brown WJ, Rybak MJ. Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother 2003; 47:3960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/68\">",
"      Saravolatz LD, Pawlak J, Johnson LB. In vitro susceptibilities and molecular analysis of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus isolates. Clin Infect Dis 2012; 55:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/69\">",
"      Boucher HW, Sakoulas G. Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus. Clin Infect Dis 2007; 45:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/70\">",
"      Fridkin SK, Hageman J, McDougal LK, et al. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis 2003; 36:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/71\">",
"      Jevitt LA, Smith AJ, Williams PP, et al. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium. Microb Drug Resist 2003; 9:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/72\">",
"      Hidayat LK, Hsu DI, Quist R, et al. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med 2006; 166:2138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/73\">",
"      Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 1991; 115:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/74\">",
"      Deresinski S. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2009; 49:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/75\">",
"      Fowler VG Jr, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006; 355:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/76\">",
"      Dhand A, Bayer AS, Pogliano J, et al. Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding. Clin Infect Dis 2011; 53:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/77\">",
"      Climo MW, Patron RL, Archer GL. Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin. Antimicrob Agents Chemother 1999; 43:1747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/78\">",
"      Howe RA, Wootton M, Bennett PM, et al. Interactions between methicillin and vancomycin in methicillin-resistant Staphylococcus aureus strains displaying different phenotypes of vancomycin susceptibility. J Clin Microbiol 1999; 37:3068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/79\">",
"      de Lassence A, Hidri N, Timsit JF, et al. Control and outcome of a large outbreak of colonization and infection with glycopeptide-intermediate Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2006; 42:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/80\">",
"      Wenzel RP, Edmond MB. Vancomycin-resistant Staphylococcus aureus: infection control considerations. Clin Infect Dis 1998; 27:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16425/abstract/81\">",
"      Evans ME, Kortas KJ. Vancomycin use in a university medical center: comparison with hospital infection control practices advisory committee guidelines. Infect Control Hosp Epidemiol 1996; 17:356.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3165 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-B3AA2FA6DE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_2_16425=[""].join("\n");
var outline_f16_2_16425=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      VISA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Mechanism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Epidemiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Heteroresistance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      VRSA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Mechanism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Epidemiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      LABORATORY TESTING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Antibiotic selection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Duration of therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19658?source=related_link\">",
"      General principles of infection control",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/5/17495?source=related_link\">",
"      Overview of antibacterial susceptibility testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/59/17338?source=related_link\">",
"      Prevention and control of methicillin-resistant Staphylococcus aureus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/43/24249?source=related_link\">",
"      Treatment of Staphylococcus aureus bacteremia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/48/21258?source=related_link\">",
"      Treatment of invasive methicillin-resistant Staphylococcus aureus infections in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/47/15096?source=related_link\">",
"      Vancomycin dosing and serum concentration monitoring in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_2_16426="Food poisoning in children";
var content_f16_2_16426=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Food poisoning in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/2/16426/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/2/16426/contributors\">",
"     Theresa J Ochoa, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/2/16426/contributors\">",
"     Thomas G Cleary, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/2/16426/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/2/16426/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/2/16426/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/2/16426/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/2/16426/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Food-borne illness accounts for approximately 76 million cases, 323,000 hospitalizations, and 5000 deaths annually in the United States, according to estimates from the Centers for Disease Control and Prevention (CDC) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/1\">",
"     1",
"    </a>",
"    ]. Clinical manifestations range from mild gastroenteritis to life-threatening neurologic, hepatic, and renal syndromes.",
"   </p>",
"   <p>",
"    Although food-borne illnesses attack patients in all age groups, young children, the elderly, and immunocompromised hosts are at highest risk for serious consequences from these diseases. The hospitalization rate for bacterial enteric diseases in children, for example, rose during 1990 to 1994 compared with 1985 to 1989 (100.8 from 57.5 per 100,000 hospital discharges in children &lt;1 year and 21.5 from 7.5 per 100,000 in those one to four years) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/2\">",
"     2",
"    </a>",
"    ]. An estimated 300 to 400 children in the United States die yearly from diarrheal illness [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Factors leading to the emergence of food-borne diseases and a brief discussion of common and emerging causes of food-borne illness in children are reviewed here. The specific agents producing these illnesses and an approach to the diagnosis of food poisoning according to the major presenting symptoms are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/44/24265?source=see_link\">",
"     \"Differential diagnosis of microbial foodborne disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Centers for Disease Control and Prevention (CDC) defines a food-borne disease outbreak as any cluster of two or more individuals who develop similar symptoms following the ingestion of a common food.",
"   </p>",
"   <p>",
"    Laboratory or clinical guidelines for confirming an etiology of a food-borne disease outbreak vary for bacterial, chemical, parasitic, and viral agents. Criteria for confirming the etiology of an outbreak have been published (",
"    <a class=\"graphic graphic_table graphicRef77956 graphicRef53848 graphicRef62562 graphicRef75804 graphicRef55831 graphicRef68671 graphicRef77344 \" href=\"UTD.htm?31/23/32114\">",
"     table 1A-G",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/5\">",
"     5",
"    </a>",
"    ]. When the agent of a food-borne outbreak cannot be determined, incubation times are used as clues (ie, &lt;1 hour = probable chemical ingestion; 1 to 7 hours = probable",
"    <em>",
"     Staphylococcus aureus",
"    </em>",
"    or",
"    <em>",
"     Bacillus cereus",
"    </em>",
"    toxin mediated; 8 to 14 hours = other agents, especially bacteria; &ge;15 hours = other agents, especially viruses).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since 1973, the Centers for Disease Control and Prevention (CDC) has maintained a collaborative surveillance program for food-borne diseases but recognizes that this system results in an underestimate of the incidence of these illnesses [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. During 1998-2002, a total of 6647 outbreaks affecting more than 128,000 people were reported [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/7\">",
"     7",
"    </a>",
"    ]. The annual number of outbreaks reported to the CDC increased during this period compared with previous years [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/6\">",
"     6",
"    </a>",
"    ], probably due to the implementation of measures to enhance outbreak surveillance. The following findings were noted [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among 2167 outbreaks for which the etiology was determined (only about a third have a defined cause), bacterial pathogens caused the largest percentage of outbreaks and cases (55 percent)",
"     </li>",
"     <li>",
"      Among bacterial pathogens, Salmonella accounted for the largest number of outbreaks, and Listeria monocytogenes accounted for the majority of deaths of any pathogen (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/19/14649?source=see_link\">",
"       \"Microbiology and epidemiology of salmonellosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/48/9993?source=see_link\">",
"       \"Epidemiology and pathogenesis of Listeria monocytogenes infection\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Viral pathogens, predominantly norovirus, caused 33 percent of outbreaks",
"     </li>",
"     <li>",
"      The proportion of outbreaks attributed to viral agents increased from 16 percent in 1998 to 42 percent in 2002, probably reflecting the increased availability of improved viral diagnostics tests",
"     </li>",
"     <li>",
"      Chemical agents caused 10 percent of outbreaks",
"     </li>",
"     <li>",
"      Parasites caused 1 percent of outbreaks",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CONTRIBUTING FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many factors contribute to the emergence of food-borne disease in the United States and around the world. They include changes in human behavior and demographics, advances in industry and technology, lack of adequate public health infrastructure, and changing antimicrobial susceptibility patterns of the organisms [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Commercially or institutionally prepared food causes 79 percent of cases of food poisoning. The increasing number of meals eaten either away from home or brought to the home for immediate consumption after being purchased elsewhere has created greater demand for food from catering services, restaurants, and institutional kitchens. The burgeoning market for quick, convenient, and inexpensive food renders careful handling and storage of foods mandatory [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Improper food storage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Holding and food storage at improper temperatures were the most common contributors to food-borne disease from 1983 through 1992, with Centers for Disease Control and Prevention (CDC) estimates reaching 97 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/9\">",
"     9",
"    </a>",
"    ]. It includes leaving prepared food at temperatures that allow bacteria to grow, improperly heating or reheating food, and allowing cross contamination of food. Cross contamination of food can occur either through direct contact or following contact with contaminated food preparation surfaces [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Food handlers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The personal hygiene practices of food handlers are a common cause of food-borne illness [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/10\">",
"     10",
"    </a>",
"    ]. Fecal-oral transmission can result from poor hygiene, particularly failure to wash hands after using bathroom facilities. The most commonly reported contamination factor that contributed to food-borne outbreaks during 1998-2002 was \"bare-handed contact by",
"    <span class=\"nowrap\">",
"     handler/worker/preparer\"",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Widespread distribution of foods",
"    </span>",
"    &nbsp;&mdash;&nbsp;Small farms, factories, and dairies are being replaced with large factories supplying millions of individuals in far-reaching parts of the world, magnifying the impact of a single contamination [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/11\">",
"     11",
"    </a>",
"    ]. Small outbreaks may be seemingly unrelated, and tracing the source of contamination becomes a greater challenge. All of these factors add to the opportunity for outbreaks of food-borne illness that may affect hundreds to thousands of people.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     COMMON AND EMERGING MICROBIAL AGENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A wide variety of microorganisms can cause food poisoning.",
"    <em>",
"     Salmonella",
"    </em>",
"    sp. produce the majority of outbreaks of food-borne disease when an etiology can be established. However,",
"    <em>",
"     Escherichia coli",
"    </em>",
"    have become frequent food-borne pathogens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Salmonella",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <em>",
"     Salmonella",
"    </em>",
"    is the number-one cause of food-borne illness in the United States, accounting for 585 outbreaks and more than 16,000 cases between 1998 and 2002. It is the second-most common cause of death from food-borne pathogens in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/7\">",
"     7",
"    </a>",
"    ]. Nontyphoidal Salmonellae are associated with animal reservoirs and therefore with agricultural products, especially eggs and poultry. The spectrum of clinical illness ranges from acute gastroenteritis to occult bacteremia and typhoid fever [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/19/14649?source=see_link&amp;anchor=H5#H5\">",
"     \"Microbiology and epidemiology of salmonellosis\", section on 'Nontyphoidal Salmonellae'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Antimicrobial resistance among",
"    <em>",
"     Salmonella",
"    </em>",
"    isolates has become a major problem, partially because of the extensive use of antimicrobial drugs in livestock [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/13-16\">",
"     13-16",
"    </a>",
"    ]. Multidrug-resistant",
"    <em>",
"     Salmonella typhimurium",
"    </em>",
"    DT104 has emerged as a cause of salmonellosis in Europe and the United States. In one outbreak, Mexican-style soft cheese made with unpasteurized milk was an important vehicle for transmission in children [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/19/14649?source=see_link&amp;anchor=H8#H8\">",
"     \"Microbiology and epidemiology of salmonellosis\", section on 'Antimicrobial resistance'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While occult nontyphoidal",
"    <em>",
"     Salmonella",
"    </em>",
"    bacteremia in children accounts for &lt;0.2 percent of fevers (&ge;39.0&ordm;C) in outpatients 3 to 36 months of age, severe complications can result if this condition is unrecognized and untreated. Persistent bacteremia, osteomyelitis, meningitis, sepsis, and death have been reported. Sequelae are much more common in infants younger than three months or immunocompromised older children [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/8/26761?source=see_link\">",
"     \"Approach to the patient with nontyphoidal Salmonella in a stool culture\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Campylobacter",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <em>",
"     Campylobacter jejuni",
"    </em>",
"    and",
"    <em>",
"     C. coli",
"    </em>",
"    most commonly cause diarrhea in humans, although 15 species of",
"    <em>",
"     Campylobacter",
"    </em>",
"    have been identified [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/6\">",
"     6",
"    </a>",
"    ].",
"    <em>",
"     Campylobacter",
"    </em>",
"    sp. account for less than 1 percent of food-borne outbreaks in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/7\">",
"     7",
"    </a>",
"    ] but have been estimated to be responsible for more than 2 million cases of diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/1\">",
"     1",
"    </a>",
"    ]. The organism is transmitted primarily through contaminated food. Risk factors for disease include handling raw chicken, eating raw or undercooked chicken, having contact with cats, and consuming untreated water, raw milk, or eggs [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/60/5065?source=see_link&amp;anchor=H9#H9\">",
"     \"Microbiology, pathogenesis, and epidemiology of Campylobacter infection\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <em>",
"     Campylobacter",
"    </em>",
"    is isolated most commonly in the first year of life, reaching rates of 15 per 100,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/19\">",
"     19",
"    </a>",
"    ]. The male to female ratio is 1.3 to 1.",
"    <em>",
"     Campylobacter",
"    </em>",
"    causes disease ranging from asymptomatic secretion to frank dysentery. It is unique in that constitutional symptoms such as coryza, headache, and general malaise may accompany the diarrhea, which can persist for two weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/19/19769?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations, diagnosis, and treatment of Campylobacter infection\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most patients with",
"    <em>",
"     C. jejuni",
"    </em>",
"    infections have a self-limited illness. Nevertheless, a substantial proportion of these infections are treated with antibiotics. The treatment of",
"    <em>",
"     Campylobacter",
"    </em>",
"    infection is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/19/19769?source=see_link&amp;anchor=H19#H19\">",
"     \"Clinical manifestations, diagnosis, and treatment of Campylobacter infection\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Escherichia coli",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <em>",
"     E. coli",
"    </em>",
"    is a prominent constituent of normal stool flora. Diarrheagenic",
"    <em>",
"     E. coli",
"    </em>",
"    are defined by presence of specific virulence genes and include enteropathogenic",
"    <em>",
"     E. coli",
"    </em>",
"    (EPEC), enteroinvasive",
"    <em>",
"     E. coli",
"    </em>",
"    (EIEC), enterotoxigenic",
"    <em>",
"     E. coli",
"    </em>",
"    (ETEC), enteroaggregative",
"    <em>",
"     E. coli",
"    </em>",
"    (EAggEC also called EAEC), enterohemorrhagic",
"    <em>",
"     E. coli",
"    </em>",
"    (EHEC), and diffusely adherent",
"    <em>",
"     E. coli",
"    </em>",
"    (DAEC). ETEC, EPEC, and EAEC are commonly associated with diarrhea in the developing world but are infrequently recognized in the developed world. DAEC and EIEC are uncommon in both developed and developing world. The precise mechanisms of disease associated with EAEC, EPEC, and DAEC remain undefined. Enterotoxigenic and enterohemorrhagic are the most common",
"    <em>",
"     E. coli",
"    </em>",
"    strains to produce food-borne illness worldwide.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Enterohemorrhagic E. coli",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enterohemorrhagic",
"    <em>",
"     E. coli",
"    </em>",
"    (EHEC) infection is characterized by bloody stool with little or no fever. EHEC was first recognized as a human pathogen in 1982, after an outbreak of severe bloody diarrhea in individuals who had consumed hamburgers from a fast-food chain [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/21\">",
"     21",
"    </a>",
"    ]. EHEC, also known as Shiga toxin-producing",
"    <em>",
"     E. coli",
"    </em>",
"    (STEC), or verotoxin-producing",
"    <em>",
"     E. coli",
"    </em>",
"    (VTEC), produce Shiga toxins (Stx1, Stx2, and variants of Stx2) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/22\">",
"     22",
"    </a>",
"    ];",
"    <em>",
"     E. coli",
"    </em>",
"    O157:H7 is the most prevalent strain in the United States. However, this prevalence may be secondary to the fact that only this strain can be identified in most clinical laboratories.",
"    <em>",
"     E. coli",
"    </em>",
"    O157:H7 is the only enterohemorrhagic stool strain for which testing is performed in clinical laboratories. An outbreak of hemorrhagic colitis and hemolytic uremic syndrome (HUS) in Europe that began in May 2011 was unusual in that the organism was an EAEC with Shigatoxin 2 genes. Whether or not this strain will be a recurring threat is currently unclear. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/19/18745?source=see_link\">",
"     \"Microbiology, pathogenesis, epidemiology, and prevention of enterohemorrhagic Escherichia coli (EHEC)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/57/14232?source=see_link\">",
"     \"Clinical manifestations, diagnosis and treatment of enterohemorrhagic Escherichia coli (EHEC) infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Improperly cooked beef and unpasteurized milk traditionally have been the source of EHEC ingestion. Healthy cattle, dogs, deer, sheep, horses, and goats serve as reservoirs. However,",
"    <em>",
"     E. coli",
"    </em>",
"    O157:H7 can be transmitted by food or water or from person to person. Young children carry the organism longer than do older children or adults. The organism has been isolated from manure, as well as water troughs. Outbreaks have been traced back to tainted fruits and vegetables. Radish sprouts, lettuce, unpasteurized apple juice and cider [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/23,24\">",
"     23,24",
"    </a>",
"    ], alfalfa sprouts, and spinach have been implicated.",
"   </p>",
"   <p>",
"    One-hundred-thirty-two outbreaks with a total of approximately 4800 cases were reported in the United States between 1998 and 2002 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/7\">",
"     7",
"    </a>",
"    ]. Because of difficulties in the detection of the organism, since",
"    <em>",
"     E. coli",
"    </em>",
"    is a prominent constituent of normal stool flora, the number of cases probably is an underestimation. In many cases, subclinical disease and lack of appropriate testing in sorbitol-MacConkey agar lead to gross underreporting [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/25\">",
"     25",
"    </a>",
"    ]. The best way to identify all STEC infections is to screen all stool samples for Shiga toxins using enzyme immunoassay (EIA) or polymerase chain reaction. Ideally, the laboratory should culture simultaneously for STEC [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A multistate outbreak of",
"    <em>",
"     E. coli",
"    </em>",
"    O157:H7 infections from fresh spinach was reported in the United States in September-October 2006 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/27\">",
"     27",
"    </a>",
"    ]. Nearly 200 individuals from 26 states who were infected with the outbreak strain were reported to the Centers for Disease Control and Prevention (CDC) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/27\">",
"     27",
"    </a>",
"    ]. Approximately 50 percent of cases were hospitalized, and 16 percent HUS. Among those who developed HUS, 29 percent were children (&lt;18 years old), 3 percent were between 18 and 59 years of age, and 14 percent were &ge;60 years. At least three deaths in confirmed cases were associated with the outbreak. The 2011 European outbreak with the Stx2 producing EAEC strain serotype O104:H4 was unusual in that life threatening HUS commonly occurred in adults.",
"   </p>",
"   <p>",
"    EHEC strains (particularly O157:H7, but also O26:H11, O103, O111:NM, as well as less common serotypes) have been linked with the development of HUS. HUS is the leading cause of renal failure in children; it is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and renal failure. HUS complicates 5 to 15 percent of EHEC infections and can begin during the first few days of diarrhea or as many as 10 days after onset [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/55/35704?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Shiga toxin associated (typical) hemolytic uremic syndrome in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In multivariate analyses, a retrospective study identified use of antimotility agents within the first three days of the development of diarrhea and vomiting for patients under the age of five years as risk factors for HUS [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/31\">",
"     31",
"    </a>",
"    ]. A prospective study of 71 children younger than 10 years of age with",
"    <em>",
"     E. coli",
"    </em>",
"    O157:H7 isolated from stool found that those receiving antibiotics were more likely to develop HUS (5 of 9 [56 percent] versus 5 of 62 [8 percent], p = 0.002) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/32\">",
"     32",
"    </a>",
"    ]. It is unclear whether these associations reflect therapy given to more severe diarrheal illnesses or whether these agents are actually contributing to the pathogenesis of HUS. The genes for toxin production are carried on phages. It is possible that early administration of some antibiotics (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/23/41336?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    ) to these children may promote the development of HUS by enhancing release of Shiga toxins via induction of phage-mediated lysis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/59/30649?source=see_link&amp;anchor=H2#H2\">",
"     \"Treatment and prognosis of Shiga toxin associated (typical) hemolytic uremic syndrome in children\", section on 'Prevention'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Enterotoxigenic E. coli",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enterotoxigenic",
"    <em>",
"     E. coli",
"    </em>",
"    (ETEC) is one of the most common causes of dehydrating diarrhea in children younger than two years of age in the developing world [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/33\">",
"     33",
"    </a>",
"    ]. These strains also frequently produce diarrhea in travelers to tropical regions as a result of being exposed to contaminated food and water. ETEC, in contrast to EHEC, usually induces watery diarrhea caused by the production of secretory toxins [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/34\">",
"     34",
"    </a>",
"    ]. The duration of illness is variable but generally is 24 to 72 hours. The appropriate treatment is oral rehydration therapy, unless the diarrhea is severe and complicated by shock, coma, or ileus; in such cases, intravenous therapy is required. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/15/18681?source=see_link&amp;anchor=H5#H5\">",
"     \"Oral rehydration therapy\", section on 'Clinical management'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/17/17688?source=see_link\">",
"     \"Treatment of hypovolemia (dehydration) in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Shigella",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <em>",
"     Shigella",
"    </em>",
"    causes classic bacillary dysentery and acute watery diarrhea. In the United States,",
"    <em>",
"     Shigella",
"    </em>",
"    species cause an estimated 450,000 cases of gastroenteritis each year, mostly among children aged &lt;5 years [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/1\">",
"     1",
"    </a>",
"    ]. Whereas",
"    <em>",
"     Shigella",
"    </em>",
"    account for less than 2 percent of outbreaks or hospitalizations for food-borne illness in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/6\">",
"     6",
"    </a>",
"    ], shigellosis is a major cause of diarrhea in the developing world [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/35\">",
"     35",
"    </a>",
"    ]. Shigellosis can be acquired through fecal-oral contact or through ingestion of contaminated food or water. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/1/42008?source=see_link&amp;anchor=H5#H5\">",
"     \"Epidemiology, microbiology, and pathogenesis of Shigella infection\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <em>",
"     S. sonnei",
"    </em>",
"    is the most common species of laboratory-confirmed",
"    <em>",
"     Shigella",
"    </em>",
"    infection in the United States and usually causes an acute, self-limited diarrheal illness.",
"    <em>",
"     Shigella dysenteriae",
"    </em>",
"    1 produces Shiga toxin (and thus sometimes is complicated by HUS), but this serotype is rarely found in the United States. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/40/38535?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations and diagnosis of Shigella infection\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Seizures may occur in children with",
"    <em>",
"     Shigella",
"    </em>",
"    infection [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/36\">",
"     36",
"    </a>",
"    ]. Risk factors for seizures include fever, dehydration, hypoglycemia, hyponatremia, and meningitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/40/38535?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical manifestations and diagnosis of Shigella infection\", section on 'Neurologic disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Numerous outbreaks of multidrug-resistant",
"    <em>",
"     S. sonnei",
"    </em>",
"    infection have been associated with day-care centers [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/37\">",
"     37",
"    </a>",
"    ]. Because few bacteria are required to transmit shigellosis from person to person through the fecal-oral route, shigellosis can propagate in settings with insufficient hygiene practices. Sometimes ingestion of as few as 10 organisms can cause illness. Consumption of cold salads, such as potato or macaroni salads, has been implicated in several common source outbreaks. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/1/42008?source=see_link&amp;anchor=H8#H8\">",
"     \"Epidemiology, microbiology, and pathogenesis of Shigella infection\", section on 'Food borne transmission'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment of",
"    <em>",
"     Shigella",
"    </em>",
"    infection, including the increasing problem of antimicrobial resistance among",
"    <em>",
"     Shigella",
"    </em>",
"    isolates, is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/16/8457?source=see_link&amp;anchor=H4#H4\">",
"     \"Treatment and prevention of Shigella infections in children\", section on 'Antibiotic therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Staphylococcus aureus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Staphylococcal food poisoning is another common food-borne illness, accounting for 101 outbreaks and 2766 cases between 1998 and 2002 in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/7\">",
"     7",
"    </a>",
"    ]. The illness is caused by toxins elaborated by the organism. Symptoms may begin as early as 30 minutes or as late as eight hours after eating contaminated food; the illness is characterized by the sudden onset of nausea, vomiting, and diarrhea. The incubation period and the severity of disease depend upon individual host factors and the amount of the inoculum.",
"   </p>",
"   <p>",
"    The disease usually is self limited, but deaths have been reported. Foods containing staphylococcal enterotoxin usually look and taste normal. Cooking does not destroy either the organism or the toxin. In fact, both the organism and its toxin proliferate in temperatures between 68&ordm;F and 99&ordm;F. Precooked, prepackaged meats with high salt contents are ideal vehicles for Staphylococci. Staphylococcal disease is reported most often as a result of ham ingestion [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. An outbreak of community-acquired food-borne illness caused by methicillin-resistant",
"    <em>",
"     S. aureus",
"    </em>",
"    has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Cyclospora",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <em>",
"     Cyclospora cayetanensis",
"    </em>",
"    is one of the emerging pathogens inducing diarrhea that were not even named until 1993 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/41\">",
"     41",
"    </a>",
"    ]. It gained increased attention as a food-borne pathogen after large outbreaks of illness in the United States in 1996 and 1997 were linked to raspberry farms in Guatemala [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/42\">",
"     42",
"    </a>",
"    ]. The exact source for contamination of the raspberries is not known, and rinsing does not prevent disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/48/31493?source=see_link\">",
"     \"Cyclospora infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Health care personnel should be aware that stool specimens examined for ova and parasites may not have been evaluated for",
"    <em>",
"     Cyclospora",
"    </em>",
"    unless such testing was specifically requested, and that",
"    <em>",
"     Cyclospora",
"    </em>",
"    infection is treatable with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/23/41336?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/48/31493?source=see_link\">",
"     \"Cyclospora infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a study from Guatemala,",
"    <em>",
"     Cyclospora",
"    </em>",
"    infection was found to be relatively uncommon among children younger than 18 months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/44\">",
"     44",
"    </a>",
"    ]. Infection was most common in children between the ages of 1.5 and 9 years. Disease was more severe in children younger than five years of age, who were more likely to have fever and tended to have diarrhea for up to 15 days, a higher median number of stools per day, and a higher probability of mucoid stools. Soil contact was a strong risk factor for disease in those under the age of two [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Cryptosporidiosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The parasite",
"    <em>",
"     Cryptosporidium parvum",
"    </em>",
"    is a prominent cause of waterborne diarrheal illness [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/45\">",
"     45",
"    </a>",
"    ]. The largest outbreak of waterborne disease occurred in 1993, when 403,000 residents of Milwaukee developed gastrointestinal symptoms after their drinking water became contaminated [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. Outbreaks associated with apple cider contaminated by Cryptosporidia oocysts also have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/40/13961?source=see_link&amp;anchor=H2#H2\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of cryptosporidiosis\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Food-borne outbreaks are uncommon. However, 88 students and four university employees became ill in one outbreak associated with consumption of food in a university cafeteria [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/50\">",
"     50",
"    </a>",
"    ]. Genotyping linked a",
"    <em>",
"     C. parvum",
"    </em>",
"    genotype 1 isolate to an infected food handler who prepared raw produce.",
"   </p>",
"   <p>",
"    Watery diarrhea, nausea, vomiting, and fever are common symptoms with cryptosporidiosis. The illness usually is self-limited in immunocompetent hosts, but it can cause severe, protracted diarrhea in immunocompromised hosts. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/40/13961?source=see_link&amp;anchor=H10#H10\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of cryptosporidiosis\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Clostridium perfringens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute self-limiting gastroenteritis caused by contaminated food products often is associated with",
"    <em>",
"     Clostridium perfringens",
"    </em>",
"    . Primary contamination of meat with spores is common when the food is allowed to stand at a temperature between 80&ordm;F and 120&ordm;F; temperatures of cooked meat must exceed 210&ordm;F to ensure that spores are killed. Symptoms are caused by the production of enterotoxins by the organism once it resides in the gut. Clinical manifestations typically include crampy abdominal pain and watery diarrhea without fever.",
"   </p>",
"   <p>",
"    <em>",
"     C. perfringens",
"    </em>",
"    type C produces a beta toxin that can cause enteritis necroticans (pigbel), a hemorrhagic necrosis of the jejunum. Pigbel is an uncommon health problem in developing countries and very rare in developed countries. Factors associated with enteritis necroticans include decreased GI acidity and motility, as well as chronic disease or malnutrition. A case of pigbel in a 12-year-old diabetic associated with the consumption of pig intestines (chitterlings) was reported [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/51\">",
"     51",
"    </a>",
"    ]. The simultaneous ingestion of sweet potatoes, which contain trypsin inhibitors preventing the intestinal degradation of the toxin, can be a potentiating factor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Botulism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Botulism is a rare but potentially life-threatening neuroparalytic syndrome resulting from the action of a neurotoxin elaborated by the spore-forming microorganism Clostridium botulinum. The spores are heat resistant and survive food preservation and preparation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/36/37448?source=see_link&amp;anchor=H2#H2\">",
"     \"Botulism\", section on 'Microbiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Botulism in children occurs in two ways:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Food-borne botulism &ndash; Ingestion of food contaminated by preformed botulinum toxin",
"     </li>",
"     <li>",
"      Infant botulism &ndash; Ingestion of clostridial spores that then colonize the gastrointestinal tract of the host and release toxin produced in vivo",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Infantile botulism is the most frequent form of the disease, with a mean of 71 cases annually in the United States and a mortality rate of up to 5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/52\">",
"     52",
"    </a>",
"    ]. Unlike other food-borne diseases, infantile botulism does not occur in outbreaks [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/53\">",
"     53",
"    </a>",
"    ]. Unlike most of the other agents discussed in this section, infant botulism is characterized by constipation, rather than diarrhea.",
"   </p>",
"   <p>",
"    From 1990 to 2000, 263 cases from 160 food-borne botulism events were reported in the United States; 39 percent of cases occurred in Alaska, all attributable to traditional Alaska Native foods. In the lower 49 states, a noncommercial food item was implicated in 91 percent of events, most commonly home-canned vegetables (44 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Honey has been directly linked to infant botulism. Corn syrup, although implicated, has never been directly linked with botulism. Currently, the recommendation is that honey not be given to infants under one year of age. Breast-fed infants older than two months of age have an increased risk for being hospitalized with botulism. However, because breast-fed infants typically present at a later age than do formula-fed infants, these children may have a slower progression of disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/55\">",
"     55",
"    </a>",
"    ]. Although initially thought to be involved in some cases of sudden infant death syndrome (SIDS), a 10-year prospective study failed to show an association [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/53\">",
"     53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/36/37448?source=see_link\">",
"     \"Botulism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/10/166?source=see_link\">",
"     \"Neuromuscular junction disorders in newborns and infants\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Listeria monocytogenes",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <em>",
"     Listeria monocytogenes",
"    </em>",
"    infection is an uncommon cause of food-borne illness, but the outcome of infection can be serious, especially in the very young and elderly. It accounts for less than 0.2 percent of food-borne illness, but 43 percent of the estimated number of deaths [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/7\">",
"     7",
"    </a>",
"    ]. Listeria is the most common cause of food-borne deaths in the United States. Sporadic non-outbreak-associated disease is very rare. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/48/9993?source=see_link&amp;anchor=H4#H4\">",
"     \"Epidemiology and pathogenesis of Listeria monocytogenes infection\", section on 'Clinical epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Infection with",
"    <em>",
"     L. monocytogenes",
"    </em>",
"    typically produces a febrile illness, sepsis, or central nervous system infection, principally in immunocompromised patients. Pregnant women also can be affected and should avoid unpasteurized dairy products. It is now recognized that",
"    <em>",
"     L. monocytogenes",
"    </em>",
"    can cause febrile gastroenteritis in immunocompetent individuals. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/44/1736?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations and diagnosis of Listeria monocytogenes infection\", section on 'Clinical syndromes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In one outbreak at primary schools, 1566 of 2189 people (72 percent) had symptoms of gastroenteritis traced to the consumption of a corn salad in the cafeterias [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/56\">",
"     56",
"    </a>",
"    ]. The median time from meal consumption to onset of symptoms was 24 hours.",
"   </p>",
"   <p>",
"    The treatment of",
"    <em>",
"     L. monocytogenes",
"    </em>",
"    infection is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/46/745?source=see_link&amp;anchor=H3#H3\">",
"     \"Treatment, prognosis, and prevention of Listeria monocytogenes infection\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Yersinia enterocolitica",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <em>",
"     Yersinia enterocolitica",
"    </em>",
"    can cause both outbreaks and sporadic cases of food-borne gastroenteritis. The most common vehicle is undercooked pork products, such as chitterlings. One outbreak involved children in Vermont and was linked to consumption of milk from one dairy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/57\">",
"     57",
"    </a>",
"    ]. A dairy pig from the farm had the organism isolated from feces, and pigs were the presumed source of contamination.",
"    <em>",
"     Y. enterocolitica",
"    </em>",
"    classically can induce a clinical picture that mimics appendicitis.",
"   </p>",
"   <p>",
"    <em>",
"     Y. enterocolitica",
"    </em>",
"    infection is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22373?source=see_link\">",
"     \"Microbiology and pathogenesis of Yersinia infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/63/41974?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Yersinia infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32885?source=see_link\">",
"     \"Treatment and prevention of Yersinia enterocolitica and Yersinia pseudotuberculosis infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Enterobacter sakazakii",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contamination of powdered infant formula preparations by",
"    <em>",
"     Enterobacter sakazakii",
"    </em>",
"    (also known as",
"    <em>",
"     Cronobacter",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/58\">",
"     58",
"    </a>",
"    ]) has been linked to invasive infections including meningitis, brain abscess, and necrotizing enterocolitis; diarrhea is not a typical finding [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/59-62\">",
"     59-62",
"    </a>",
"    ]. A European study to analyze environmental contamination with",
"    <em>",
"     E. sakazakii",
"    </em>",
"    isolated this pathogen from sweeping surfaces or vacuum cleaner bags in eight of nine food factories, and from vacuum cleaner bags in 5 of 16 households [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/63\">",
"     63",
"    </a>",
"    ]. The investigators conclude that this organism is widespread in the environment, which should be taken into account in designing measures for preventing infant formula contamination. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/44/24265?source=see_link\">",
"     \"Differential diagnosis of microbial foodborne disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Brucella",
"    </span>",
"    &nbsp;&mdash;&nbsp;Brucellosis is uncommon in the United States and most industrialized countries, but worldwide it is a significant cause of disease in domesticated animals; humans serve an incidental hosts. Most reported cases in the United States are from California or Texas [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/61/33751?source=see_link&amp;anchor=H3#H3\">",
"     \"Microbiology, epidemiology, and pathogenesis of Brucella\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Brucellosis is acquired from ingestion of contaminated food, such as raw milk, cheeses made from unpasteurized milk (often imported), or raw meat. This food-borne illness does not typically produce diarrhea; brucellosis is characterized by fever and a protean variety of other manifestations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/43/16058?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations, diagnosis, and treatment of brucellosis\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SEAFOOD INGESTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seafood is a frequent source of food-borne illness. Such illness can arise from consumption of fish, especially shellfish, contaminated by viruses such as Norwalk or Hepatitis A; ingestion of a toxin such as scombroid, found in certain finfish; or poisoning from fish or shellfish contaminated with toxins from algae and other marine life forms, such as dinoflagellates that produce toxins causing ciguatera fish poisoning and paralytic shellfish poisoning, or",
"    <em>",
"     Gymnodinium breve",
"    </em>",
"    , which causes red tide [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/64\">",
"     64",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/14/43241?source=see_link\">",
"     \"Epidemiology, clinical manifestations and diagnosis of norovirus and related viruses\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16295?source=see_link\">",
"     \"Overview of hepatitis A virus infection in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Human calicivirus and other viruses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viruses such as the caliciviruses, the prototype of which are the noroviruses (formerly known as Norwalk-like viruses), probably account for a sizable proportion of food-borne illness [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/1\">",
"     1",
"    </a>",
"    ]. The application of new molecular diagnostic methods suggests that the calicivirus family is the most common cause of acute viral gastroenteritis outbreaks in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/7,65\">",
"     7,65",
"    </a>",
"    ]. Between 1998 and 2002, 657 outbreaks of norovirus resulting in more than 27,000 cases were reported to the CDC [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/7\">",
"     7",
"    </a>",
"    ]. Calicivirus was responsible for 42 percent of outbreaks of shellfish-associated illness in which a pathogen was identified [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Viruses can be transmitted from contaminated food or water, and food handlers often are suspected as the source of food-borne outbreaks. Genomic characterization of viruses has allowed the development of reverse transcriptase polymerase chain reaction assays that can be used in the testing of clinical stool samples. The assays were used in an outbreak of gastroenteritis to trace the source to a food handler whose infant was sick with the infection [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incubation period generally is 24 to 48 hours, with a range from 18 to 72 hours. Clinical manifestations include nausea, vomiting, abdominal pain, and diarrhea. Disease manifestations generally last 48 to 72 hours with a full and rapid recovery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/14/43241?source=see_link\">",
"     \"Epidemiology, clinical manifestations and diagnosis of norovirus and related viruses\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Vibrio species",
"    </span>",
"    &nbsp;&mdash;&nbsp;The",
"    <em>",
"     Vibrio",
"    </em>",
"    species, which include",
"    <em>",
"     Vibrio vulnificus",
"    </em>",
"    ,",
"    <em>",
"     V. parahaemolyticus",
"    </em>",
"    , and",
"    <em>",
"     V. cholerae",
"    </em>",
"    , are major causes of seafood- and fish-acquired food poisoning [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/68\">",
"     68",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36073?source=see_link\">",
"     \"Overview of Vibrio cholerae infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/4/18502?source=see_link\">",
"     \"Infections due to non-O1/O139 Vibrio cholerae\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <em>",
"       V. cholera",
"      </em>",
"      serogroups 01 and 0139 cause pandemic and epidemic cholera, a disease characterized by voluminous watery diarrhea [",
"      <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/69\">",
"       69",
"      </a>",
"      ]. An isolate indistinguishable from the epidemic Latin American strain was identified in oysters from Mobile Bay, Alabama in 1991 and 1992, but no clinical cases of cholera resulted [",
"      <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/70\">",
"       70",
"      </a>",
"      ]. In the United States, three outbreaks of",
"      <em>",
"       V. cholera",
"      </em>",
"      , affecting 12 people, were reported to the CDC from 1998 to 2002 [",
"      <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/7\">",
"       7",
"      </a>",
"      ]. Although noncholeragenic",
"      <em>",
"       Vibrio",
"      </em>",
"      illnesses were reported in 22 residents of Louisiana and Mississippi after Hurricane Katrina, no epidemic of cholera was identified, and no evidence exists of increased risk to Gulf Coast residents [",
"      <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/71\">",
"       71",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <em>",
"       V. vulnificus",
"      </em>",
"      most frequently is implicated in outbreaks from the United States.",
"      <em>",
"       V. vulnificus",
"      </em>",
"      infection can be acquired by eating raw or undercooked shellfish, as well as directly by contaminating open wounds while swimming or cleaning shellfish [",
"      <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/72\">",
"       72",
"      </a>",
"      ].",
"      <em>",
"       V. vulnificus",
"      </em>",
"      infection usually results in cellulitis, wound infection, or septicemia. Among 236",
"      <em>",
"       Vibrio",
"      </em>",
"      illnesses associated with recreational water exposure reported to the Cholera and Other Vibrio Illness Surveillance System during2007-2008,",
"      <em>",
"       V. vulnificus",
"      </em>",
"      had the highest rate of hospitalization and mortality (75 and 13 percent, respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/73\">",
"       73",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/42/44710?source=see_link\">",
"       \"Vibrio vulnificus infections\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <em>",
"       V. parahaemolyticus",
"      </em>",
"      infection typically produces a diarrheal illness. Outbreaks of",
"      <em>",
"       V. parahaemolyticus",
"      </em>",
"      infection have been associated with raw oysters and clams from the northeastern, as well as Pacific northwestern, coasts of the United States [",
"      <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/74-76\">",
"       74-76",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/14/27878?source=see_link\">",
"       \"Vibrio parahaemolyticus infections\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Scombroid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Scombroid fish poisoning occurs after the ingestion of finfish, notably tuna, mahi-mahi, and bluefish [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/77,78\">",
"     77,78",
"    </a>",
"    ]. One of the largest reported outbreaks of scombroid fish poisoning in the United States was associated with a rare vehicle, escolar fish [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/79\">",
"     79",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/41/19096?source=see_link&amp;anchor=H9#H9\">",
"     \"Marine toxins\", section on 'Scombroid'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The illness is caused by histamine and other products from bacteria that propagate on the fish in warm water or when they are inadequately refrigerated. Prompt harvesting and refrigeration until the fish is cooked are the best means of preventing this poisoning.",
"   </p>",
"   <p>",
"    The CDC reported 118 outbreaks of scombroid from 1998 to 2002, resulting in 163 cases [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/7\">",
"     7",
"    </a>",
"    ]. One Pennsylvania outbreak was associated with consumption of a tuna-and-spinach salad in a restaurant [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/77\">",
"     77",
"    </a>",
"    ]. Flushing, nausea, sweating, diarrhea, and headache occurred from five minutes to two hours after ingestion and resolved within hours. Histamine levels were found to be elevated in the fish, which had been caught in the Gulf of Mexico by a long-line method that kept the fish suspended for 12 to 24 hours on the line in the relatively warm water prior to harvesting [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Ciguatera fish poisoning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ciguatera poisoning is the most common form of seafood poisoning and occurs after ingestion of certain species of local reef fish, which vary from location to location. Between 1998 and 2002, 84 outbreaks resulting in 315 cases were reported to the CDC [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/7\">",
"     7",
"    </a>",
"    ]; several outbreaks have been described in Australia [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/80\">",
"     80",
"    </a>",
"    ]. The fish appear and taste normal; cooking does not destroy the toxin, and, thus, avoidance of these fish is the only means of prevention. Most resort areas in the Caribbean and Hawaii do not serve implicated species of local reef fish.",
"   </p>",
"   <p>",
"    Patients develop gastrointestinal symptoms generally within three to six hours of eating the fish. Neurologic symptoms, including circumoral paresthesias and weakness in the lower extremities, can occur later; occasionally a reversal of hot-cold taste sensation is reported [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/64\">",
"     64",
"    </a>",
"    ]. Neurologic symptoms often persist for several weeks, but in some cases can last for years.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     MUSHROOM INGESTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mushroom ingestions are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/47/1786?source=see_link\">",
"     \"Clinical manifestations and evaluation of mushroom poisoning\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42615?source=see_link\">",
"     \"Management of mushroom poisoning\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/28/10698?source=see_link\">",
"     \"Amatoxin-containing mushroom poisoning including ingestion of Amanita phalloides\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/57/36759?source=see_link\">",
"     \"Amanita smithiana mushroom poisoning\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     PREVENTION THROUGH FOOD IRRADIATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Irradiation is extremely effective in reducing pathogens associated with food products. Irradiation of flour, fruits, vegetables, meats, and spices has been approved by the United States Food and Drug Administration (FDA). Meat, pork, and poultry also have been approved by the United States Department of Agriculture (USDA) for irradiation up to 3.0 Grays. This dose of irradiation destroys",
"    <em>",
"     S. aureus",
"    </em>",
"    ,",
"    <em>",
"     Salmonella",
"    </em>",
"    ,",
"    <em>",
"     Shigella",
"    </em>",
"    ,",
"    <em>",
"     Campylobacter",
"    </em>",
"    , and",
"    <em>",
"     Cyclospora",
"    </em>",
"    . However,",
"    <em>",
"     E. coli",
"    </em>",
"    O157:H7 requires much higher doses. Food irradiation at approved levels causes no significant change in the amino acid or fatty acid content of food. Reduction in thiamine is minimal [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Irradiating food prolongs shelf life, delays ripening time for fruit, and destroys the bacteria that cause food-borne illnesses. Many countries already use irradiation widely. In the United States, many foods are irradiated. Although food irradiation is a safe and useful technology, it remains underutilized [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to food irradiation, there are other new nonthermal technologies for microbial inactivation, such as high hydrostatic pressure, pulsed electric field, and ultrasound under pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/82\">",
"     82",
"    </a>",
"    ]. Nonthermal methods allow microorganisms to be inactivated at sub-lethal temperatures, thus better preserving the sensory, nutritional and functional properties of foods [",
"    <a class=\"abstract\" href=\"UTD.htm?16/2/16426/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     PREVENTION THROUGH SAFE FOOD HANDLING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Proper food storage and preparation also can reduce the risk of food poisoning. The United States Department of Agriculture (USDA) has identified several \"critical control points\" in food safety:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Purchase",
"     </li>",
"     <li>",
"      Home storage",
"     </li>",
"     <li>",
"      Preparation",
"     </li>",
"     <li>",
"      Cooking",
"     </li>",
"     <li>",
"      Serving",
"     </li>",
"     <li>",
"      Storage of leftovers",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Further information is available from the",
"    <a class=\"external\" href=\"file://www.fsis.usda.gov/Fact_Sheets/index.asp\">",
"     USDA",
"    </a>",
"    . Major control measures include (",
"    <a class=\"graphic graphic_table graphicRef73216 \" href=\"UTD.htm?4/17/4381\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Avoid contact between cooked and uncooked foods",
"     </li>",
"     <li>",
"      Refrigerate foods promptly after purchase, preparation, or eating",
"     </li>",
"     <li>",
"      Wash hands and preparation surfaces after handling raw meats, poultry, fish, and eggs before contact with other items",
"     </li>",
"     <li>",
"      Cook meats, poultry, fish, and eggs thoroughly",
"     </li>",
"     <li>",
"      Maintain proper refrigerator and freezer temperatures, and never leave cooked foods at room temperature for more than two hours (shorter if ambient temperatures are higher)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Additional information",
"    </span>",
"    &nbsp;&mdash;&nbsp;Additional information about food safety is available from the USDA's",
"    <a class=\"external\" href=\"file://www.fsis.usda.gov/\">",
"     Food Safety and Inspection Service",
"    </a>",
"    ; the",
"    <a class=\"external\" href=\"file://www.fda.gov/Food/default.htm\">",
"     United States Food and Drug Administration",
"    </a>",
"    ; the Meat and Poultry Hotline (1-800-535-4555); or the Food Information Line (1-888-SAFEFOOD).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?10/22/10595?source=see_link\">",
"       \"Patient information: Food poisoning (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?28/30/29156?source=see_link\">",
"       \"Patient information: Food poisoning (food-borne illness) (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?0/1/27?source=see_link\">",
"       \"Patient information: Acute diarrhea in children (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?21/54/22371?source=see_link\">",
"       \"Patient information: Nausea and vomiting in infants and children (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25318477\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Centers for Disease Control and Prevention defines a food-borne disease outbreak as any cluster of two or more individuals who develop similar symptoms following the ingestion of a common food. Laboratory or clinical guidelines for confirming an etiology of a food-borne disease outbreak vary for bacterial, chemical, parasitic, and viral agents (",
"      <a class=\"graphic graphic_table graphicRef77956 graphicRef53848 graphicRef62562 graphicRef75804 graphicRef55831 graphicRef68671 graphicRef77344 \" href=\"UTD.htm?31/23/32114\">",
"       table 1A-G",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definitions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Factors that contribute to food-borne disease include improper food storage and handling and lack of adequate public health infrastructure. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Contributing factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A wide variety of microorganisms can cause food poisoning (",
"      <a class=\"graphic graphic_table graphicRef77956 graphicRef53848 graphicRef62562 graphicRef75804 graphicRef55831 graphicRef68671 graphicRef77344 \" href=\"UTD.htm?31/23/32114\">",
"       table 1A-G",
"      </a>",
"      ).",
"      <em>",
"       Salmonella",
"      </em>",
"      species cause the majority of outbreaks when an etiology can be established. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Common and emerging microbial agents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Food poisoning due to ingestion of seafood may be caused by human caliciviruses (eg, noroviruses), other viruses (hepatitis A),",
"      <em>",
"       Vibrio",
"      </em>",
"      species, scombroid, and ciguatera fish poisoning. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Seafood ingestions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Mushroom ingestions are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/47/1786?source=see_link\">",
"       \"Clinical manifestations and evaluation of mushroom poisoning\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42615?source=see_link\">",
"       \"Management of mushroom poisoning\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/28/10698?source=see_link\">",
"       \"Amatoxin-containing mushroom poisoning including ingestion of Amanita phalloides\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/57/36759?source=see_link\">",
"       \"Amanita smithiana mushroom poisoning\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Food poisoning can be prevented through food irradiation and safe food handling (",
"      <a class=\"graphic graphic_table graphicRef73216 \" href=\"UTD.htm?4/17/4381\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H32\">",
"       'Prevention through food irradiation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H33\">",
"       'Prevention through safe food handling'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/1\">",
"      Mead PS, Slutsker L, Dietz V, et al. Food-related illness and death in the United States. Emerg Infect Dis 1999; 5:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/2\">",
"      Frost F, Craun GF, Calderon RL. Increasing hospitalization and death possibly due to Clostridium difficile diarrheal disease. Emerg Infect Dis 1998; 4:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/3\">",
"      Santosham M, Keenan EM, Tulloch J, et al. Oral rehydration therapy for diarrhea: an example of reverse transfer of technology. Pediatrics 1997; 100:E10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/4\">",
"      Glass RI, Lew JF, Gangarosa RE, et al. Estimates of morbidity and mortality rates for diarrheal diseases in American children. J Pediatr 1991; 118:S27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/5\">",
"      Bean NH, Goulding JS, Lao C, Angulo FJ. Surveillance for foodborne-disease outbreaks--United States, 1988-1992. MMWR CDC Surveill Summ 1996; 45:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/6\">",
"      Olsen SJ, MacKinnon LC, Goulding JS, et al. Surveillance for foodborne-disease outbreaks--United States, 1993-1997. MMWR CDC Surveill Summ 2000; 49:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/7\">",
"      Lynch M, Painter J, Woodruff R, et al. Surveillance for foodborne-disease outbreaks--United States, 1998-2002. MMWR Surveill Summ 2006; 55:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/8\">",
"      Altekruse SF, Cohen ML, Swerdlow DL. Emerging foodborne diseases. Emerg Infect Dis 1997; 3:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/9\">",
"      Shewmake RA, Dillon B. Food poisoning. Causes, remedies, and prevention. Postgrad Med 1998; 103:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/10\">",
"      Collins JE. Impact of changing consumer lifestyles on the emergence/reemergence of foodborne pathogens. Emerg Infect Dis 1997; 3:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/11\">",
"      Nightingale SL. Foodborne disease: an increasing problem. Am Fam Physician 1987; 35:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/12\">",
"      Udall JN Jr. Secretory diarrhea in children: newly recognized toxins and hormone-secreting tumors. Pediatr Clin North Am 1996; 43:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/13\">",
"      Davis MA, Hancock DD, Besser TE, et al. Changes in antimicrobial resistance among Salmonella enterica Serovar typhimurium isolates from humans and cattle in the Northwestern United States, 1982-1997. Emerg Infect Dis 1999; 5:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/14\">",
"      M&oslash;lbak K, Baggesen DL, Aarestrup FM, et al. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104. N Engl J Med 1999; 341:1420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/15\">",
"      Parry CM. Antimicrobial drug resistance in Salmonella enterica. Curr Opin Infect Dis 2003; 16:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/16\">",
"      Su LH, Chiu CH, Chu C, Ou JT. Antimicrobial resistance in nontyphoid Salmonella serotypes: a global challenge. Clin Infect Dis 2004; 39:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/17\">",
"      Villar RG, Macek MD, Simons S, et al. Investigation of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Washington State. JAMA 1999; 281:1811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/18\">",
"      Kuppermann N. Occult bacteremia in young febrile children. Pediatr Clin North Am 1999; 46:1073.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/19\">",
"      Cornick NA, Gorbach SL. Campylobacter. Infect Dis Clin North Am 1988; 2:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/20\">",
"      Tauxe RV, Hargrett-Bean N, Patton CM, Wachsmuth IK. Campylobacter isolates in the United States, 1982-1986. MMWR CDC Surveill Summ 1988; 37:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/21\">",
"      Lederberg J. Infectious disease as an evolutionary paradigm. Emerg Infect Dis 1997; 3:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/22\">",
"      Bower JR. Foodborne diseases: Shiga toxin producing E. coli (STEC). Pediatr Infect Dis J 1999; 18:909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/23\">",
"      Centers for Disease Control and Prevention (CDC). Outbreak of Salmonella serotype Muenchen infections associated with unpasteurized orange juice--United States and Canada, June 1999. MMWR Morb Mortal Wkly Rep 1999; 48:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/24\">",
"      Centers for Disease Control and Prevention (CDC). Outbreaks of Escherichia coli O157:H7 infection and cryptosporidiosis associated with drinking unpasteurized apple cider--Connecticut and New York, October 1996. MMWR Morb Mortal Wkly Rep 1997; 46:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/25\">",
"      Mead PS, Griffin PM. Escherichia coli O157:H7. Lancet 1998; 352:1207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/26\">",
"      Centers for Disease Control and Prevention (CDC). Importance of culture confirmation of shiga toxin-producing Escherichia coli infection as illustrated by outbreaks of gastroenteritis--New York and North Carolina, 2005. MMWR Morb Mortal Wkly Rep 2006; 55:1042.",
"     </a>",
"    </li>",
"    <li>",
"     Updates From the multi-state outbreak of E. coli O157:H7 infections from fresh spinach, September&ndash;October 2006. www.cdc.gov/ecoli/2006/september/updates (Accessed on November 09, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/28\">",
"      Su C, Brandt LJ. Escherichia coli O157:H7 infection in humans. Ann Intern Med 1995; 123:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/29\">",
"      Lutter R. Policy forum: food safety. Food irradiation--the neglected solution to food-borne illness. Science 1999; 286:2275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/30\">",
"      Boyce TG, Swerdlow DL, Griffin PM. Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med 1995; 333:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/31\">",
"      Bell BP, Griffin PM, Lozano P, et al. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 1997; 100:E12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/32\">",
"      Wong CS, Jelacic S, Habeeb RL, et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 2000; 342:1930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/33\">",
"      Black RE, Brown KH, Becker S, et al. Contamination of weaning foods and transmission of enterotoxigenic Escherichia coli diarrhoea in children in rural Bangladesh. Trans R Soc Trop Med Hyg 1982; 76:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/34\">",
"      Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998; 11:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/35\">",
"      Ahmed F, Clemens JD, Rao MR, et al. Epidemiology of shigellosis among children exposed to cases of Shigella dysentery: a multivariate assessment. Am J Trop Med Hyg 1997; 56:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/36\">",
"      Khan WA, Dhar U, Salam MA, et al. Central nervous system manifestations of childhood shigellosis: prevalence, risk factors, and outcome. Pediatrics 1999; 103:E18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/37\">",
"      Centers for Disease Control and Prevention (CDC). Outbreaks of multidrug-resistant Shigella sonnei gastroenteritis associated with day care centers--Kansas, Kentucky, and Missouri, 2005. MMWR Morb Mortal Wkly Rep 2006; 55:1068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/38\">",
"      Centers for Disease Control and Prevention (CDC). Outbreak of staphylococcal food poisoning associated with precooked ham--Florida, 1997. MMWR Morb Mortal Wkly Rep 1997; 46:1189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/39\">",
"      Centers for Disease Control (CDC). Staphylococcal food poisoning on a cruise ship. MMWR Morb Mortal Wkly Rep 1983; 32:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/40\">",
"      Jones TF, Kellum ME, Porter SS, et al. An outbreak of community-acquired foodborne illness caused by methicillin-resistant Staphylococcus aureus. Emerg Infect Dis 2002; 8:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/41\">",
"      Ortega YR, Sterling CR, Gilman RH, et al. Cyclospora species--a new protozoan pathogen of humans. N Engl J Med 1993; 328:1308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/42\">",
"      Herwaldt BL, Ackers ML. An outbreak in 1996 of cyclosporiasis associated with imported raspberries. The Cyclospora Working Group. N Engl J Med 1997; 336:1548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/43\">",
"      Herwaldt BL. Cyclospora cayetanensis: a review, focusing on the outbreaks of cyclosporiasis in the 1990s. Clin Infect Dis 2000; 31:1040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/44\">",
"      Bern C, Hernandez B, Lopez MB, et al. Epidemiologic studies of Cyclospora cayetanensis in Guatemala. Emerg Infect Dis 1999; 5:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/45\">",
"      Fricker CR, Crabb JH. Water-borne cryptosporidiosis: detection methods and treatment options. Adv Parasitol 1998; 40:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/46\">",
"      Levy DA, Bens MS, Craun GF, et al. Surveillance for waterborne-disease outbreaks--United States, 1995-1996. MMWR CDC Surveill Summ 1998; 47:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/47\">",
"      MacKenzie WR, Schell WL, Blair KA, et al. Massive outbreak of waterborne cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission. Clin Infect Dis 1995; 21:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/48\">",
"      Millard PS, Gensheimer KF, Addiss DG, et al. An outbreak of cryptosporidiosis from fresh-pressed apple cider. JAMA 1994; 272:1592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/49\">",
"      From the Centers for Disease Control and Prevention. Outbreaks of Escherichia coli O157:H7 infection and cryptosporidiosis associated with drinking unpasteurized apple cider--Connecticut and New York, October 1996. JAMA 1997; 277:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/50\">",
"      Quiroz ES, Bern C, MacArthur JR, et al. An outbreak of cryptosporidiosis linked to a foodhandler. J Infect Dis 2000; 181:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/51\">",
"      Petrillo TM, Beck-Sagu&eacute; CM, Songer JG, et al. Enteritis necroticans (pigbel) in a diabetic child. N Engl J Med 2000; 342:1250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/52\">",
"      Shapiro RL, Hatheway C, Swerdlow DL. Botulism in the United States: a clinical and epidemiologic review. Ann Intern Med 1998; 129:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/53\">",
"      Cherington M. Clinical spectrum of botulism. Muscle Nerve 1998; 21:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/54\">",
"      Sobel J, Tucker N, Sulka A, et al. Foodborne botulism in the United States, 1990-2000. Emerg Infect Dis 2004; 10:1606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/55\">",
"      Golding J, Emmett PM, Rogers IS. Does breast feeding protect against non-gastric infections? Early Hum Dev 1997; 49 Suppl:S105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/56\">",
"      Aureli P, Fiorucci GC, Caroli D, et al. An outbreak of febrile gastroenteritis associated with corn contaminated by Listeria monocytogenes. N Engl J Med 2000; 342:1236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/57\">",
"      Ackers ML, Schoenfeld S, Markman J, et al. An outbreak of Yersinia enterocolitica O:8 infections associated with pasteurized milk. J Infect Dis 2000; 181:1834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/58\">",
"      Iversen C, Lehner A, Mullane N, et al. Identification of \"Cronobacter\" spp. (Enterobacter sakazakii). J Clin Microbiol 2007; 45:3814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/59\">",
"      Lai KK. Enterobacter sakazakii infections among neonates, infants, children, and adults. Case reports and a review of the literature. Medicine (Baltimore) 2001; 80:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/60\">",
"      Muytjens HL, Koll&eacute;e LA. Enterobacter sakazakii meningitis in neonates: causative role of formula? Pediatr Infect Dis J 1990; 9:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/61\">",
"      Drudy D, Mullane NR, Quinn T, et al. Enterobacter sakazakii: an emerging pathogen in powdered infant formula. Clin Infect Dis 2006; 42:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/62\">",
"      Bowen AB, Braden CR. Invasive Enterobacter sakazakii disease in infants. Emerg Infect Dis 2006; 12:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/63\">",
"      Kandhai MC, Reij MW, Gorris LG, et al. Occurrence of Enterobacter sakazakii in food production environments and households. Lancet 2004; 363:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/64\">",
"      Morris JG Jr. Pfiesteria, \"the cell from hell,\" and other toxic algal nightmares. Clin Infect Dis 1999; 28:1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/65\">",
"      Glass RI, Noel J, Ando T, et al. The epidemiology of enteric caliciviruses from humans: a reassessment using new diagnostics. J Infect Dis 2000; 181 Suppl 2:S254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/66\">",
"      Wallace BJ, Guzewich JJ, Cambridge M, et al. Seafood-associated disease outbreaks in New York, 1980-1994. Am J Prev Med 1999; 17:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/67\">",
"      Daniels NA, Bergmire-Sweat DA, Schwab KJ, et al. A foodborne outbreak of gastroenteritis associated with Norwalk-like viruses: first molecular traceback to deli sandwiches contaminated during preparation. J Infect Dis 2000; 181:1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/68\">",
"      Munoz J. Foodborne diseases: seafood. Pediatr Infect Dis J 1999; 18:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/69\">",
"      Basu A, Garg P, Datta S, et al. Vibrio cholerae O139 in Calcutta, 1992-1998: incidence, antibiograms, and genotypes. Emerg Infect Dis 2000; 6:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/70\">",
"      Centers for Disease Control and Prevention (CDC). Isolation of Vibrio cholerae O1 from oysters--Mobile Bay, 1991-1992. MMWR Morb Mortal Wkly Rep 1993; 42:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/71\">",
"      Centers for Disease Control and Prevention (CDC). Two cases of toxigenic Vibrio cholerae O1 infection after Hurricanes Katrina and Rita--Louisiana, October 2005. MMWR Morb Mortal Wkly Rep 2006; 55:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/72\">",
"      Centers for Disease Control and Prevention (CDC). Vibrio vulnificus infections associated with raw oyster consumption--Florida, 1981-1992. MMWR Morb Mortal Wkly Rep 1993; 42:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/73\">",
"      Hlavsa MC, Roberts VA, Anderson AR, et al. Surveillance for waterborne disease outbreaks and other health events associated with recreational water --- United States, 2007--2008. MMWR Surveill Summ 2011; 60:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/74\">",
"      Outbreak of Vibrio parahaemolyticus infections associated with eating raw oysters--Pacific Northwest,1997. MMWR Morb Mortal Wkly Rep 1998; 47:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/75\">",
"      Centers for Disease Control and Prevention (CDC). Outbreak of Vibrio parahaemolyticus infection associated with eating raw oysters and clams harvested from Long Island Sound--Connecticut, New Jersey, and New York, 1998. MMWR Morb Mortal Wkly Rep 1999; 48:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/76\">",
"      Centers for Disease Control and Prevention (CDC). Vibrio parahaemolyticus infections associated with consumption of raw shellfish--three states, 2006. MMWR Morb Mortal Wkly Rep 2006; 55:854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/77\">",
"      Scombroid fish poisoning&mdash;Pennsylvania, 1998. MMWR Morb Mortal Wkly Rep 2000; 49:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/78\">",
"      Centers for Disease Control and Prevention (CDC). Scombroid fish poisoning associated with tuna steaks--Louisiana and Tennessee, 2006. MMWR Morb Mortal Wkly Rep 2007; 56:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/79\">",
"      Feldman KA, Werner SB, Cronan S, et al. A large outbreak of scombroid fish poisoning associated with eating escolar fish (Lepidocybium flavobrunneum). Epidemiol Infect 2005; 133:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/80\">",
"      Karalis T, Gupta L, Chu M, et al. Three clusters of ciguatera poisoning: clinical manifestations and public health implications. Med J Aust 2000; 172:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/81\">",
"      Parnes RB, Lichtenstein AH. Food irradiation: a safe and useful technology. Nutr Clin Care 2004; 7:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/2/16426/abstract/82\">",
"      Ma&ntilde;as P, Pag&aacute;n R. Microbial inactivation by new technologies of food preservation. J Appl Microbiol 2005; 98:1387.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6013 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-76D4E16EBB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_2_16426=[""].join("\n");
var outline_f16_2_16426=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25318477\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CONTRIBUTING FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Improper food storage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Food handlers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Widespread distribution of foods",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      COMMON AND EMERGING MICROBIAL AGENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Salmonella",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Campylobacter",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Escherichia coli",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Enterohemorrhagic E. coli",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Enterotoxigenic E. coli",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Shigella",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Staphylococcus aureus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Cyclospora",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Cryptosporidiosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Clostridium perfringens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Botulism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Listeria monocytogenes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Yersinia enterocolitica",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Enterobacter sakazakii",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Brucella",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SEAFOOD INGESTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Human calicivirus and other viruses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Vibrio species",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Scombroid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Ciguatera fish poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      MUSHROOM INGESTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      PREVENTION THROUGH FOOD IRRADIATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      PREVENTION THROUGH SAFE FOOD HANDLING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Additional information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25318477\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6013\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6013|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/60/3021\" title=\"table 1A\">",
"      Food-borne diseases I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/39/9853\" title=\"table 1B\">",
"      Food-borne diseases II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/16/1293\" title=\"table 1C\">",
"      Food-borne diseases III",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/46/6893\" title=\"table 1D\">",
"      Food-borne diseases IV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/59/7101\" title=\"table 1E\">",
"      Food-borne diseases V",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?18/61/19421\" title=\"table 1F\">",
"      Food-borne diseases VI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/11/7356\" title=\"table 1G\">",
"      Food-borne diseases VII",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/17/4381\" title=\"table 2\">",
"      Safe food handling practices",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/57/36759?source=related_link\">",
"      Amanita smithiana mushroom poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/28/10698?source=related_link\">",
"      Amatoxin-containing mushroom poisoning including ingestion of Amanita phalloides",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/8/26761?source=related_link\">",
"      Approach to the patient with nontyphoidal Salmonella in a stool culture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/36/37448?source=related_link\">",
"      Botulism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/44/1736?source=related_link\">",
"      Clinical manifestations and diagnosis of Listeria monocytogenes infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/55/35704?source=related_link\">",
"      Clinical manifestations and diagnosis of Shiga toxin associated (typical) hemolytic uremic syndrome in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/40/38535?source=related_link\">",
"      Clinical manifestations and diagnosis of Shigella infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/63/41974?source=related_link\">",
"      Clinical manifestations and diagnosis of Yersinia infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/47/1786?source=related_link\">",
"      Clinical manifestations and evaluation of mushroom poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/57/14232?source=related_link\">",
"      Clinical manifestations, diagnosis and treatment of enterohemorrhagic Escherichia coli (EHEC) infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/19/19769?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of Campylobacter infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/43/16058?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of brucellosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/48/31493?source=related_link\">",
"      Cyclospora infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/44/24265?source=related_link\">",
"      Differential diagnosis of microbial foodborne disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/48/9993?source=related_link\">",
"      Epidemiology and pathogenesis of Listeria monocytogenes infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/14/43241?source=related_link\">",
"      Epidemiology, clinical manifestations and diagnosis of norovirus and related viruses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/40/13961?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of cryptosporidiosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/1/42008?source=related_link\">",
"      Epidemiology, microbiology, and pathogenesis of Shigella infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/4/18502?source=related_link\">",
"      Infections due to non-O1/O139 Vibrio cholerae",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42615?source=related_link\">",
"      Management of mushroom poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/41/19096?source=related_link\">",
"      Marine toxins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/19/14649?source=related_link\">",
"      Microbiology and epidemiology of salmonellosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22373?source=related_link\">",
"      Microbiology and pathogenesis of Yersinia infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/61/33751?source=related_link\">",
"      Microbiology, epidemiology, and pathogenesis of Brucella",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/60/5065?source=related_link\">",
"      Microbiology, pathogenesis, and epidemiology of Campylobacter infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/19/18745?source=related_link\">",
"      Microbiology, pathogenesis, epidemiology, and prevention of enterohemorrhagic Escherichia coli (EHEC)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/10/166?source=related_link\">",
"      Neuromuscular junction disorders in newborns and infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/15/18681?source=related_link\">",
"      Oral rehydration therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36073?source=related_link\">",
"      Overview of Vibrio cholerae infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16295?source=related_link\">",
"      Overview of hepatitis A virus infection in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?0/1/27?source=related_link\">",
"      Patient information: Acute diarrhea in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?10/22/10595?source=related_link\">",
"      Patient information: Food poisoning (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/30/29156?source=related_link\">",
"      Patient information: Food poisoning (food-borne illness) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/54/22371?source=related_link\">",
"      Patient information: Nausea and vomiting in infants and children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/16/8457?source=related_link\">",
"      Treatment and prevention of Shigella infections in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32885?source=related_link\">",
"      Treatment and prevention of Yersinia enterocolitica and Yersinia pseudotuberculosis infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/59/30649?source=related_link\">",
"      Treatment and prognosis of Shiga toxin associated (typical) hemolytic uremic syndrome in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/17/17688?source=related_link\">",
"      Treatment of hypovolemia (dehydration) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/46/745?source=related_link\">",
"      Treatment, prognosis, and prevention of Listeria monocytogenes infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/14/27878?source=related_link\">",
"      Vibrio parahaemolyticus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/42/44710?source=related_link\">",
"      Vibrio vulnificus infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_2_16427="Transjugular liver biopsy complications";
var content_f16_2_16427=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F83414&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F83414&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Complications of transjugular liver biopsy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Fever",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abdominal pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neck hematoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Transient Horner's syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Transient dysphonia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiac arrhythmias",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pneumothorax",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Perforation of the liver capsule",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fistulas between hepatic vein, hepatic artery, portal vein and/or biliary system",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemoperitoneum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatic hematoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemobilia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatic vein thrombosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inadvertent biopsy of an adjacent organ",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Death",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_2_16427=[""].join("\n");
var outline_f16_2_16427=null;
var title_f16_2_16428="B virus postexposure ppx";
var content_f16_2_16428=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F55170&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F55170&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommendations for postexposure prophylaxis for persons exposed to B virus",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Prophylaxis recommended",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Skin exposure* (with loss of skin integrity) or mucosal exposure (with or without injury) to a high-risk source (eg, a macaque that is ill, immunocompromised, or known to be shedding virus or that has lesions compatible with B virus disease)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inadequately cleaned skin exposure (with loss of skin integrity) or mucosal exposure (with or without injury)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Laceration of the head, neck, or torso",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Deep puncture bite",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Needlestick associated with tissue or fluid from the nervous system, lesions suspicious for B virus, eyelids, or mucosa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Puncture or laceration after exposure to objects (a) contaminated either with fluid from monkey oral or genital lesions or with nervous system tissues, or (b) known to contain B virus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A postcleansing culture is positive for B virus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Prophylaxis considered",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mucosal splash that has been adequately cleaned",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Laceration (with loss of skin integrity) that has been adequately cleaned",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Needlestick involving blood from an ill or immunocompromised macaque",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Puncture or laceration occurring after exposure to (a) objects contaminated with body fluid (other than that from a lesion), or (b) potentially infected cell culture",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Prophylaxis not recommended",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Skin exposure in which the skin remains intact",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Exposure associated with nonmacaque species of nonhuman primates",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Exposures include macaque bites; macaque scratches; or contact with ocular, oral, or genital secretions, nervous system tissue, or material contaminated by macaques (eg, cages or equipment).",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Cohen, JI, Davenport, DS, Stewart, JA, et al. Recommendations for Prevention of and Therapy for Exposure to B Virus (Cercopithecine Herpesvirus 1). Clin Infect Dis 2002; 35:1191. Copyright &copy; 2002 University of Chicago Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_2_16428=[""].join("\n");
var outline_f16_2_16428=null;
var title_f16_2_16429="Etiology of microcephaly";
var content_f16_2_16429=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F75479&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F75479&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Selected causes of microcephaly",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Isolated microcephaly (true microcephaly, microcephaly vera)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Autosomal recessive (eg, autosomal recessive primary microcephaly types 1 through 6, Amish lethal microcephaly",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Autosomal dominant",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            X-linked microcephaly",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Chromosomal abnormalities and syndromes",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Trisomies (eg, 21, 18, 13)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Monosomy 1p36 deletion",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Seckel syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Smith-Lemli-Opitz syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Williams syndrome (7q11.23 deletion)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cornelia de Lange syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Miller-Dieker syndrome (17p13.3 deletion)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Wolf-Hirschhorn syndrome (4p deletion)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cri-du-chat syndrome (5p15.2 deletion)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Mowat-Wilson syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Rubinstein-Taybi syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pseudo-TORCH syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cockayne syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Bloom syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Angelman syndrome",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Neuroanatomic abnormalities",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Neural tube defects (eg, anencephaly, hydranencephaly, encephalocele)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Holoprosencephaly",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Atelencephaly (aprosencephaly)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lissencephaly",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Schizencephaly",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Polymicrogyria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pachygyria (macrogyria)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Fetal brain disruption sequence",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Metabolic disorders",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Maternal diabetes mellitus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Untreated maternal phenylketonuria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Phenylketonuria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Methylmalonic aciduria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Citrullinemia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Neuronal ceroid lipofuscinosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Environmental causes",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Congenital infection (eg, cytomegalovirus, herpes simplex virus, rubella, varicella, toxoplasmosis, human immunodeficiency virus, syphilis, enterovirus)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Meningitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            In utero drug or toxin exposure (eg, alcohol, tobacco, marijuana, cocaine, heroin, antineoplastic agents, antiepileptic agents, radiation, toluene)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Perinatal insult (eg, hypogycemia, hypothyroidims, hypopituitarism, hypoadrenocorticism)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Anoxia/ischemia",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     <p>",
"      &nbsp;",
"     </p>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_2_16429=[""].join("\n");
var outline_f16_2_16429=null;
var title_f16_2_16430="EST v TIPS variceal rebleed";
var content_f16_2_16430=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F52679&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F52679&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 505px\">",
"   <div class=\"ttl\">",
"    Variceal rebleeding rate with TIPS versus esophageal sclerotherapy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 485px; height: 284px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Effects of endoscopic sclerotherapy (EST) and transjugular intrahepatic portosystemic shunt (TIPS) on variceal rebleeding rates in published clinical trials of secondary prevention of variceal hemorrhage. All but the last trial showed a significantly lower rate of rebleeding with TIPS.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from:&nbsp;",
"     <ol>",
"      <li>",
"       Jalan R, et al. Hepatology 1997; 26:1115.",
"      </li>",
"      <li>",
"       Rossle M, et al. Lancet 1997; 349:1043.",
"      </li>",
"      <li>",
"       Merli M, et al. Hepatology 1998; 27:48.",
"      </li>",
"      <li>",
"       Cello JP, et al. Ann Intern Med 1997; 126:858.",
"      </li>",
"      <li>",
"       Cabrera J, et al. Gastroenterology 1996; 110:832.",
"      </li>",
"      <li>",
"       Sanyal AJ, et al. Ann Intern Med 1997; 126:849.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_2_16430=[""].join("\n");
var outline_f16_2_16430=null;
var title_f16_2_16431="Serial WBC after radiation";
var content_f16_2_16431=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F65095&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F65095&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 550px\">",
"   <div class=\"ttl\">",
"    Leukocyte counts in Chernobyl accident victims",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 530px; height: 329px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This graph shows serial changes in the total white blood cell count (WBC, vertical axis) as a function of the time following radiation exposure (days, weeks; horizontal axis) for victims of the Chernobyl reactor accident. The data are separated into five groups, with exposures ranging from 1.0 to &gt;5 Gy. Because of the profound radiation-induced lymphocytopenia at these doses, the total WBC counts shown here are almost entirely composed of neutrophils. Note that the time of the initial WBC nadir at 7 to 9 days post-exposure (shown in orange) is similar in all five exposure groups. This is followed by a transient (\"abortive\") rise, shown by the (*) symbol, in those groups receiving a dose of 5 Gy (500 rads) or less. A period of profound leukopenia/neutropenia follows this abortive rise, which may be delayed for up to 5 weeks in those with lower exposures (eg, 2 Gy). At the higher exposures (eg, &ge;5 Gy), profound neutropenia may last for several weeks before recovery ensues.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Vorobiev, AI. Acute radiation disease and biological dosimetry in 1993. Stem Cells 1997; 15:269. Copyright &copy; 1997 AlphaMed Press.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.StemCells.com\">",
"      file://www.StemCells.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_2_16431=[""].join("\n");
var outline_f16_2_16431=null;
